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ABSTRACT 
 
Advancements in the fields of tissue engineering, biomaterials, additive manufacturing, 
synthetic and systems biology, data acquisition, and nanotechnology have provided 21st-century 
biomedical engineers with an extensive toolbox of techniques, materials, and resources. These 
“building blocks” could include biological materials (such as cells, tissues, and proteins), 
biomaterials (bio-inert, -instructive, -compatible, or -degradable), soluble factors (growth factors 
or small molecules), and external signals (electrical, chemical, or mechanical). “Forward 
engineering” attempts to integrate these building blocks in different ways to yield novel systems 
and machines that, by promoting new relationships and interactions among their individual 
components, are greater than the sum of their parts. Drawing from an extensive reserve of parts 
and specifications, these bio-integrated forward-engineered cellular machines and systems could 
acquire the ability to sense, process signals, and produce force, and could also contain a 
countless array of applications in drug screening and delivery, programmable tissue engineering, 
and biomimetic machine design. 
An intuitive demonstration of a biological machine is one that can produce motion in 
response to controllable external signaling. In contrast to traditional machines that use external 
energy to produce an output, muscle cells can be fueled by glucose and other biomolecules. 
While cardiac cell driven biological actuators have been demonstrated, the requirements of these 
machines to respond to stimuli and exhibit controlled movement merit the use of skeletal muscle, 
the primary generator of actuation in animals, as a contractile power source. Here, we report the 
development of 3D printed hydrogel “bio-bots” powered by the actuation of an engineered 
mammalian skeletal muscle strip to result in net locomotion of the bio-bot upon applied electrical 
stimulation. The muscle strips were composed of differentiated skeletal myofibers in a matrix of 
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natural proteins, including fibrin, that provide physical support and cues to the cells as an 
engineered basement membrane. The hierarchical organization, modularity, and scalable nature 
of mature skeletal muscle fibers (which can be combined in parallel to increase force production, 
for example), lends itself to “building with biology.” 
Few systems have shown net movement from an autonomous, freestanding biological 
machine composed of skeletal muscle, and even fewer have attempted to incorporate multiple 
cell types for greater functionality. Modular and flexible platforms for fabrication of such multi-
cellular modules and their characterization have been lacking. We also present a modular 
heterotypic cellular system, made up of multi-layered tissue rings containing integrated skeletal 
muscle and motor neurons embedded in an extracellular matrix. Site-specific innervation of a 
group of muscle fibers in the multi-layered tissue rings allowed for muscle contraction via 
chemical stimulation of motor neurons with glutamate, a major excitatory mammalian 
neurotransmitter, with the frequency of contraction increasing with glutamate concentration. The 
addition of the nicotinic receptor antagonist tubocurarine chloride halted the contractions, 
indicating that muscle contraction was motor neuron-induced. We also present a thorough 
characterization and optimization of a co-culture system that harnesses the potential of 
engineered skeletal muscle tissue as the actuating component in a biological machine through the 
incorporation of motor neurons, and creates an environment that is amenable to both cell types 
and prime for functional neuromuscular formation. 
With a bio-fabricated system permitting controllable mechanical and geometric attributes 
on a range of length scales, our novel engineered cellular system can be utilized for easier 
integration of other modular “building blocks” in living cellular and biological machines. We are 
poised to design the next generation of complex biological machines with controllable function, 
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specific life expectancy, and greater consistency. In the future, we envision that this system can 
be used for applications beyond bio-robotics and muscular actuators; as a functioning heterotypic 
co-culture, the muscle- neuron arrangement is also a highly relevant machine for the study of 
neuromuscular diseases and related drug toxicity studies. These results could prove useful for the 
study of disease-specific models, treatments of myopathies such as muscular dystrophy, and 
tissue engineering applications. 
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CHAPTER 1: INTRODUCTION AND LITERATURE 
REVIEW 
 
1.1 Motivation 
 “The scientist describes what is; the engineer creates what never was.” 
- Theodore von Kármán 
 
The work presented in this Thesis exemplifies the above quotation. The task of an 
engineer is not insignificant: to merge scientific discoveries and conclusions with new ideas and 
innovative methods of integration, for problem solving and the benefit of society – and, in the 
field of biomedical engineering, provide some substantial advancement to human health, 
medicine, and biology. While the quest to uncover the natural world for the sake of 
understanding is truly a significant responsibility (and necessary for the progression of science 
and technology), it is equally important to use that understanding to generate anew.  
Advancements in the fields of tissue engineering, biomaterials, additive manufacturing, 
synthetic and systems biology, data acquisition, and nanotechnology have provided 21st-century 
biomedical engineers with an extensive toolbox of techniques, materials, and resources. These 
“building blocks” could include biological materials (such as cells, tissues, and proteins), 
biomaterials (bio-inert, -instructive, -compatible, or -degradable), soluble factors (growth factors 
or small molecules), and external signals (electrical, chemical, or mechanical). The study of the 
natural world affords an opportunity to use these building blocks to reconstruct that which 
already exists but perhaps has been damaged, injured, or needs replacement (e.g., functional 
tissues or organs), and is referred to as “tissue engineering” or “reverse engineering.” Tissue 
engineering typically combines cells, growth factors, and other molecules in a biocompatible 
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matrix or scaffold system that offers physical and biochemical support1. Its importance cannot 
(and should not) be understated for its value in improving life expectancy and quality of life, 
curing disease, and advancing scientific understanding; a brief overview is presented later in this 
chapter. However, this Thesis is focused on the development of a contrasting principle. “Forward 
engineering” attempts to integrate these building blocks from a vast library of parts or 
specifications2. Integrating these parts in different ways yields novel systems and machines that, 
by promoting new relationships and interactions among their individual components, are greater 
than the sum of their parts. These bio-integrated forward-engineered cellular machines and 
systems could have a countless array of applications in drug screening and delivery, 
programmable tissue engineering, and biomimetic machine design. By drawing from an 
extensive reserve of biological building blocks, we have the potential to restructure the way a 
problem is resolved, investigate bioengineered solutions while utilizing less energy and waste, 
design machines that outperform their organic counterparts and can more efficiently complete 
specific programmed tasks, construct a new scientific disciple, and to create “what never was.” 
 
1.2 Thesis Overview 
The basic aims of most biological machines would likely include some combination of 
force production, locomotion, sensing, processing, signaling, and long-term maintenance. In 
contrast to traditional machines that use external energy to produce an output, muscle cells can 
be fueled by glucose and other biomolecules. Our focus has been on the development of bio-
integrated living machines and cellular systems that could produce force and net motion in 
response to a stimulus; thus, the basic power source is composed of contractile skeletal muscle. 
Unlike cardiac tissue, it does not spontaneously contract, thus providing more control, and can be 
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combined in three dimensions (3D) to produce modular and hierarchical structures with 
increased strength and regulation3. 
In Chapters 2 and 3, we introduce the development of biological machines powered by 
skeletal muscle. C2C12 myoblasts were combined with extracellular matrix (ECM) proteins to 
form a solid muscle strip, which was coupled to a 3D printed hydrogel skeleton. Upon applied 
electrical stimulation, the differentiated myotubes contracted synchronously, deforming the 
asymmetric hydrogel and producing net motion. We also studied the effect of altering various 
mechanical cues, such as backbone stiffness, which could be modified using the enabling 
technology of stereolithographic 3D printing. Despite the addition of a proteolytic inhibitor that 
slowed the breakdown of fibrin, the ECM proteins were still susceptible to hydrolysis by cell-
secreted enzymes. Eventual breakdown of the proteins in the muscle strip diminished their 
supportive capacity, leading to rupture and eventual device failure. We used gelatin zymography 
to study the activity of cell-secreted and cell-associated enzymes such as cathepsin L, matrix 
metalloproteinases (MMP)-2, and MMP-9. 
In Chapters 4 and 5, we demonstrate the integration of skeletal muscle with motor 
neurons (MNs) in order to create a heterotypic cellular system on 3D printed biological machines. 
MNs were differentiated from mouse embryonic stem cells (HBG3 mESCs) through the 
formation of embryoid bodies (EBs), and then assimilated with a mature skeletal muscle tissue 
ring that had been differentiated in parallel. We examined and characterized the development of 
motor neurons, potential for innervation, co-culture conditions, and applied chemical stimulation 
of MNs to produce muscle contraction.  
In Chapter 6, we discuss potential future directions, including subsequent work to 
engineer controllable life expectancies for skeletal muscle bio-bots, further advancements to the 
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neuromuscular bio-bots in order to generate autonomous locomotive machines powered by 
chemical or optical stimulation, a neuromuscular tissue-on-a-chip platform for drug screening, 
and the incorporation of additional cell types for greater functionality (Figure 1.1). 
 
1.3 Literature Review 
1.3.1 Skeletal Muscle Development and Physiology 
Skeletal muscle is the only type of voluntary muscle in the human body and can comprise 
up to 50% of adult human mass. Without it, all movement, locomotion, and even respiration 
would be impossible for the human body4,5. Adult skeletal muscle connects to the skeleton via 
tendons and is aligned longitudinally in a modular hierarchy, the foundation of which are single 
fibrils that fuse together to form fibers and fascicles6 (Figure 1.2a-b). The relationship between 
structure and function is preserved over this wide range of length scales, which also accounts for 
the span of observed forces, frequencies, and dimensions of skeletal muscle7. 
During embryogenesis, progenitor cells in the vertebrate limb proliferate extensively and 
begin to express deterministic myogenic factors before fully differentiating into mature skeletal 
muscle8. These myoblast precursor cells withdraw from the cell cycle and fuse during the 
process of myogenic differentiation, producing multi-nucleated myotubes (or myofibers, ranging 
from 10-100 µm) that share one cytoplasm and express muscle-specific genes9. Quiescent 
progenitor cells can also be recruited from the basal lamina in the event of adult muscle injury or 
other stimulation; they can then proliferate, differentiate, and fuse with other myofibers6,10. 
In vivo, three layers of connective tissue surround and protect skeletal muscle from 
physical damage and stress. The endomysium surrounds individual myofibers, the perimysium 
encompasses the fascicles, and the epimysium surrounds the entire muscle4,11 (Figure 1.2c-d). 
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The basement membrane (or basal lamina) of skeletal muscle is critical in providing necessary 
elasticity and structural support, sequestering myogenic growth factors for development, 
preserving an electrolytic balance, and maintaining neuromuscular junctions (NMJs). Containing 
laminin-2, collagen IV, and proteoglycans in abundance, its formation is initiated by fibroblasts, 
which can also play a role in maturation and support. After damage, injury, or excessive exercise, 
the basal lamina can play an important role in the repair of muscle fibers5,12. 
At the sub-cellular level, the sarcomeric organization of actin and myosin produces 
myofibrils’ striated structure (Figure 1.3a). Their binding shortens the sarcomere and ultimately 
produces muscle contraction (“sliding filament theory”). As the muscle cell is depolarized, an 
action potential travels along the myofiber membrane (termed “excitation-contraction coupling”). 
The action potential along a muscle fiber is originally of neural origin. Each muscle fiber is 
innervated at an NMJ by a single motor neuron (MN), and a motor unit coupled to the 
downstream myofibers is termed a “motor unit”13 (Figure 1.3b). When a MN is stimulated by an 
excitatory neurotransmitter, an action potential travels through the cell. This prompts 
neurotransmitter-containing vesicles to fuse to the cell membrane and release their contents into 
the extracellular space between the MN and muscle cell. When the neurotransmitter 
acetylcholine (ACh) is released, it diffuses across the unidirectional synaptic cleft and binds to a 
specific receptor on the muscle membrane (AChR; Figure 1.3c). A neurotransmitter can 
depolarize the cell on which it acts, thus increasing that cell’s excitability and heightening the 
probability of the muscle cell firing an action potential. When the action potential reaches a T-
tubule, an intracellular signaling cascade results in the eventual release of calcium ions (key 
regulators of muscle contraction and force production) from the sarcoplasmic reticulum. Ca2+ 
increases in intracellular concentration and binds to troponin C. This shifts the tropomyosin 
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molecule away from myosin’s binding site on actin, which otherwise prevents myosin binding 
and thus contraction. Eventually, the neurotransmitter is cleared from the synaptic cleft4,14–16. 
 
1.3.2 3D Tissue Engineering of Skeletal Muscle  
Due to the limited capacity of skeletal muscle to self-regenerate, in addition to 
therapeutic strategies that fail to overcome the high survival rate of transplanted cells and donor 
site morbidity, tissue engineering of skeletal muscle is a significant strategy for the regeneration 
or replacement of pathologically damaged tissue due to injury or myopathies. Collagen I and 
fibrin are natural ECM hydrogels that provide an environment supporting cell proliferation, 
alignment, and tissue contraction on a macroscopic scale. Consequently, these proteins have 
been used abundantly in skeletal muscle engineering as a natural mimic to the native basal 
lamina by helping to maintain processes that are imperative in the normal development of 
skeletal cells17,18. However, the volume fraction of myofibers is large compared to that of ECM, 
and an engineered muscle tissue containing excess ECM material could hinder myotube 
formation and restrict force output19. Another important consideration is the proteolysis of ECM 
proteins by cell-secreted proteases, which are enzymes that hydrolyze the peptide bonds between 
amino acids. Proteases are synthesized in latent pre-enzymatic (pro-peptide) forms and require 
activation (pH change for cathepsins, NH2 peptide cleavage for MMPs)20,21. 
Despite these limitations, many groups have successfully designed and fabricated 
cylindrically shaped engineered skeletal muscle constructs, supported or tethered by fabricated 
artificial tendons. 3D culture models more closely mimic a physiological muscle arrangement, 
allow for more accurate force measurements, and (when supported by a relevant ECM) favor 
myogenic development. Huang et al first demonstrated a novel technique to create 3D tubules of 
 7 
fibrin gel and primary myoblasts. The cell-matrix solution contracted around a pair of suture 
posts separated by 12 mm in a polydimethylsiloxane (PDMS)-coated dish. After three weeks in 
culture, the tissue constructs demonstrated maximal tetanic contraction of 800 µN with applied 
electrical stimulation. The group also investigated the addition of insulin-like growth factor 
(IGF), and reported length-time and force-frequency relationships on the same order of those of 
native muscle19. 
Bian, Bursac, and associates developed a PDMS array of micro-molded hexagonal posts 
around which were seeded skeletal muscle cells in a mixture of collagen and fibrin, both natural 
hydrogels. Dense cell-matrix networks formed in a spatially controlled manner around the 
“microfabricated tissue pores,” which helped to guide cellular organization and alignment while 
promoting endorsed diffusion of nutrients and oxygen. Muscle tissue morphology, arrangement, 
and complexity could be altered by simply changing the PDMS post architecture and relative 
position22,23. The system was further utilized to examine the effects of pore length and geometry 
on engineered tissue alignment, maturation, and contraction. This customizable setup 
demonstrated that the researchers could yield global changes in functional muscle tissue output 
from local modifications to tissue architecture24. 
Li et al. developed engineered muscle tissue from primary mouse myoblasts and 
embryonic fibroblasts (MEFs) in various ratios to examine the impact of fibroblasts in skeletal 
muscle self-assembly. The cells were allowed to self-organize into muscle tissue constructs on 
3D gels composed of laminin and fibrin. Tension forces generated from both the spontaneous 
contraction of the muscle strip and the polymerized fibrin gel resulted in an aligned, 
physiological fascicle-like structure after 10 days of differentiation. Co-culture with MEFs in a 
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1:1 ratio resulted in a significant increase in the viability, size, and number of myotubes; 
fibroblasts are known to play a role in the secretion of myogenic growth factors6. 
Though numerous groups have demonstrated the use of primary myoblasts in 3D skeletal 
muscle constructs, the use of the C2C12 myoblast cell line has broadly gained popularity in 
parallel. Many have argued that because C2C12s express myogenic markers on a timeline that is 
nearly analogous to that observed in vivo, their maturation and differentiation is comparable to 
primary cells; consequently, they provide an acceptable (and simpler) model for in vitro studies25. 
Khodabukus and Baar also used fibrin as a supportive matrix material for muscle tissue 
engineered with C2C12s, hypothesizing that its mechanical properties and stiffness (which 
emulated that of native tissue) would permit more accurate functional testing of engineered 
skeletal muscle tissue. Variations in C2C12 clones, serum batch, and serum content all 
significantly affected maximal force production. The addition of NIH/3T3 fibroblasts helped to 
eliminate the observed force deficit of the muscle constructs, but decreased overall specific force. 
Despite repeated testing for weeks, output forces remained in the range of 100-200 µN11. 
A study by Hinds and colleagues probed the influence on formation and contractile force 
of engineered skeletal muscle constructs that was held by ECM composition and density. Muscle 
bundles were formed by combining primary skeletal myoblasts in a gel solution of collagen, 
MatrigelTM, and fibrin of varying concentrations. Researchers found that while the choice of 
ECM protein influenced the degree of compaction and passive tension, it did not significantly 
affect cellular organization or spontaneous muscle bundle contraction. Ultimately, they 
determined that fibrin-based muscle bundles (optimally containing 4 mg ml-1 fibrinogen and 40% 
MatrigelTM) exhibited larger myotube diameters, further mechanical integrity, and contractile 
forces up to three times greater than collagen I-based muscle bundles17. 
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Sakar and colleagues developed a “skeletal muscle on a chip” using a suspension of 
C2C12 myoblasts, MatrigelTM, and collagen I. The matrix compacted longitudinally around two 
cantilevers, which anchored the tissue as artificial tendons while providing simultaneous force 
measurement. C2C12s were transfected with a plasmid to express an optogenetic ion channel, 
channelrhodopsin-2 (ChR2)26,27, which can trigger cellular contraction by depolarizing the cell in 
response to blue light exposure. Stimulation of individual myofibers allowed for selective, 
localized contraction and pillar movement3. 
 
1.3.3 Fibrin as a Biomaterial 
Fibrin is a natural hydrogel displaying a 3D branching fiber network (Figure 1.4a). 
When fibrinogen (a glycoprotein containing polypeptide chains) is cleaved by the proteolytic 
enzyme thrombin, fibrinopeptides that normally prevent spontaneous polymerization are 
removed from the molecule. This exposes specific binding sites, allowing for subsequent 
aggregation of fibrin protofibrils in a half-staggered arrangement. These monomers can then 
polymerize into staggered two-stranded protofibrils, and then into twisted fibers that branch into 
a 3D network (Figure 1.4b-c). This branching is responsible for fibrin’s role as a space-filling 
hydrogel material28–31. 
When compared to other natural ECM hydrogels, fibrin boasts many characteristics that 
make it advantageous for tissue engineering and drug delivery applications: it polymerizes more 
quickly than collagen or laminin and has a gelation time that can be precisely regulated32; it has a 
high water content and degree of biodegradability, thus supporting many cell processes; it 
displays a similar structure both in vivo and in vitro33; its filaments are softer in elastic modulus 
(within 1.5-10 MPa) and can undergo larger deformations before breaking (up to 120% strain)34; 
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and individual fibers comprise a low volume fraction35. Its viscoelastic properties (merging those 
of elastic solids and viscous liquids) and mechanical attributes are closely linked to its intrinsic 
function in blood clotting28,36, and also provide benefits for use as a scaffold material for the 
engineering of cartilage, nerve, and muscle tissue32. Moreover, fibrin displays two RGD (Arg-
Gly-Asp) sites that promote binding to cellular integrins, cadherins, proteins, and growth 
factors29,37. Due of its wide range of capabilities, fibrin gels have been used in almost every 
tissue engineering application over the past decade and a half: hydrogel carrier for lentiviral gene 
delivery systems33,38; scaffolds to deliver mesenchymal stem cells to wound sites39; an 
engineered ocular surface40; an “injectable” liver designed to transfer immobilized hepatocytes41; 
a bioengineered cardiac heart muscle42; a millimeter-scale vascular graft containing arterial-
derived cells; and an engineered aortic heart valve43,44, among others. 
Not surprisingly, fibrin has also been used extensively in skeletal muscle tissue 
engineering. Huang et al used fibrin as a supportive matrix in their presentation of 3D engineered 
muscle constructs; they claimed not only that it allowed for increased cell migration and 
proliferation, but also was degraded as cells began to produce their own ECM proteins, and that 
it could bind to select myogenic growth factors19. More recently, Chiron and colleagues 
extensively characterized the interaction between human myocytes and fibrin matrix proteins in a 
physiologically relevant 3D culture model. Embedded myoblasts (and actin stress fibers) became 
oriented along the gel axis on the first day after polymerization, relative to the direction of 
tension provided by silicone structures, and remained aligned as they differentiated into 
myofibers. (In contrast, myotubes on 2D substrates are often randomly aligned.) The gel’s elastic 
modulus (measured in a similar range as that of native skeletal tissue) increased with muscular 
differentiation, demonstrating the significant implications of microenvironment and substrate 
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elasticity on cellular organization and fate45. Previously, Engler et al had confirmed that 
sarcomere formation was dependent on substrate stiffness being nearly equal to that of 
physiological tissue46. 
Fibrin has also been used for skeletal muscle regeneration strategies. Beier et al 
demonstrated a therapeutic approach of creating an injectable cell-matrix solution of fibrin and 
myoblasts to add to a muscle fiber defect47. Gerard et al encapsulated myoblasts in a gel as a 
transplantation method for dystrophin restoration in cases of Duchenne Muscular Dystrophy, 
noting that lower concentrations proved more effective for metabolic activity, cellular survival, 
and dystrophin expression10. 
 
1.3.4 Three-Dimensional Stereolithography 
Stereolithography is a rapid prototyping technology that uses a light source to rapidly 
polymerize a liquid resin into a solid material. The solid part is built from a computer design in 
an additive, layer-by-layer fashion. Since its commercialization in the mid-1980s, 
stereolithography has been used for a wide range of applications on different size scales48. 
Though a range of other rapid prototyping techniques exist (solid-based fused deposition 
modeling, liquid-based two-photon polymerization, or powder-based selective laser sintering, for 
example), and are favored compared to traditional methods of casting or molding, 
stereolithography offers a relative ease of printing iterations, lower fabrication cost and cycle 
time, a short time frame from idea conception to a resulting physical part, and the ability to 
rapidly print a wide range of bio-compatible materials48. 
Basic solid freeform fabrication using a stereolithography apparatus (SLA) includes five 
steps: (1) a computer-aided design (CAD or equivalent); (2) conversion into a standard 
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tessellation language (.stl) file; (3) horizontal slicing into parallel layers; (4) input of 
polymerization specifications (e.g., layer thickness, cure depth, etc.); and (5) building. During 
the last step, a laser beam (of liquid, solid, or gaseous form) focused at the resin surface is 
directed to trace a 2D pattern. The liquid resin solidifies rapidly upon exposure to light, 
presuming that the material has absorbed adequate energy to make up for the difference between 
ground and excited states. Reactive species are then produced, and chemical cross-linking of the 
polymer occurs. After polymerization of this first layer to a certain depth, the build platform is 
layered, the resin is re-coated (manually or automatically), and the second layer is polymerized 
in a similar fashion. The additive process of polymerizing a series of 2D layers yields a 3D 
solid48–51 (Figure 1.5). 
When a photoinitiator (PI) in the pre-polymer solution reacts with photons from the light 
source, catalytic free radicals are produced. They propagate through the material and chemically 
link individual monomers into polymeric chains. Polymer surface tension and reactiveness, the 
speed of the scanning mirrors, and laser power and wavelength can all impact polymerization 
speed50. The laser beam diameter dictates the feature size, which is traditionally ~250 µm but has 
been demonstrated as low as 75 µm in higher resolution systems. The laser scans the resin 
surface; thus, the horizontal resolution is equal to about half the beam width49,52,53. 
Stereolithography has been used considerably for biomedical applications (from surgical 
modeling54 to bone reconstruction, replacement of articular joints, nerve guidance channels, and 
customized implants48,55), with the end application dictating the material choice. Scaffolds 
printed for tissue engineering require eventual degradation, whereas materials printed for use in 
bone defects, vascular stents, and dental implants need to maintain structural integrity over time. 
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Finally, depending on the material, storage of the fabricated object in a solvent can result in 
significant swelling51. 
In the realm of tissue engineering, stereolithography offers significant advantages. The 
rapid fabrication and easily modified parameters offered by this 3D printing technique allow the 
user to quickly polymerize a wide range of bio-compatible materials with varying mechanical 
properties, geometric features, and degradability51. Dhariwala et al were the first to demonstrate 
successful cell encapsulation using SLA technology, using poly(ethylene oxide) (PEO) and 
poly(ethylene glycol) dimethacrylate (PEGDMA) hydrogels mixed with Chinese hamster ovary 
(CHO-B2) cells56. Others soon followed, establishing encapsulation methods for cell types such 
as marrow stromal cells and fibroblasts, with many cells demonstrating improved post-
fabrication viability with the incorporation of RGD peptide sequences48,57. Arcaute and 
colleagues were the first to polymerize photoreactive PEGDMA (MW 1000) structures containing 
encapsulated cells (dermal fibroblasts). They modified applied energy dose, pre-polymer 
concentrations, and PI concentration to determine optimal conditions for long-term viability. A 
PI concentration lower than 0.5% was recommended for long-term studies with cells53,58. These 
results were furthered with the fabrication of multi-material PEG-based scaffolds that contained 
polymerized bio-active domains for specific cell adhesion (cells will not inherently bind to inert 
PEG hydrogels)59. 
Chan et al polymerized poly(ethylene glycol) diacrylate (PEGDA) hydrogels (MW 700, 
3400, and 5000, representing physiologically relevant stiffness values ranging from 5-500 kPa) 
with encapsulated NIH/3T3 fibroblasts. Increasing the molecular weight increased the hydrogel 
swelling ratio and pore size, but decreased the modulus. Polymerization with PEG MW 3400 
(chemically linked with RGDS [Arg-Gly-Asp-Ser] peptides) yielded the highest relative cell 
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viability after two weeks. Fluorescent labeling of cells also demonstrated the SLA’s multi-layer 
patterning capability60,61. Subsequent studies from this group included encapsulation of C2C12s, 
PC12 neuron-like cells, primary neurons, and adipose-derived stem cells in various materials, 
examining the effect of cellular interaction and spatial organization regulated by the SLA61,62. 
The researchers also printed NIH/3T3 fibroblasts into a “microvascular stamp” of polymerized 
PEGDA-MA (methacrylic alginate) hydrogels. The cells were induced to release pro-angiogenic 
growth factors, which were confined to cylindrical micro-channels within the stamp. The stamp 
was implanted onto the chorioallantoic membrane (CAM) of a chick embryo, and neovessels 
sprouted from preexisting blood vessels according to the pattern of features printed within the 
stamp63. 
 
1.3.5 Engineered Biological Machines 
Biological machines are defined as cellular systems that have the capacity to perform 
work. These machines can exist on length scales ranging from the molecular (e.g., enzyme) to 
organ (e.g., kidney) level. Even an entire organism such the human body, made up of a large 
number of smaller, pre-programmed mechanisms with specific tasks, can be considered a natural 
biological machine. Just as any man-made machine requires an input of energy, a biological 
machine must be powered by electrical, chemical, mechanical, or biological stimuli. Thus, the 
design and formation of engineered biological machines – composed of biological “building 
block” sub-components – must take these limitations into consideration. However, designing a 
living cellular system also provides engineers with the opportunity to capitalize on the innate 
abilities of cells and tissues to self-replicate, organize, migrate, align, regulate gene and protein 
expression, and interact with other living entities2. 
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At the sub-cellular level, work is performed on a molecular level by machines that pump 
or drive fluid motion and the transport of other molecules and ions. Biomolecular motors (such 
as ATPase and kinesin) have been used to carry actin filaments, microtubules, and micro posts 
across a distance; however, their force output is generally limited to a few pN per molecule64–67. 
Moving up in size scale, the combined strength of a few (or sheet of) cells generates greater force 
(nN to µN range), and can be harnessed for actuation or fluid displacement in the absence of an 
exogenous energy source68. Previously published examples have included unicellular 
photosynthetic algae directed by light69, a micro-motor powered by the movement of bacteria 
along a track70, a cardiomyocyte-powered force measurement system that measured the 
displacement of hydrogel micro-pillars71, and a “hybrid cell motor” driven by the contractile 
forces of a few cardiomyocytes72. An engineered machine designed to perform more substantial 
tasks, however, would naturally require the coordinated efforts of a larger number of cells. Thus, 
many recent biological machines have been driven by a cluster or sheet of cells (Figure 1.6). 
The many positive attributes of muscle tissue render it an obvious choice for a higher-
order biological machine that, at the very least, would be expected to produce a force. Muscle 
cells have the ability to instinctively respond to environmental forces and displacements, sense 
and adapt to external cues and stimuli, synchronize their contractile output, perform almost 
silently while producing biodegradable waste, and yield a greater force of contraction than any 
other cell type – all on range of length scales73–75. A number of engineered muscle-powered bio-
actuators evolved from constrained or tethered structures to freestanding devices capable of net 
locomotion. Xi et al seeded cardiac cells over a microelectromechanical system (MEMS) 
cantilever device integrated with a sacrificial thermally responsive polymer. The components 
‘self-assembled’ and were guided by the system’s surface chemistry to create a functional system. 
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Cantilevers of varying length were used to analyze the cardiac cells’ mechanical properties as 
they displaced the beams during contraction. The devices could also be released and were 
powered by the muscle bundle, which bent the MEMS-based thin film backbone upon 
contraction76 (Figure 1.7a). Feinberg et al pioneered centimeter-scale PDMS-based “bio-hybrid 
muscular thin films” that harnessed and released energy from the material’s unique structure-
function relationship, as well as its geometric and mechanical properties. The 2D films 
spontaneously adopted a specific 3D conformation depending on PDMS stiffness, thickness, and 
temperature. A walking “myopod” was seeded with cardiomyocytes and programmed to move 
upon applied electrical stimulation of the cells7 (Figure 1.7b). Kim et al produced a “crab-like 
micro-robot” that contained three PDMS legs extending from a central body that contained 
contractile cardiomyocytes. The backbone surface was grooved and functionalized with 
fibronectin, allowing for an increased cardiac output. The geometric asymmetry inherent in the 
varying leg lengths allowed for net motion at 100 µm sec-1, on average77. Finally, Chan and 
colleagues pioneered a biological actuator manufactured with a simple and flexible 
stereolithographic fabrication technique. Building on previous work that established the use of 
3D printing to create a stationary, multi-material PEG-based cantilever, researchers developed a 
millimeter-scale “bio-bot” that achieved net motion upon a surface in fluid. Cardiomyocytes 
were seeded in a sheet on top of the cantilever, and contracted spontaneously and synchronously 
to induce a power stroke, propelling the bio-bot forward with a velocity of approximately 2 body 
lengths (BL) per minute78 (Figure 1.7c). 
Lastly, when considering the biological environment present in the human body, it is 
likely that the type of task that a biological machine might be programmed to perform would 
require the net movement of itself or the surrounding fluid – much as a swimming organism or a 
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heart valve could do. Tung and colleagues employed flagellar motors tethered to magnetic 
micro-beads and copper coils to create a microfluidic pump. Rotation of the tethered cells 
generated AC power and produced a “fluidic conveyor belt” to move liquid across a channel79. A 
variety of bio-actuating pumps have used sheets of cardiomyocytes, which contract in synchrony 
to produce force. Tanaka et al designed a “pump on a microchip” in which pulsation of a cardiac 
cell sheet produced oscillatory fluid motion inside of a micro-channel80. The researchers 
expanded this concept to create a micro-heart pump by constructing a cardiomyocyte cell sheet 
around a hollow elastic sphere containing inlet and outlet ports. The beating of the contracting 
cells produced oscillatory capillary fluid motion in the culture medium without an external 
electrical or wired source81. 
Feinberg’s PDMS-based thin films also displayed different movement characteristics 
pertinent to fluid movement (pumping, rotation, swimming) based on cyclic contraction cycles of 
cardiomyocytes on their surfaces7. Nawroth, Feinberg, Parker and colleagues later used a similar 
concept (the beating of cardiac cells seeded on a thin film) to reverse engineer a jellyfish-like 
structure (“medusoid”) that operated as a muscle-based pump, reaching maximum velocities of 
0.4-0.7 BL per stroke82 (Figure 1.8a). As an organism, the jellyfish proved to be an ideal model 
for the demonstration of a basic reverse engineered biological machine, as it only requires 
muscle and motor neurons for locomotion. Williams et al fabricated a micro-scale bio-hybrid 
swimming robot that operated at low Reynolds number. A synthetic flagellar swimmer was 
fabricated from a PDMS filament containing a stiff head and a soft tail, onto which 
cardiomyocytes were cultured. Spontaneous cardiac contraction deformed the filament tail and 
propelled the swimmer forward through a fluid. Addition of a second tail significantly increased 
the swimming velocity of the robot83 (Figure 1.8b). Most recently, Park and colleagues designed 
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a 1/10-scale reverse engineered stingray powered by cardiomyocytes that phototactically 
followed an applied light source. The elastomer-metal-muscle layered composite mimicked the 
Leucoraja erinacea animal, with optogenetic cells that responded to spatiotemporal optical 
stimuli producing sufficient contraction to move the robot through the fluid and around 
obstacles84 (Figure 1.8c). 
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1.4 Figures 
 
 
Figure 1.1. Development and Applications of Engineered Biological Machines. Bio-integrated 
forward-engineered cellular machines and systems could have a countless array of applications 
in drug screening and delivery, programmable tissue engineering, and biomimetic machine 
design. 
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Figure 1.2. Physiological Arrangement of Skeletal Muscle. (a) Adult skeletal muscle connects to 
the skeleton via tendons and is aligned longitudinally in a modular hierarchy. (Reproduced from 
Ref16.) (b) The foundation of the skeletal muscle hierarchy are single fibrils that fuse together to 
form fibers and fascicles. The relationship between structure and function is preserved over this 
wide range of length scales. (Reproduced from Ref85.) (c) In vivo, three layers of connective 
tissue surround and protect skeletal muscle from physical damage and stress. (Reproduced from 
Ref12.) (d) Scanning micrograph of the endomysial basal lamina surrounding skeletal muscle 
fibers. (Reproduced from Ref86.) 
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Figure 1.3. Skeletal Muscle Contraction. (a) At the sub-cellular level, the sarcomeric 
organization of actin and myosin produces myofibrils’ striated structure. (b) Each muscle fiber is 
innervated at a neuromuscular junction (NMJ) by a single motor neuron (MN), and a motor unit 
coupled to the downstream myofibers is termed a “motor unit.” (c) When the ACh 
neurotransmitter acetylcholin is released, it diffuses across the unidirectional synaptic cleft and 
binds to a specific receptor on the muscle membrane (AChR). (All images reproduced from 
Ref16.) 
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Figure 1.4. Structure and Polymerization of Fibrin. (a) Fibrin is a natural hydrogel displaying 
3D branching fiber network. (Reproduced from Ref32.) (b) When fibrinogen is cleaved by the 
proteolytic enzyme thrombin, fibrinopeptides that normally prevent spontaneous polymerization 
are removed from the molecule. This exposes specific binding sites, allowing for subsequent 
aggregation of fibrin protofibrils in a half-staggered arrangement. These monomers can then 
polymerize into staggered two-stranded protofibrils, and then into twisted fibers that branch into 
a 3D network. (Reproduced from Ref29.) (c) Fibrin polymerization is oppositely opposed by 
hydrolysis. (Reproduced from Ref29.) 
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Figure 1.5. Stereolithography Process. Basic solid freeform fabrication using a stereolithography 
apparatus (SLA) includes five steps: (1) design of a computer-aided model (CAD or equivalent); 
(2) conversion into a standard tessellation langauge (.stl) file; (3) horizontal slicing into parallel 
layers; (4) input of polymerization specifications (e.g., layer thickness, cure depth, etc.); and (5) 
building. During the last step, a laser beam (of liquid, solid, or gaseous form) focused at the resin 
surface is directed to trace a 2D pattern. The liquid resin solidifies rapidly upon exposure to light, 
presuming that the material has absorbed adequate energy to make up for the difference between 
ground and excited states. Reactive species are then produced, and chemical cross-linking of the 
polymer occurs. After polymerization of this first layer to a certain depth, the build platform is 
layered, the resin is re-coated (manually or automatically), and the second layer is polymerized 
in a similar fashion. (Adapted from Ref48.) 
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Figure 1.6. Length Scales of Muscle-Based Biological Machines. At the sub-cellular level, work 
is performed on a molecular level by machines that pump or drive fluid motion and the transport 
of other molecules and ions. An engineered machine designed to perform more substantial tasks, 
however, would naturally require the coordinated efforts of a larger number of cells. Thus, many 
recent biological machines have been driven by a cluster or sheet of cells. (Reproduced from 
Ref87.) 
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Figure 1.7. Walking Engineered Biological Machines. (a) Xi et al seeded cardiac cells over a 
MEMS cantilever device integrated with a sacrificial thermally responsive polymer. The 
components ‘self-assembled’ and were guided by the system’s surface chemistry to create a 
functional system. Cantilevers of varying length were used to analyze the cardiac cells’ 
mechanical properties as they displaced the beams during contraction. The devices could also be 
released and were powered by the muscle bundle, which bent the MEMS-based thin film 
backbone upon contraction. (Reproduced from Ref76.) (b) Feinberg et al pioneered centimeter-
scale PDMS-based “bio-hybrid muscular thin films” that spontaneously adopted a specific 3D 
conformation depending on PDMS stiffness, thickness, and temperature. A walking “myopod” 
was seeded with cardiomyocytes and programmed to move upon applied electrical stimulation of 
the cells. (Reproduced from Ref7.) (c) Building on previous work that established the use of 3D 
printing to create a stationary, multi-material PEG-based cantilever, Chan and colleagues 
developed a millimeter-scale “bio-bot” that achieved net motion upon a surface in fluid. 
Cardiomyocytes were seeded in a sheet on top of the cantilever, and contracted spontaneously 
and synchronously to induce a power stroke, propelling the bio-bot forward. (Reproduced from 
Ref78.)  
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Figure 1.8. Swimming Engineered Biological Machines. (a) Nawroth and colleagues later used a 
concept similar to the bio-hybrid thin films to reverse engineer a cardiac-powered jellyfish-like 
structure (“medusoid”) that operated as a muscle-based pump, reaching maximum velocities of 
0.4-0.7 BL per stroke. (Reproduced from Ref82.) (b) Williams et al fabricated a synthetic 
flagellar swimmer from a PDMS filament containing a stiff head and a soft tail, onto which 
cardiomyocytes were cultured. Spontaneous cardiac contraction deformed the filament tail and 
propelled the swimmer forward through a fluid. (Reproduced from Ref83.) (c) Park and 
colleagues designed a 1/10-scale reverse engineered stingray powered by cardiomyocytes that 
phototactically followed an applied light source. The elastomer-metal-muscle layered composite 
mimicked the Leucoraja erinacea animal, with optogenetic cells that responded to 
spatiotemporal optical stimuli producing sufficient contraction to move the robot through the 
fluid and around obstacles. (Reproduced from Ref84.) 
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CHAPTER 2: 3D PRINTED ELECTRICALLY PACED 
SKELETAL MUSCLE POWERED BIOLOGICAL 
MACHINES ∗ 
 
2.1 Introduction 
 Soft robotic devices composed of adaptable materials permit deformation, locomotion, 
and control with greater degrees of freedom in a simple, low power, and cost-effective manner 
compared to traditional robotics composed of metallic and rigid structures1–3. Combining 
biological entities such as cells or tissues with soft materials can yield biological machines with 
the ability to dynamically sense and adapt to environmental cues and applied stimuli. A bio-
integrated approach to soft robotics can allow for the realization of biological machines with the 
ability to interface with the environment and other living systems. An intuitive demonstration of 
a biological machine is a system that can generate force resulting in net locomotion. To that end, 
many studies have explored the use of biological components, such as DNA4, swarms of 
bacterial cells5, motile sperm cells6, and contractile muscular tissues excised from living 
organisms7–9 as power sources with the ability to exhibit a dynamic locomotive response across 
length scales10–13.  
Recent advances in cardiac muscle tissue engineering have yielded dense tissues that 
form a syncytium, enabling the coordinated propagation of electrical signals and synchronous 
contraction of engineered muscle14. This advantageous property has helped to produce machines 																																																								
* This chapter has been adapted from the following publication: Caroline Cvetkovic*, Ritu 
Raman*, Vincent Chan, Brian J. Williams, Madeline Tolish, Piyush Bajaj, Mahmut Selman 
Sakar, H. Harry Asada, Taher A, Saif, and Rashid Bashir. “Three-dimensionally printed 
biological machines powered by skeletal muscle.” Proc Natl Acad Sci USA 2014; 111: 10125–
10130. * These authors contributed equally to this work. 
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that include self-assembling microelectromechanical system (MEMS)-based cantilevers15, 2D 
biohybrid “muscular thin films”16, and “crab-like” robots17. These systems were powered by 
applied electric field stimulation or spontaneous contraction of engineered cardiac muscle, which 
have also been utilized as power sources for locomotive machines such as a swimming muscle-
elastomer “jellyfish”18, a self-propelled swimming robot19, and a walking millimeter-scale 
“biological bimorph” cantilever20,21, respectively.  
Though these soft robots have utilized cardiac muscle, it should be noted that skeletal 
muscle is the primary generator of actuation in animals. In vivo, skeletal muscle exhibits 
organized modular tissue architecture on a range of length scales and supports uniaxial force 
production. Unlike cardiac tissue, it does not demonstrate significant spontaneous contractility, 
allowing for more precise control over actuation via external signaling from sources such as 
electrical stimulation, neural signals, or optogenetics22. Furthermore, skeletal muscle can 
interface with multiple other mammalian cell types, such as neurons and endothelial cells, 
making it an ideal platform for producing locomotion in living cellular systems11,12,23.  
 In this paper, we present an untethered locomotive biological machine, or “bio-bot,” 
powered by the contraction of engineered skeletal muscle. The structure of the bio-bot was 
fabricated from a synthetic hydrogel using stereolithographic 3D printing, which boasts a short 
fabrication time, potential for scalability, and spatial control. The use of additive manufacturing 
processes for a myriad of biomedical applications has increased in recent years, owing to the 
user’s ability to rapidly polymerize an assortment of biocompatible materials with controllable 
geometric and mechanical properties at the micro- and macro- scales24. Skeletal muscle 
myoblasts were embedded in a natural ECM of collagen I and fibrin matrix proteins, 
differentiated in the presence of IGF-1 growth factor, and self-assembled into a 3D muscle strip 
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capable of contractility and sufficient force generation to power net locomotion of the bio-bot 
upon electrical signaling (Figure 2.1). To our knowledge, this is the first demonstration of an 
untethered biological machine powered by engineered mammalian skeletal muscle and 
controlled purely via external signaling, and hence represents an important advance in building 
bio-integrated soft robotic devices for a myriad array of applications in sensing and actuation. 
 
2.2 Materials and Methods 
2.2.1 Design and Fabrication of Parts 
Pre-polymer solution for bio-bots consisted of 20% (v/v) poly(ethylene glycol) diacrylate 
of MW 700 g mol-1 (PEGDA MW 700, Sigma-Aldrich) dissolved in phosphate buffered saline 
(PBS), with 0.5% (w/v) 1-[4-(2-hydroxyethoxy)phenyl]-2-hydroxy-2-methyl-1-propanone-1-one 
photoinitiator (Irgacure 2959, BASF) mixed from a 50% (w/v) stock solution in dimethyl 
sulfoxide (DMSO, Fisher Scientific). Material properties and swelling ratio of this polymerized 
hydrogel have been previously characterized25. Pre-polymer solution for holders was made from 
20% (w/v) poly(ethylene glycol) dimethacrylate of MW 1,000 g mol-1 (PEGDMA MW 1,000, 
Polysciences, Inc.) dissolved in PBS and mixed with 0.5% (w/v) Irgacure 2959. 
A commercial Stereolithography Apparatus (SLA, 250/50, 3D Systems) was modified for 
polymerization as previously described20,25. Parts generated using computer-aided design 
software were exported to 3D Lightyear software (v1.4, 3D Systems), which sliced the part into 
layers. For fabrication of bio-bots (Figure 2.2), an 18x18 mm square cover glass was secured to 
the center of a 35-mm culture dish (both with hydrophilic surfaces) before fabrication. For bio-
bot holders, cover glass slides were first treated with 2% (v/v) 3-(trimethoxysilyl)propyl 
methacrylate (3-TPM, Sigma-Aldrich) in 200 proof ethanol (100% EtOH) for 5 min and then 
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washed in 100% EtOH for 3 min, dried, and taped to the bottom of a 35-mm dish. Following 
fabrication, each structure was rinsed in PBS, sterilized in 70% EtOH for 1 h, and allowed to re-
swell in PBS for at least 1 h. 
 
2.2.2 Characterization of Working Curve and Control of Energy Dose  
After the SLA polymerizes the first layer of a part, the stage moves down a distance that 
is equal to the height of the first layer, the surface is re-coated with pre-polymer solution, the 
laser power is recalibrated, and the second layer is polymerized. This “bottom-up” assembly 
process continues until the entire part is built. Because the SLA fabricates a part in multiple steps, 
layers can be produced with different materials or properties. Following a well-characterized 
Working Curve Equation26,27, which quantifies the relationship between maximum exposure 
(polymerization energy) and thickness of the fabricated layer, we varied two parameters that 
control the polymerization energy of the SLA (laser penetration depth into the material and 
critical energy dose needed to polymerize the material from a liquid to a solid gel state) to obtain 
bio-bots with varying beam stiffness and bending profiles.  
The Working Curve Equation is derived from the Beer-Lambert Law, which describes 
the intensity of light’s exponential decay as it travels through an absorbing medium. The 
equation quantifies the relationship between the maximum exposure (Emax), the critical energy 
dose needed to polymerize the material from a liquid to a solid gel state (EC), the thickness or 
cure depth (CD), and the penetration depth (DP) of the laser into the material26. 
𝐶! = 𝐷! ∙ ln 𝐸!"#𝐸!  (Eq.1) 
Cylinders with a radius of 1 cm and a height of 100 µm were fabricated from PEGDA 
MW 700 with 0.2 µm Nile Red fluorescent microbeads (Spherotech) encapsulated in a 1:500 ratio 
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of beads to polymer. Emax was varied from 71 to 512 mJ cm-2 by maintaining a constant EC value 
and changing the input DP value. The thicknesses of the fabricated parts (CD) were measured 
using an inverted fluorescent microscope with a TRITC excitation filter. The beads encapsulated 
in the bottom-most plane of the cylinder were brought into focus and this location was set as zero. 
The focus was then set on the top-most plane of encapsulated beads in the cylinder and this 
change in displacement was recorded as the height of the cylinder. Four parts were fabricated for 
each energy dose and an average height was taken from four points per part. The average 
thickness was plotted against the applied energy dose and a logarithmic trendline was fit to the 
data to create a Working Curve (Figure 2.3a). As described in the text, the energy dose of the 
laser was altered by inputting values of DP and EC in order to polymerize with a certain Emax. The 
hydrogel’s stiffness varied logarithmically with Emax. 
 
2.2.3 Mechanical Testing  
To characterize the mechanical properties of PEGDA MW 700, dogbone-shaped test 
specimens (PEGDA MW 700) were fabricated with the same thickness as that of the beam and 
with energy doses ranging from 105 – 513 mJ cm-2. Specimens were super glued to stainless 
steel bars, then fixed in custom-fabricated structures in a hydrated 37ºC sample chamber filled 
with PBS using custom-fabricated structures subjected to tensile loading (Figure 2.3b). An 
ElectroForce® BioDynamic® test instrument (5100, Bose) with a 1,000 g load cell applied 
uniaxial tension at each end of the structure at 0.05 mm s-1. A video extensometer tracked the 
displacement of four points on the sample until fracture, which was used to calculate elastic 
modulus for different polymerization energy doses. Control software (Wintest) was used to track 
load, displacement, and strain ε. Elastic modulus E (Figure 2.4a) was determined from the linear 
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portion of stress-strain curves according to Hooke’s Law (σ = εE = F/A), assuming a slow strain 
rate. Moduli of energy doses not measured were extrapolated from a best-fit curve curve. Cross-
sectional area was measured with calipers. 
 
2.2.4 Seeding of Collagen- and Fibrin-Based Muscle Strips 
C2C12 murine myoblasts were transfected with pAAV-Cag-Chr2-GFP-2A-Puro plasmid 
to express ChR222. Cells were maintained in growth medium (GM) or differentiation medium 
(DM). GM consisted of Dulbecco’s Modified Eagle Medium with L-glutamine and sodium 
pyruvate (DMEM, Corning Cellgro), supplemented with 10% fetal bovine serum (Lonza), 1% 
penicillin-streptomycin, and 1% L-glutamine (both Cellgro Mediatech, Inc.). Differentiation 
medium (DM) consisted of DMEM supplemented with 10% horse serum (HS, Lonza), 1% 
penicillin-streptomycin, and 1% L-glutamine. 
Before cell seeding, bio-bots were positioned beam-down in polymerized holders in a 35-
mm cell culture dish and aspirated of excess liquid. For collagen muscle strips, an ice-cold cell-
matrix solution of MatrigelTM basement membrane matrix (30% of total cell-matrix volume, BD 
Biosciences), liquid type I collagen (1.4 mg ml-1, BD Biosciences) neutralized with NaOH (0.01 
N), and C2C12s of densities varying from 1 – 10 x 106 cells ml-1 suspended GM (at a volume 
equal to that of collagen) were added to each holder in a total volume of 100 µl. For fibrin 
muscle strips, an ice-cold cell-matrix solution of MatrigelTM (30% of total cell-matrix volume), 
fibrinogen (4 mg ml-1, Sigma-Aldrich), thrombin from bovine plasma (0.5 U mg fibrinogen-1, 
Sigma-Aldrich), and C2C12s suspended in GM at a concentration of 5 x 106 cells ml-1 were 
added to each holder in a total volume of 120 µl unless otherwise specified. After 1 h, 4 ml of 
GM was added. After 24 h, bio-bots were released from holders and switched to DM with anti-
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fibrinolytic 6-aminocaproic acid (ACA) and human insulin-like growth factor-1 (IGF-1, both 
Sigma-Aldrich) as noted. All cells and bio-bots were maintained at 37ºC and 5% CO2, with daily 
media changes. 
 
2.2.5 Study of Compaction Area, Stiffness, and Bending 
To measure the cross-sectional compaction area, holders containing the bio-bots seeded 
with 90 µl of cell-matrix suspension were imaged at 0.8X using a stereoscope with a digital 
microscope camera at 1, 6, 12, and 24 h after cell seeding. The Measure tool in ImageJ was used 
to calculate the cross-sectional area by quantifying the visible compacted area of the cell-matrix 
solution and subtracting the cross-sectional area of the pillars.  
To examine the effects on stiffness and bending, bio-bots structures were polymerized 
with varying energy doses from 109 – 512 mJ cm-2. The cell density was kept constant at 1 x 106 
cells ml-1 and bio-bots were cultured in GM with 10% FBS. Images were acquired daily using a 
stereoscope with a digital microscope camera (Figure 2.4b). 
 
2.2.6 Calculation of Passive Tension and Beam Deflection 
Side-view images of symmetric bio-bots were taken every 24 h using a stereomicroscope 
(MZ FL III, Leica Microsystems) with a digital microscope camera (Flex, SPOT Imaging 
Solutions). Passive tension in the muscle strip at rest was determined using Euler-Bernoulli 
linear beam theory relating deflection of a curved beam to an applied moment. Assuming 
negligible rotation in the beam and a small angle approximation, equating the applied moment M 
to tension P times the moment arm l from the muscle strip to the beam reduced the second-order 
differential equation to 
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𝑑!𝑦𝑑𝑥! =  𝑀𝐸𝐼 (Eq.2) 
where 𝐼  is the moment of inertia of the rectangular cross-section and y is the horizontal 
deflection of the beam. Boundary conditions were applied by assuming zero deflection at ends of 
the beam (L = 0) and maximum deflection δmax at the center (L/2).  
𝛿!"# =  𝑦 𝐿/2  =  𝑀𝐿!8𝐸𝐼 =  𝑃𝑙𝐿!8𝐸𝐼  (Eq.3) 
Beam dimensions, moment arm, and maximum deflection were averaged from 3 measurements 
of each device using the Measure Tool in ImageJ (NIH). Solving for P yielded the relation 
𝑃 =  8𝐸𝐼𝛿!"#𝑙 𝐿!  (Eq.4) 
Stress was calculated by dividing the tension by the muscle strip’s cross-sectional area A, 
determined from transverse H&E sections (Figure 2.4c). To verify the accuracy of the 
calculation method, the computed passive tension values were input into ANSYS (finite element 
software), and the simulation produced values for deflection of the beam. To model bio-bot 
deformation in the passive (bent but unmoving) state, designs was reconstructed using 
SolidWorks and imported into ANSYS. Appropriate material properties were assigned and a 
force equal to the calculated passive tension was applied to the base at a distance specified by the 
measured moment arm. Resultant solutions of total deformation were examined to find 
maximum beam deflection. 
 
2.2.7 Electrical Stimulation Setup 
A custom-designed electrical setup was built as previously described28. The output from a 
waveform generator was amplified through an AD797 inverting amplifier. A capacitor C was 
added in series to minimize electrolysis of the media by converting the square pulse to a biphasic 
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pulse; the system was then treated as an RC circuit (Figure 2.5a). A 35-mm culture dish was 
modified to allow Pt electrodes of diameter 0.762 mm to pass through the lid of the dish28. The 
average resistance of the electrical stimulation medium (DMEM without serum) was calculated 
by measuring the time constant τ from the oscilloscope and dividing by C for each volume at 
23ºC and 37ºC. The conductivity of the medium was measured using a pH/Conductivity meter 
(Orion 4-Star, Thermo Scientific), at 23ºC and 37ºC (Figure 2.5b). During stimulation, the bio-
bot was placed in 4 ml of warm electrical stimulation medium between the positive and ground 
electrodes and a current was applied perpendicular to the long axis, with stimulation frequencies 
up to 10 Hz and never exceeding more than half of the sampling frequency, as per the Nyquist 
criterion. Bio-bots were stimulated with bipolar electrical pulses of 20 V amplitude (21.6 V/cm 
field strength) and 50 ms pulse width. Top-view movies were acquired with a stereomicroscope 
with a digital microscope camera at 9.2 fps. Side-view movies were acquired using a camcorder 
(Handycam DCR-SR65, Sony) at 30 fps. Electrodes were sterilized in 70% EtOH and rinsed 
with PBS between experiments (Figure 2.5c-d). 
 
2.2.8 Characterization of Movement and Force 
An automated Matlab script was designed to track the location of a user-specified feature 
with a normalized 2D cross-correlation and provided X-Y coordinates of a specific point on the 
bio-bot for each frame. This software tracked the distance between the longer and shorter pillar 
caps during stimulation from a top-view movie (Figure 2.6). Frequency was measured by 
manually counting contractions in identical time segments. 
The active stress generated by the muscle strip was computed as a function of the strain 𝜀 𝑡  and strain rate !"(!)!"  observed in the hydrogel beam with viscosity 𝜂.  
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𝜎 𝑡 =  𝐸𝜀 𝑡 +  𝜂 𝑑𝜀(𝑡)𝑑𝑡  (Eq.5) 
The time-varying displacement data was converted into time-varying strain and Eq.5 was used to 
compute the resulting active stress. 
 
2.2.9 Relative Pillar Displacement and Simulation of Locomotion 
To find the time-averaged ratios of pillar movement, the difference in X and Y 
coordinates of the pillar caps for each point was converted to a total distance moved between 
individual frames (i.e., from n to n+1), then divided.  
𝑝!𝑝! = (∆𝑥!!)! + (∆𝑦!!)!(∆𝑥!!)! + (∆𝑦!!)! = 𝑥!! !!! − 𝑥!! !
! + 𝑦!! !!! − 𝑦!! ! !𝑥!!(!!!) − 𝑥!!(!) ! + 𝑦!!(!!!) − 𝑦!!(!) ! 
(Eq.6) 
The difference in X and Y position between two consecutive frames is shown for one pillar in 
Figure 2.6. 
To model deformation and stress in the active (contracting) state, pillar displacements 
(from the Matlab script) were imported into the simulation to recapitulate the walking motion 
captured from top-view movies of symmetric and asymmetric bio-bots. Bio-bots were placed on 
a frictionless support surface (“ground”) and allowed to deform and move with respect to the 
ground in response to the displacement input. The simulation provided time-varying stresses in 
the bio-bot structure and time-varying reaction forces from the ground.  
 
2.2.10 Immunofluorescence and Histology 
Bio-bot pillars were cut to allow for muscle strip isolation and removal. Tissues were 
rinsed in PBS, fixed in 4% (v/v) paraformaldehyde and permeabilized with 0.2% (v/v) Triton X-
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100 (Sigma-Aldrich) for 5-10 min. Image-iT® FX Signal Enhancer (Invitrogen) was added for 
30 min. Tissues were first incubated with mouse MF-20 anti-myosin heavy chain (1:400, 
Developmental Studies Hybridoma Bank (DSHB), The University of Iowa Department of 
Biology) and rabbit sarcomeric α-actinin (1:600, Abcam) primary antibodies in Image-iT® FX 
Signal Enhancer (Invitrogen) for 2 h at room temperature (fibrin muscle strips) or overnight at 
4ºC (collagen muscle strips) and washed with PBS. Fibrin muscle strips were incubated with 
Alexa Fluor® 488 goat anti-mouse IgG and Alexa Fluor® 568 F(ab')2 fragment of goat anti-
rabbit IgG secondary antibodies (1:400, Invitrogen) in Image-iT® FX for 2 h in the dark. 
Collagen tissues were incubated with Alexa Fluor 594 goat anti-rabbit and Alexa Fluor 488 goat 
anti-mouse secondary antibodies for 2 h. 4′,6-diamindino-2-phenylindole (DAPI, 1:5000 in 
sterilized DI water, Sigma-Aldrich) was added for 5-10 min in the dark. Muscle strips were fixed 
to a 35-mm glass-bottom microwell dish (MatTek) with warm agarose gel. Muscle strips were 
imaged with a confocal microscope (LSM 710, Zeiss) or inverted fluorescent microscope (IX81, 
Olympus). Image stacks were processed using Zen software (2010, Zeiss) and ImageJ. 
For histological staining, muscle strips were fixed for a minimum of 12 h in 70% EtOH, 
then dehydrated and fixed in an overnight tissue processor (ASP300, Leica). Samples were 
embedded in paraffin, cut into 5-15 µm sections with a microtome (Leica), mounted on glass 
slides, and stained with hematoxylin and eosin (H&E). After 24 h, they were imaged with a 
Digital Pathology System (Nanozoomer). For quantification of cell distribution, a threshold was 
applied to each H&E image to distinguish nuclei from background. The ImageJ Analyze 
Particles feature was used to determine X-Y coordinates of each nucleus on every image, and the 
minimum distance of each nucleus to the perimeter was calculated. 	  
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2.2.11 Cell Viability Assay 
Muscle strips containing 5 x 10-6 cells ml-1 and supplemented with IGF-1 and ACA were 
incubated with MTS ([3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, Promega) and phenazine methosulfate (PMS, Sigma-Aldrich) in 
DMEM without phenol red for 4 h at 37ºC and 5% CO2. Absorbance of MTS formazan product 
formation was measured at 490 nm using a Synergy HT microplate reader (BioTek) for 4 
different time points (n = 4 each) and normalized to Day 0 (day of cell seeding). The absorbance 
was assumed to be directly related to the quantity of living cells. 
 
2.2.12 Statistical Analysis 
Results are presented as mean ± standard deviation (SD). All statistical analyses were 
performed with OriginPro software and represent one-way ANOVA followed by Tukey’s 
Multiple Comparison Test for p < 0.001, p < 0.01 or p < 0.05 as noted. 
 
2.3 Results and Discussion 
2.3.1 Design and Fabrication of 3D Bio-Bots 
To construct the structure of the bio-bot, we utilized a modified Stereolithography 
Apparatus (SLA), a liquid-based rapid prototyping technology24, to print a millimeter-scale 
hydrogel (PEGDA MW 700) device composed of two stiff pillars connected by a compliant beam 
(Figure 2.7a-b). A liquid suspension of C2C12 skeletal muscle myoblasts and ECM proteins 
was added around the pillars of the bio-bot and polymerized via gelation of the matrix proteins 
(Figure 2.7c). Embedded cells exerted traction forces on the fibrous proteins via integrin 
attachments to compact the matrix into a 3D muscle strip over time (Figure 2.7d-f), and the 
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capped pillars acted as a physical anchor for the muscle strip. We utilized a linear elastic 
simulation to determine optimal beam and pillar dimensions that would combine high deflection 
with a robust mechanical structure (Figure 2.8a). This bio-inspired design mimics the in vivo 
musculoskeletal arrangement in which force transmission occurs from a contracting muscle to 
bone through a connecting tendon (Figure 2.8b). 
The ECM contributes to maintaining cellular processes and communication in normal 
growth and maturation of skeletal myoblasts. Collagen I and fibrin are natural hydrogels that 
allow for muscle cell proliferation, spreading, and alignment, as well as tissue contraction on a 
macroscopic scale29,30. We tested both matrix proteins for their ability to support the 
development and organization of embedded myoblasts and provide a compliant system for tissue 
contraction. The cell-matrix solution consisted of either matrix protein with cell concentrations 
varying from 1 – 10 x 106 cells ml-1 (Figure 2.9). We observed that cell traction forces increased 
with cell concentrations; lower concentrations resulted in less compaction, whereas higher cell 
concentrations caused muscle strip fracture. We deemed an intermediate concentration of 5 x 106 
cells ml-1 as optimal.  
 
2.3.2 Muscle Strip Differentiation and Robustness 
To improve the formation and functional performance of 3D muscle strips, we studied the 
effect of insulin-like growth factor 1 (IGF-1) on myotube formation in 2D and 3D culture. 
Insulin-like growth factors play a role in skeletal tissue growth in vertebrates by encouraging 
myoblast proliferation and differentiation31,32. Over-expression or exogenous addition of IGF-1 
also enhances muscle hypertrophy33 and decelerates muscle decline in differentiated myofibers34. 
In 2D culture, as expected, the fusion of myoblast precursor cells during myogenesis produced 
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elongated, multi-nucleated myotubes35. Over 2.5 weeks, the average myotube density of 
myoblast cultures supplemented with 50 ng ml-1 IGF-1 significantly increased from 31.8 ± 8.3 to 
126.9 ± 30.3 myotubes mm-2 compared to the control with no added IGF-1 (Figure 2.10), and 
did not change significantly after day 7, when muscle strips were electrically stimulated. 
Translating these results to 3D, we then studied the effect of IGF-1 addition (beyond that 
included in the MatrigelTM basement membrane) on the formation and functionality of fibrin and 
collagen muscle strips. Differentiated, multinucleated myotubes were distributed throughout 
muscle strips supplemented with IGF-1 (Figure 2.11a-b). Muscle strips cultured without IGF-1 
contained populations of both undifferentiated myoblasts as well as multinucleated myotubes at 
later time points (Figure 2.11c-d), signaling that although IGF-1 increased the rate of fusion and 
maturation, its absence did not hinder muscle strip development. With the addition of 50 ng ml-1 
IGF-1, the portion of the fibrin-based muscle strip occupied by cells significantly increased 
(Figure 2.11e).  
Despite cross-linking during polymerization, fibrinogen is extremely susceptible to rapid 
degradation by cell-secreted proteases such as plasmin36. In vivo, natural inhibitors of plasmin 
prevent indiscriminate matrix digestion; however, in vitro, C2C12s can produce plasmin-
activating plasminogen, and a protease inhibitor such as ε-aminocaproic acid (ACA) must be 
added to ensure stability of the system37. Addition of 1 mg ml-1 ACA helped to maintain the 
structural integrity of the muscle strip, significantly increasing the lifetime of the muscle strip 
before rupture (Figure 2.12a). The bio-bots presented in this study were supplemented with 1 
mg ml-1 ACA, and 0 (without) or 50 (with) ng ml-1 IGF-1. 
H&E staining of histological sections of IGF-1 supplemented fibrin muscle strips 
revealed an increased peripheral cell density compared to the center (Figure 2.12b-e). We 
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located over 75% of cells within 200 µm of the edge of the fibrin muscle strip, a distance 
consistent with the upper limit of diffusion of oxygen within a tissue38. Finally, we used a MTS 
assay to evaluate cell viability over time. The relative absorbance of muscle strips (normalized to 
day 0) indicated a 85.76 ± 10.74% and 79.71 ± 14.78% viability of cells within the muscle strip 
after days 6 and 9, respectively (Figure 2.12f). As compared to the control muscle strips on day 
9, the IGF-1 supplemented muscle strips demonstrated enhanced cell proliferation. 
 
2.3.3 Optimization of Muscle Force Generation 
To optimize force production capabilities of the engineered muscle strip, we studied the 
effect of varying biological and mechanical environmental cues during muscle differentiation 
and maturation. By varying the laser energy dose of polymerization of the SLA, we created 
hydrogel structures with a range of tunable properties and conformations without changing the 
composition or molecular weight of the material. The elastic modulus of the hydrogel beam (as 
measured by tensile testing in a hydrated sample chamber) increased logarithmically from 214.6 
– 741.6 kPa with laser energy doses varying from 108.7 – 512.6 mJ cm-2, due to a higher degree 
of cross-linking by higher energy doses. With compaction of the muscle strip, traction forces 
exerted by cells produced an inward force on the pillars, which gave rise to varying degrees of 
bending in the beam. As expected, the stiffer hydrogel structures offered a greater resistance to 
bending; thus, beams with higher elastic moduli exhibited a lower deflection in response to 
passive tension forces exerted by the muscle strips (Figure 2.13a-b).  
Using Euler-Bernoulli linear bending theory (Figure 2.13c), we derived a formula 
relating the observed hydrogel beam deflection to the muscle-generated passive tension force. 
An increase in beam stiffness resulted in an increased tension in the muscle strip at rest. For 
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elastic moduli of 214.6, 319.4, 411.2, and 489.3 kPa, the passive tension averaged 860.6 ± 47.2, 
992.7 ± 34.3, 1103.6 ± 45.8, and 1146.0 ± 69.0 µN, respectively, in fibrin-based muscle strips 
cultured with IGF-1 (Figure 2.13d). We then used finite element analysis (ANSYS) to model 
and simulate global displacement of the beam and pillars in response to an applied force. The 
simulated deflection values differed 18-19% from actual measurements (Figure 2.13e), 
validating our methods to extract passive tension and predict muscle force output. 
The bio-bot pillars provided uniaxial constraint for cell alignment during compaction, 
allowing the myotubes to mature in a macro-environment that mimics the native organization of 
functional skeletal muscle. The increase in passive tension generated by the muscle strip with 
increasing hydrogel stiffness indicated that the forces exerted by cells could be modified in 
relation to mechanical environment of the muscle. Others have validated an increase in force 
output with dynamics mechanical stimulation39; here, we also demonstrate that a static 
mechanical cue imposed during muscle development contributes to improved functionality, 
providing further evidence that many types of mechanical stresses are required for muscle 
development40. Bio-bot hydrogel structures with a beam stiffness of 319.4 kPa were selected for 
subsequent experiments, as they combined the advantages of sufficiently high passive tension 
forces with deformable structures suitable for locomotion.  
To determine an optimal matrix system for engineered muscle functionality, we 
compared the passive tension forces generated by collagen- and fibrin-based cell-matrix systems. 
In muscle strips containing the same number of cells, we observed a significant increase in 
passive tension in those containing fibrin (629.3 ± 8.2 µN) compared to collagen (534.2 ± 5.8 
µN) (Figure 2.13f). Advantageously, fibrin polymerizes relatively quickly when compared to 
other ECM proteins, and it can undergo large deformations without breaking41,42. The ability to 
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sustain large strains while maintaining structural integrity during muscle contraction was a 
necessary characteristic for applications in bio-actuation. 
Examining the effect of varying other biological environmental cues, we observed that 
fibrin-based muscle strips supplemented with IGF-1 demonstrated a 70.7% increase in passive 
tension force, from 581.4 ± 20.6 to 992.7 ± 34.3 µN (p < 0.001, n = 4), compared to the control 
without IGF-1 (Figure 2.13d). We attributed this significant increase in force production to a 
greater number of differentiated myotubes in muscle strips supplemented with IGF-1, an 
observation confirmed by immunostaining and other reported variations of 3D engineered 
muscle constructs43. We calculated a normalized stress in the muscle strips with IGF-1 by 
dividing the passive tension by the cross-sectional area of the tissue, which averaged 1.2 ± 0.04 
mm2 (n = 9). The passive stress in the muscle strips averaged 0.84 ± 0.03 kPa, values that are 
comparable to those of similar muscle-based 3D cell-matrix systems with collagen or 
fibrin22,30,44,45. 
 
2.3.4 Electrically Paced Actuation of Bio-Bots 
To externally control muscle contraction and bio-bot locomotion, we utilized a custom-
designed setup28 to stimulate reproducible contraction of excitable cells within the muscle strip 
with a bipolar electrical pulse train (Figure 2.14a). By mimicking signals necessary for the 
generation of an action potential in vivo, electrical pulse stimulation can induce protein 
expression, contractile ability, cell alignment, and differentiation of skeletal muscle in vitro46–49; 
here, we harnessed the stimulation to coordinate contraction of multiple myotubes within the 
muscle strip, which collectively generated sufficient force to visibly deform the hydrogel 
structure of the bio-bot. Fibrin-based muscle strips supplemented with IGF-1 and stimulated at 
 49 
constant frequencies of 1, 2, or 4 Hz demonstrated a consistent output of 1.01 ± 0.003, 2.01 ± 
0.01, and 3.95 ± 0.05 contractions s-1, respectively (n = 10, Figure 2.14b), establishing that the 
bio-bots could reliably paced with this method. We witnessed twitch contractions below 8-10 Hz 
and tetanus above this upper frequency limit. In contrast, non-IGF-1 supplemented muscle strips 
did not respond to stimulation during this time period, a result attributed to fewer myotubes. We 
predict a response at later time points, as others have shown electrically induced contractility of 
C2C12s or primary cells in 3D tissue constructs after 14 (and sometimes up to 30+) days 
following formation30,50–53. However, IGF-1 treatment presents a simple and physiologically 
relevant method to enhance differentiation for functional output via electrical stimulation on a 
shorter time scale (here, as early as day 7). Additionally, we observed that the range of active 
tension remained above 99.3% of the initial value during 8 min of electrical stimulation at hour 0, 
and above 98.8% of the initial value at hour 6, revealing a consistent force output from the 
engineered muscle strips both within a constant stimulation period and at later time points 
(Figure 2.14c). 
A Kelvin-Voight viscoelasticity model that correlated the observed cyclic displacement 
to the contractile force was used to extract the active tension generated by IGF-1 supplemented 
muscle strips in response to electrical stimulation (Figure 2.14d). The range of active tension 
during contraction decreased with increasing stimulation frequency, from a dynamic fluctuation 
of 198.68 µN during 1 Hz stimulation to 109.48 µN during 4 Hz stimulation (Figure 2.14e). The 
active tension data followed a positive force-frequency relationship in which the magnitude of 
the active tension exerted by the muscle increased, even while the range of pillar motion 
decreased. Furthermore, as a consequence of muscle relaxation times exceeding the period 
between electrical pulses at higher frequencies, we observed a temporal summation of force that 
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resulted in a baseline tension increase over time. The muscle strips therefore displayed functional 
behavior characteristic to physiological skeletal muscle, in which force output increases with 
frequency before reaching tetanus11.  
 
2.3.5 Demonstration of Controlled Directional Movement 
We aimed to create a biomimetic ‘crawling’ mechanism reminiscent of an inchworm’s 
movement. Using finite element simulations, we explored a symmetric and an asymmetric design 
for the bio-bots (Figure 2.15a). For the asymmetric design, we extended the length of one pillar 
of the bio-bot hydrogel structure, allowing for asymmetric bending of the flexible beam, 
hypothesizing that the introduction of deliberate asymmetry within the structure would increase 
the moment arm between the muscle strip anchor point and the beam, as well as the range of 
motion between pillars during displacement. It would also change the contact area of the base to 
the surface for one pillar versus the other. These simulations revealed that as expected, the 
symmetric structure did not demonstrate significant locomotion. However, an asymmetric 
structure exhibited non-uniform distribution of stress in the hydrogel structure in response to 
muscle contraction, corresponding to asymmetric pillar displacements (Figure 2.15a). 
Simulations revealed that asymmetric actuation and force generation of the muscle strips by 
geometric design of the bio-bot would produce greater net displacement over a fixed time and 
create a more efficient and predictable locomotive mechanism as compared to the symmetric 
design. 
Consistent with the simulation results, we experimentally observed that for a symmetric 
hydrogel structure, electrical pacing of skeletal muscle strips attached to bio-bot structures either 
did not result in net locomotion of the bio-bot across a substrate, or in some cases, resulted in a 
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very small locomotion (Figure 2.15b). Since the hydrogel structure itself was symmetric, we 
hypothesized that any observed small locomotion of the symmetric structure was attributed to 
asymmetry in muscle strip formation and force distribution. From a top-view video, we tracked 
bio-bot pillar displacements in response to muscle contractions over time and observed that when 
both pillars displaced equally, the bio-bot did not move. Interestingly, for the minimally 
locomotive bio-bots, when one pillar displaced more than the other (Figure 2.15c), the bio-bot 
always ‘crawled’ in the direction of the pillar that demonstrated greater displacement in response 
to muscle contraction. For the case of these symmetric devices, these small velocities were found 
to be less than 4.34 µm s-1 at electrical stimulation of 1 Hz frequency (Figure 2.15d). We found 
that muscle strips coupled to the asymmetric compliant hydrogel structure drove inchworm-like 
crawling locomotion with maximum velocity. Contraction of muscle strips on asymmetric bio-
bots resulted in a maximum velocity of 117.8 µm s-1 in response to electrical stimulation of 1 Hz 
frequency, an increase in velocity of more than 25-fold increase compared to the symmetric 
design (Figure 2.15e-f). During electrically paced locomotion, the asymmetric bio-bot produced 
an active tension force of 394.7 ± 56.6 µN, or 27.9% of the maximum force (Figure 2.15g).  
Although bio-bot pillar displacement decreased with increasing stimulation frequency, 
the observed increase in force generation led us to test the effect of stimulation frequency on bio-
bot locomotion. The increased number of contractions with increasing stimulation frequency 
within a given time period resulted in an increased average velocity of the asymmetric bio-bot, 
which was measured to be 117.8, 132.2, and 156.1 µm s-1 at 1, 2, and 4 Hz, respectively, during 
the time period shown (Figure 2.15h). At all frequencies, the asymmetric bio-bot moved in the 
direction of the pillar that demonstrated greater displacement, as predicted (Figure 2.16). 	  
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2.4 Conclusions 
Soft robotic devices integrated with biological systems combine the advantages of high 
degree-of-freedom compliant response with dynamic sensing and actuation capabilities. We 
report the design and fabrication of a skeletal muscle powered machine that can be controlled 
and paced via external signaling, instead of relying on spontaneous muscle contraction. 
Modeling and simulations were used to study the effect of changing design parameters on 
functional response, resulting in a more comprehensive picture of the locomotive mechanisms. 
We improved the force generation capacity and functional performance of this engineered tissue 
by differentiating muscle strips in an optimized fibrin-based ECM environment supplemented 
with IGF-1 growth factor. Muscle strips displayed a tunable functional response in relation to the 
static stress imposed by a 3D printed hydrogel structure, mimicking the in vivo mechanical 
environment of muscle maturation. Finally, electrical stimulation triggered contraction of 
engineered muscle, driving a biomimetic and controllable directional locomotion.  
While other studies have explored the use of excised and engineered biological 
components such as cardiac muscle tissues for applications in bio-actuation, these studies lack a 
fabrication methodology that offers flexibility in precisely specifying geometric, material, and 
biological component design parameters (Figure 2.17). Our stereolithographic 3D printing based 
bio-fabrication system supports the integration of a variety of scaffolding materials and multiple 
cell types, representing a significant advancement towards engineering biological machines 
capable of complex and controllable functional behaviors. Furthermore, our bio-fabrication 
methodology can readily be modified to demonstrate other mechanisms of locomotion and force 
output (such as swimming and pumping) while also creating a platform for future studies 
integrating different biomaterials and cell types. The incorporation of motor neurons resulting in 
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neuromuscular junction formation would lead to more complex mechanisms of functional 
control of the engineered muscle. Additionally, integration of endothelial cells to engineer an 
internal vasculature would increase diffusion of nutrients and oxygen to the muscle tissue, 
thereby increasing efficiency and long-term viability of a living biological machine. 
Forward engineering of biological machines can help to advance the understanding of the 
fundamental scientific and design principles underlying living systems and lead to a quantitative 
understanding of the way integrated cellular systems sense and respond to environmental signals1. 
In the long term, we envision that this system could serve as a basis for target applications such 
as micro-scale tissue fabrication for drug screening and tissue- and organ-on-a-chip mimics, 
dynamic biocompatible microelectronics and medical implants, and forward-engineered 
biological machines and systems. 	  
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2.5 Figures  
 
 
Figure 2.1. Bio-Bot Development and Timeline. (a) Flow-chart of design and optimization 
parameters, including structural design, material properties, ECM microenvironment, and 
conditions of cell seeding and culture. (b) A timeline representing the development of a 
functional bio-bot. 
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Figure 2.2. Bio-Bot Design and Fabrication. SolidWorks parts and dimensions of the bio-bot are 
shown. The asymmetric design for the walking bio-bot had a taller cap at the end of the pillar 
and is shown from top angled and side views. 
 
 
 
 
 
 
 
 
Figure 2.3. Mechanical Testing. (a) A Working Curve for PEGDA MW 700 correlates the energy 
dose from the SLA laser with the polymerized layer thickness. (b) Setup of hydrated tensile 
testing chamber. 
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Figure 2.4. Mechanical Characterization of Stiffness, Tension, and Stress. (a) Elastic modulus of 
the beam as a function of energy dose (R2>0.99, n = 5). Increasing polymerization energy 
resulted in a higher modulus and less bending. (b) Effect of beam stiffness on collagen bio-bot 
bending. The bending in the stiffer beams was negligible in comparison to those with lower 
elastic moduli, and could not support net displacement of the bio-bot. (c) Transverse histological 
cross-sections were used to calculate the cross-sectional area of the muscle strips for calculation 
of stresses. 
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Figure 2.5. Electrical Stimulation Setup and Characterization. (a) Schematic of custom-built 
electrical stimulation setup. (b) Average resistance (n = 3) and conductivity (inset, n = 4) of the 
electrical stimulation medium (DMEM without serum) at 23ºC and 37ºC. Boxes represent 25th, 
50th, and 75th percentile; • represents mean value; whiskers represent minimum/maximum 
values. (c-d) Stimulation and imaging setup. In most cases, net movement was observed with 
electrical stimulation multiple times per day over consecutive days, without significant adverse 
effects. 
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Figure 2.6. Calculation Method to Determine Time-Averaged Ratios of Relative Pillar 
Displacement. The difference in X and Y position between two consecutive frames is shown for 
one pillar in this figure. The unequal range of motion between the pillars was attributed to two 
causes: first, variability in cell-matrix compaction which led to uneven moment arms in the two 
pillars, causing uneven bending in the beam and hence unequal pillar displacements; and second, 
time-varying normal reaction forces and therefore time-varying frictional forces that restricted 
the range of motion of each pillar, due to an imbalanced distribution of mass within the muscle 
strip that caused the weight assumed by each pillar to vary during movement. 
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Figure 2.7. Fabrication of Hydrogel Structures and Formation of 3D Muscle Strips. (a) 
Computer-aided design software was used to design bio-bots with desired dimensions. 
Measurements are in mm. (b) A Stereolithography Apparatus (SLA) was used to polymerize 
hydrogel structures in an additive process. (c) The cell-matrix solution consisted of C2C12 
skeletal muscle myoblasts, matrix proteins (fibrin or collagen I), and MatrigelTM. (d) Fabricated 
bio-bot (i, side view) and holder (ii, top view). Cell-matrix solution was pipetted into a 
polymerized holder containing the bio-bot structure (iii-iv, side view). Cells and matrix 
compacted around the pillars to form a solid muscle strip (v-vi, top view with immunostaining 
for MF-20, green, and DAPI, blue) and the device was released from the holder (vii, side view). 
All scale bars, 1 mm. (e) Time-lapse compaction of cell-matrix solution with IGF-1. During the 
24-48 h after seeding, the liquid suspension of cells and fibrin/MatrigelTM matrix polymerized 
and condensed around the pillars to form a solid muscle strip (top view). Skeletal myoblasts 
embedded in ECM proteins were induced to differentiate and self-assemble into 3D muscle strips 
anchored at both ends, an arrangement which facilitated cell growth, spreading, and 
differentiation in a supportive and constrained environment. (f) Cross-sectional compaction area 
of muscle strips decreased over the first 24 h due to compaction of the matrix and the exertion of 
traction forces from the cells (n = 20). Data are presented as mean ± SD (shaded region). 
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Figure 2.8. Simulations and Design. (a) Linear elastic simulation of PEGDA hydrogel bio-bot 
deflection with varying dimensions. The deflection was simulated using ANSYS in response to a 
constant passive tension force of 992.7 µN (corresponding to a modulus of 319.4 kPa). Bio-bot 
dimensions were optimized to maximize deflection and reduce scaffold weight, while preserving 
ease of manipulation during experimentation and electrical stimulation. The optimal design was 
chosen for its ability to combine high deflection with a robust mechanical structure. Shown are 
structures with global deflection and plots of deflection versus varied dimensions. Optimal 
dimensions are indicated by a dotted box on the plots. Scale bar, 1 mm. (b) Schematic of a 
physiological muscle-tendon-bone (MTB) architecture (left), as the inspiration for the basic 
design of our bio-actuator (right). 
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Figure 2.9. Effect of Cell Density on Bio-Bot Bending with Constant Modulus. Bio-bots 
structured fabricated with 138 mJ cm-2 energy dose were seeded with collagen-based cell-matrix 
solutions with varying cell densities (1 – 10 x 106 cells ml-1) in growth medium. After 72 hours, 
DM with 1 mg ml-1 aminocaproic acid was added. 
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Figure 2.10. Muscle Strip Differentiation. (a) Fluorescent images demonstrating the 
differentiation and maturation of myotubes over time with the addition of 50 ng ml-1 IGF-1 to 
differentiation medium containing 2% HS. Scale bar, 100 µm. (b) The myotube density was 
significantly increased for each time point after Day 3 with the addition of IGF-1 compared to 
the control (n = 3). Fusion of multinucleated myotubes with additional myoblasts during 
myogenic differentiation explains the decrease in density between Days 3 and 7. Non IGF-1 
supplemented samples displayed an average myotube density of 11 ± 0 myotubes mm2 on Day 3, 
which explains the lack of error bar at this time point. Statistics represent one-way ANOVA and 
Tukey’s Test, with * = p < 0.01. 
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Figure 2.11. Biological Characterization of Muscle Strips. (a) Longitudinal fibrin muscle strip 
slice (day 9). Scale bar, 500 µm. Inset: scale bar, 200 µm. (b) Myotubes aligned along the fibrin 
muscle strip perimeter. Scale bar, 200 µm. (c) Longitudinal collagen muscle strip slice (day 14). 
Scale bar, 500 µm. (d) Multinucleated myotubes in the collagen muscle strip. Scale bar, 50 µm. 
(e) A longitudinal slice (-IGF-1) and region of the fibrin muscle strip with immunostaining of 
anti-myosin heavy chain MF-20 and DAPI staining contained myoblasts and myotubes. Scale 
bars, 500 µm. Fluorescence analysis demonstrated a significantly higher portion of cells in 
muscle strip sections (as indicated by percentage of MF-20 fluorescence area, representing 
skeletal muscle cells) with the addition of IGF-1 (74.7 ± 12.2%, n = 7) compared to no IGF-1 
treatment (41.4 ± 8.7%, n = 4). Statistics represent one-way ANOVA and Tukey’s Test, with * = 
p < 0.01. 
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Figure 2.12. Lifetime and Viability of Bio-Bots. (a) The lifetime of the fibrin bio-bots (i.e. days 
until fracture of the muscle strip) was characterized by culture in differentiation medium in the 
presence or absence of 50 ng ml-1 IGF-1 and/or 1 mg ml-1 aminocaproic acid (ACA). We noted a 
significant increase in the muscle strip lifetime compared to the control of 10% HS (from 8.75 ± 
7.63 to 25 ± 1.15 days; p < 0.01, n = 4) with the addition of 1 mg ml-1 ACA. The addition of 50 
ng ml-1 IGF-1 decreased the number of days until fracture compared to the control (51.43% 
decrease) and 1 mg ml-1 ACA condition (22.0% decrease). Statistics represent one-way ANOVA 
and Tukey’s Test, with * = p < 0.01 and ** = p < 0.001. (b-e) H&E staining of fibrin muscle 
strip sections (day 9). All scale bars, 200 µm. (b) Longitudinal and (c) transverse muscle strip 
sections. (d) Quantitative analysis of transverse sections demonstrated 75% of cells within 200 
µm from the edge (n = 8). (e) Perimeter of transverse section of the muscle strip. (f) Relative 
absorbance, indicative of viability of cells (right) within the muscle strip at various time points 
from Day 0 (day of cell seeding) to Day 9 (day of electrical stimulation). Statistical significance 
was not calculated between +IGF-1 and –IGF-1 samples on Day 9, since differences in cell 
density (resulting from addition of IGF-1) can lead to differences in absorbance values. The 
image at left demonstrates a qualitative difference in formazan product formation. * = p < 0.05. 
For all charts, values are presented as mean ± SD.  
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Figure 2.13. Analysis of Bending and Passive Tension.  
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Figure 2.13 (cont.). (a) Over time, bio-bot beams polymerized with varying energy doses 
exhibited different bending profiles. Scale bar, 1 mm. (b) Finite element analysis simulation 
demonstrating global deflection of the bio-bot beam and pillars on day 8. (c) Schematic showing 
beam in compression undergoing nonlinear bending. The midpoint of the beam is set as the 
origin. 𝛿max is the maximum deflection of the beam and l is the moment arm from the muscle 
strip to the beam. (d) Passive tension in the muscle strip as a function of time, modulus, and 
addition of IGF-1 (n = 3, 489.3 kPa; n = 4, others). Increasing beam stiffness resulted in a higher 
muscle strip tension. Inset: Addition of IGF-1 significantly increased the average tension by 
70.7% (for 319.4 kPa stiffness) over time period shown. (e) The measured and simulated values 
of maximum beam deflection recorded for bio-bots of various energy doses on Day 8. To verify 
the accuracy of the calculation method, the computed passive tension values were input into 
ANSYS (finite element software), and the simulation produced values for deflection of the beam. 
The error between the actual and simulated values was calculated as ~18% for the three bio-bots, 
validating the use of linear bending theory to predict the force in the muscle strip. (f) Fibrin 
muscle strips exhibited 17.8% higher passive tension, on average (n = 6 for days 3 and 4; n = 2 
for day 5), compared to collagen muscle strips (n = 2) over the time period shown for 1 x 106 
cells ml-1 density. All data are presented as mean ± SD. Statistics represent one-way ANOVA 
and Tukey’s Test, with * = p < 0.01 and ** = p < 0.001.  
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Figure 2.14. Electrical Control and Pacing. (a) During stimulation, bio-bots were placed 
standing up on the surface of the dish, with the muscle strip’s longitudinal axis parallel to the 
electrodes and perpendicular to the applied field. (b) IGF-supplemented bio-bots were reliably 
paced at stimulation frequencies of 1, 2, or 4 Hz. Bio-bots not supplemented with IGF-1 did not 
respond to stimulation at any frequency in the observed time period. (c) Over 8 minutes, the 
range of active tension remained between 99.3-111.0% of the initial tension (i.e., the first time 
point of 0-10 s) for hour 0, and between 98.8-150 % for hour 6 of the same bio-bot. (d) A 
Kelvin-Voigt viscoelasticity model was used to extract active tension generated by the muscle 
strip in response to electrical stimulation. (e) Muscle strip time-varying active tension was 
calculated for a bio-bot undergoing varying electrical stimulation (0, 1, 2, 3, 4, 0 Hz) during one 
experiment, and followed a positive force-frequency relationship.  
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Figure 2.15. Simulation and Movement Profiles of Symmetric and Asymmetric Bio-Bots 
Supplemented with IGF-1. (a) von Mises stress of a symmetric and asymmetric bio-bot. The 
range of one contraction is shown over a period of 10 s (10 ‘steps’ at 1 Hz stimulation). (b,e). 
Top-view time-lapse images of the (b) symmetric and (e) asymmetric bio-bot’s movement. All 
scale bars, 1 mm. (c,f) Relative ratios of pillar movement over time during 1 Hz stimulation. The 
bio-bots moved in the direction of greater pillar movement during contraction. (d) Displacement 
(µm) of a symmetric bio-bot at 1 Hz stimulation during a 25 s interval when contraction 
produced maximum displacement along the surface. (g) Active tension force of the asymmetric 
bio-bot during locomotion. (h) The increased number of contractions with increasing stimulation 
frequency within a given time period resulted in an increased average velocity of the asymmetric 
bio-bot. Inset, left: Velocity (grey) and total displacement. Inset, right: Zoom of boxed region. 
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Figure 2.16. Characterization of Bio-Bot Movement at Various Stimulation Frequencies. (a) 
Top-view time-lapse montage (1 s increments) showing the movement and net displacement of 
the bio-bot characterized in Figure 2.15 with electrical stimulation at 1 Hz. Scale bar, 1 mm. (b) 
Top-view time-lapse images of the movement of the bio-bot characterized in Figure 2.15 with 
electrical stimulation at 2 Hz (left) and 4 Hz (right). Examination of top-view movies revealed 
the relative range of motion of each pillar during contraction, which dictated the degree of net 
displacement. The direction of net displacement corresponded to that of the pillar with a greater 
average range of motion (ratio > 1). (c) Normal forces are shown for a symmetric (left) and 
asymmetric (right) bio-bot, shown over a time period of 3 s (3 contractions at 1 Hz stimulation). 
Directional movement occurred when discrepancies in coefficients of friction between the pillars 
and the ground, resulting from a phase delay in the spatially varying contractile response of the 
muscle strip in response to electrical stimulation, caused one to ‘stick’ and the other to ‘slide’ 
with respect to the surface.  
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Figure 2.17. Due to a fabrication technology offering a great deal of flexibility in specifying 
geometric and design parameters, the designs presented in the main figures were adapted to 
demonstrate the ability to build machines with varying number and arrangement of pillars (legs). 
Images of computer-aided designs (a), fabricated hydrogel machines (top views, b, and side 
angled views, c), and finite element analysis simulations of deflections (d) are shown for three 
different designs. Scale bars, 2 mm. 
  
a	
b	
c	
 71 
2.6 References 
1. Kovač, M. The bioinspiration design paradigm: a perspective for soft robotics. Soft Robot. 
1, 28–37 (2013). 
2. Majidi, C. Soft robotics: a perspective—current trends and prospects for the future. Soft 
Robot. 1, 5–11 (2013). 
3. Shepherd, R. F. et al. Multigait soft robot. Proc. Natl. Acad. Sci. U. S. A. 108, 20400–
20403 (2011). 
4. Yurke, B., Turber, A. J., Jr, A. P. M., Simmel, F. C. & Neumann, J. L. A DNA-fuelled 
molecular machine made of DNA. Nature 406, 605–608 (2000). 
5. Martel, S., Tremblay, C. C., Ngakeng, S. & Langlois, G. Controlled manipulation and 
actuation of micro-objects with magnetotactic bacteria. Appl. Phys. Lett. 89, 233904 
(2006). 
6. Magdanz, V., Sanchez, S. & Schmidt, O. G. Development of a sperm-flagella driven 
micro-bio-robot. Adv. Mater. 25, 6581–6588 (2013). 
7. Herr, H. & Dennis, R. G. A swimming robot actuated by living muscle tissue. J. Neuroeng. 
Rehabil. 1, 1–9 (2004). 
8. Akiyama, Y. et al. Atmospheric-operable bioactuator powered by insect muscle packaged 
with medium. Lab Chip 13, 4870–4880 (2013). 
9. Akiyama, Y., Hoshino, T., Iwabuchi, K. & Morishima, K. Room temperature operable 
autonomously moving bio-microrobot powered by insect dorsal vessel tissue. PLoS One 7, 
e38274 (2012). 
10. Dennis, R. G. & Herr, H. in Biomimetics Biol. Inspired Technol. (Bar-Cohen, Y.) 243–266 
(CRC Press, 2005). 
11. King, A. M., Loiselle, D. S. & Kohl, P. Force generation for locomotion of vertebrates: 
skeletal muscle overview. IEEE J. Ocean. Eng. 29, 684–691 (2004). 
12. Duffy, R. M. & Feinberg, A. W. Engineered skeletal muscle tissue for soft robotics: 
fabrication strategies, current applications, and future challenges. WIREs Nanomed 
Nanobiotechnol 6, 178–195 (2014). 
13. Chan, V., Asada, H. H. & Bashir, R. Utilization and Control of Bioactuators Across 
Multiple Length Scales. Lab Chip (2013). doi:10.1039/C3LC50989C 
14. Vunjak-Novakovic, G. et al. Challenges in cardiac tissue engineering. Tissue Eng. Part B. 
Rev. 16, 169–87 (2010). 
15. Xi, J., Schmidt, J. J. & Montemagno, C. D. Self-assembled microdevices driven by muscle. 
Nat. Mater. 4, 180–184 (2005). 
16. Feinberg, A. W. et al. Muscular thin films for building actuators and powering devices. 
Science (80-. ). 317, 1366–1370 (2007). 
17. Kim, J. et al. Establishment of a fabrication method for a long-term actuated hybrid cell 
robot. Lab Chip 7, 1504–1508 (2007). 
 72 
18. Nawroth, J. C. et al. A tissue-engineered jellyfish with biomimetic propulsion. Nat. 
Biotechnol. 30, 792–797 (2012). 
19. Williams, B. J., Anand, S. V, Rajagopalan, J. & Saif, M. T. A. A self-propelled biohybrid 
swimmer at low Reynolds number. Nat. Commun. 5, 3081 (2014). 
20. Chan, V. et al. Development of miniaturized walking biological machines. Sci. Rep. 2, 1–
8 (2012). 
21. Chan, V. et al. Multi-material bio-fabrication of hydrogel cantilevers and actuators with 
stereolithography. Lab Chip 12, 88–98 (2012). 
22. Sakar, M. S. et al. Formation and optogenetic control of engineered 3D skeletal muscle 
bioactuators. Lab Chip 12, 4976–4985 (2012). 
23. Lieber, R. L. Skeletal Muscle Structure, Function, & Plasticity. (Lippincott Williams & 
Wilkins, 2002). 
24. Melchels, F. P. W., Feijen, J. & Grijpma, D. W. A review on stereolithography and its 
applications in biomedical engineering. Biomaterials 31, 6121–6130 (2010). 
25. Chan, V., Zorlutuna, P., Jeong, J. H., Kong, H. & Bashir, R. Three-dimensional 
photopatterning of hydrogels using stereolithography for long-term cell encapsulation. 
Lab Chip 10, 2062–2070 (2010). 
26. Jacobs, P. F. Rapid Prototyping and Manufacturing: Fundamentals of StereoLithography. 
(Society of Manufacturing Engineers, 1992). 
27. Arcaute, K., Mann, B. K. & Wicker, R. B. Stereolithography of three-dimensional 
bioactive poly(ethylene glycol) constructs with encapsulated cells. Ann. Biomed. Eng. 34, 
1429–1441 (2006). 
28. Bajaj, P. et al. Patterning the differentiation of C2C12 skeletal myoblasts. Integr. Biol. 3, 
897–909 (2011). 
29. Bian, W. & Bursac, N. Tissue engineering of functional skeletal muscle: challenges and 
recent advances. IEEE Eng. Med. Biol. Mag. 27, 109–113 (2008). 
30. Hinds, S., Bian, W., Dennis, R. G. & Bursac, N. The role of extracellular matrix 
composition in structure and function of bioengineered skeletal muscle. Biomaterials 32, 
3575–3583 (2011). 
31. Duan, C., Ren, H. & Gao, S. Insulin-like growth factors (IGFs), IGF receptors, and IGF-
binding proteins: roles in skeletal muscle growth and differentiation. Gen. Comp. 
Endocrinol. 167, 344–351 (2010). 
32. Florini, J. R., Ewton, D. Z. & Coolican, S. A. Growth hormone and the insulin-like growth 
factor system in myogenesis. Endocr. Rev. 17, 481–517 (1996). 
33. Vandenburgh, H. H., Karlisch, P., Shansky, J. & Feldstein, R. Insulin and IGF-I induce 
pronounced hypertrophy of skeletal myofibers in tissue culture. Am. J. Physiol. - Cell 
Physiol. 260, C475–C484 (1991). 
34. Barton-Davis, E. R., Shoturma, D. I., Musaro, A., Rosenthal, N. & Sweeney, H. L. Viral 
mediated expression of insulin-like growth factor I blocks the aging-related loss of 
skeletal muscle function. Proc. Natl. Acad. Sci. U. S. A. 95, 15603–15607 (1998). 
 73 
35. Miller, J. B., Schaefer, L. & Dominov, J. A. Seeking muscle stem cells. Curr. Top. Dev. 
Biol. 43, 191–219 (1999). 
36. Prentice, C. R. M. Basis of antifibrinolytic therapy. J. Clin. Pathol. 14, 35–40 (1980). 
37. Kupcsik, L., Alini, M. & Stoddart, M. J. Epsilon-aminocaproic acid is a useful fibrin 
degradation inhibitor for cartilage tissue engineering. Tissue Eng. Part A 15, 2309–2313 
(2009). 
38. Novosel, E. C., Kleinhans, C. & Kluger, P. J. Vascularization is the key challenge in tissue 
engineering. Adv. Drug Deliv. Rev. 63, 300–311 (2011). 
39. Powell, C. A., Smiley, B. L., Mills, J. & Vandenburgh, H. H. Mechanical stimulation 
improves tissue-engineered human skeletal muscle. Am. J. Physiol. - Cell Physiol. 283, 
C1557–C1565 (2002). 
40. Goldspink, G. et al. Gene expression in skeletal muscle in response to stretch and force 
generation. Am. J. Physiol. 262, R356–R363 (1992). 
41. Liu, W. et al. Fibrin fibers have extraordinary extensibility and elasticity. Science (80-. ). 
313, 634 (2006). 
42. Janmey, P. A., Winer, J. P. & Weisel, J. W. Fibrin gels and their clinical and 
bioengineering applications. J. R. Soc. Interface 6, 1–10 (2009). 
43. Huang, Y.-C., Dennis, R. G., Larkin, L. & Baar, K. Rapid formation of functional muscle 
in vitro using fibrin gels. J. Appl. Physiol. 98, 706–713 (2005). 
44. Boudou, T. et al. A microfabricated platform to measure and manipulate the mechanics of 
engineered cardiac microtissues. Tissue Eng. Part A 18, 910–919 (2012). 
45. West, A. R. et al. Development and characterization of a 3D multicell microtissue culture 
model of airway smooth muscle. Am. J. Physiol. - Lung Cell. Mol. Physiol. 304, L4–L16 
(2013). 
46. Ahadian, S. et al. Electrical stimulation as a biomimicry tool for regulating muscle cell 
behavior. Organogenesis 9, 87–92 (2013). 
47. Wehrle, U., Düsterhöft, S. & Pette, D. Effects of chronic electrical stimulation on myosin 
heavy chain expression in satellite cell cultures derived from rat muscles of different fiber-
type composition. Differentiation 58, 37–46 (1994). 
48. Hosseini, V. et al. Engineered contractile skeletal muscle tissue on a microgrooved 
methacrylated gelatin substrate. Tissue Eng. Part A 18, 2453–2465 (2012). 
49. Flaibani, M. et al. Muscle differentiation and myotubes alignment is influenced by 
micropatterned surfaces and exogenous electrical stimulation. Tissue Eng. Part A 15, 
2447–2457 (2009). 
50. Bian, W., Juhas, M., Pfeiler, T. W. & Bursac, N. Local tissue geometry determines 
contractile force generation of engineered muscle networks. Tissue Eng. Part A 18, 957–
967 (2012). 
51. Dennis, R. G. & Kosnik, P. E. Excitability and isometric contractile properties of 
mammalian skeletal muscle constructs engineered in vitro. Vitr. Cell. Dev. Biol. - Anim. 
36, 327–335 (2000). 
 74 
52. Dennis, R. G., Kosnik, P. E., Gilbert, M. E. & Faulkner, J. A. Excitability and contractility 
of skeletal muscle engineered from primary cultures and cell lines. Am. J. Physiol. - Cell 
Physiol. 280, C288–C295 (2001). 
53. Bian, W. & Bursac, N. Soluble miniagrin enhances contractile function of engineered 
skeletal muscle. FASEB J. 26, 955–965 (2012).  
  
 75 
CHAPTER 3: INVESTIGATING THE LIFE 
EXPECTANCY AND PROTEOLYTIC DEGRADATION 
OF ENGINEERED SKELETAL MUSCLE BIOLOGICAL 
MACHINES ∗ 
 
3.1 Introduction  
As the primary actuating source for mammals, skeletal muscle’s modular and scalable 
architecture makes it an ideal power supply for producing force and locomotion in engineered 
living systems and biological actuators. A combination of techniques from the fields of 3D 
printing, tissue engineering, and biomaterials has recently yielded a new class of skeletal muscle-
powered biological robots (“bio-bots”) that could be reliably controlled and paced via applied 
electrical1 or optical2 signals. This engineered hydrogel-muscle platform is ideal for introducing 
different cell types and biomaterials, and permits control over physical, mechanical, biological, 
and biochemical cues3.  
 In vivo, skeletal muscle is supported by a basal lamina containing layers of connective 
tissue that provide a barrier from physical stress and damage4,5. An analog in the skeletal muscle 
powered bio-bots is a combination of extracellular matrix (ECM) proteins, including the natural 
hydrogel fibrin, that provide physical support and cues to the cells as an engineered basement 
membrane. The polymerization of a liquid cell-ECM suspension yields a solid muscle strip1. 
Fibrin’s viscoelastic mechanical properties, which can be tuned to those of native connective 
tissue or skeletal muscle, make it a useful scaffold material for the engineering of myriad types 																																																								
* This chapter has been adapted from the following publication: Caroline Cvetkovic*, Meghan C. 
Ferrall-Fairbanks*, Eunkyung Ko, Lauren Grant, Hyunjoon Kong, Manu O. Platt, and Rashid 
Bashir. “Investigating the Life Expectancy and Proteolytic Degradation of Engineered Skeletal 
Muscle Biological Machines.” (Submitted.) 2017. * These authors contributed equally to this 
work. 
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of tissue4,6,7. However, maintaining consistent results becomes challenging when sustaining an 
autonomous living cellular system in vitro for weeks or months. Skeletal muscle must be 
preserved in a differentiated state at environmental conditions3. Moreover, the system is subject 
to degradation by cell-secreted proteases that can break down the mechanical integrity of the 
ECM in tissue and thus eventually lead to device failure, despite the presence of some protease 
inhibitors1.  
The polymerization of fibrin into a 3D branching network is actively and equally opposed 
in a physiological equilibrium by fibrinolysis; despite cross-linking, the protein is extremely 
susceptible to degradation by cell-secreted enzymatic proteases8,9 (Figure 3.1). Plasmin is a 
serine protease secreted by many different cells to rapidly degrade fibrin10,11. In skeletal muscle, 
inhibition of plasmin can result in fibrin build up and reduced myoblast fusion, differentiation, 
and regeneration12. Furthermore, other proteases secreted during myoblast differentiation, 
including cysteine cathepsins and matrix metalloproteinases (MMPs) must also be considered as 
contributors to fibrin network destabilization13–15. Cysteine cathepsins are powerful lysosomal 
proteases that degrade intracellular and extracellular matrix proteins and include the most 
powerful mammalian collagenase and elastase16–20; their upregulation during myogenic 
differentiation has been documented13. MMPs are another group of ECM-degrading enzymes 
involved in remodeling and maintenance of the ECM in both normal and pathological states14,15. 
Specifically MMP-2 and MMP-9 have been seen to be involved with skeletal muscle ECM 
remodeling in muscle satellite cell migration and differentiation14,15,21,22. 
Here we examine the life expectancy and breakdown of engineered skeletal muscle bio-
bots by loss of form and function, as a result of degradation by three major classes of proteases: 
plasmin, cathepsin L (CatL), and MMPs (including MMP-2 and MMP-9). We first examined the 
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effect of adding a serine protease inhibitor, aminocaproic acid (ACA), on the maintenance of 
machine life expectancy and structural integrity. We also demonstrate the use of gelatin 
zymography, a substrate gel electrophoresis technique, to determine the effects of differentiation 
time, inhibitor concentration, and electrical stimulation on cysteine protease expression within 
muscle strips on differential time scales. Finally, we demonstrate the ability to measure CatL and 
MMP activity while modifying certain design parameters involved in bio-bot fabrication. To our 
knowledge, this is the first investigation into the life expectancy and failure of an engineered 
biological machine. With this understanding, we are poised to design the next generation of 
machines with controllable gain and loss of function. Our studies can also have important 
applications in skeletal muscle based tissue engineering, muscles on a chip, and related fields of 
studies. 
 
3.2 Materials and Methods 
3.2.1 Design and 3D Printing of Bio-Bot Skeletons 
Bio-bot skeletons and holders were fabricated using a commercial Stereolithography 
apparatus (SLA 250/50, 3D Systems) as previously described1. Briefly, parts were designed in 
CAD software (AutoCAD), exported in .STL format for slicing into layers (3D Lightyear 
software, v1.4, 3D Systems), and built in a layer-by-layer fashion on a modified SLA stage. 
Liquid pre-polymer hydrogel solutions were composed of 20% poly(ethylene glycol) diacrylate 
of MW 700 g mol-1 (PEGDA 700, Sigma-Aldrich) or poly(ethylene glycol) dimethacrylate of MW 
1000 g mol-1 (PEGDMA 1000, Polysciences, Inc.)1,2. After fabrication, skeletons and holders 
were rinsed in PBS, sterilized in 70% EtOH, and stored in sterile PBS until use. 	  
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3.2.2 Cell Culture and Seeding 
C2C12 murine myoblasts were proliferated in growth medium (GM) and passaged before 
confluence. For optogenetic bio-bots, ChR2-C2C12s were used, as previously described2,23. GM 
consisted of Dulbecco’s Modified Eagle Medium (DMEM, Corning Cellgro) with 10% (v/v) 
fetal bovine serum (FBS, VWR) and 1% (v/v) each of L-glutamine and penicillin-streptomycin 
(both Corning Cellgro). For the seeding of muscle strips, bio-bot skeletons were placed in 
polymerized holders and aspirated of excess liquid. 5 x 106 cells ml-1 (final concentration of 
myoblasts in cell-gel solution, unless otherwise noted) were resuspended in GM and mixed with 
ice-cold MatrigelTM basement membrane (30% of total volume, Corning), fibrinogen (4 mg ml-1, 
Sigma-Aldrich), and thrombin from bovine plasma (0.5 U mg-1 fibrinogen, Sigma-Aldrich). The 
cell-gel solution was added to each holder (day 0) and incubated for 1.5 hr before adding warm 
GM. All cells and cultures were maintained at 37ºC and 5% CO2. 
 
3.2.3 Skeletal Muscle Differentiation and Stimulation 
After 3 days in GM, bio-bots were released from the holders and switched to 
differentiation media (DM), consisting of DMEM with 10% (v/v) heat-inactivated horse serum 
(HS, Gibco), 1% (v/v) each of L-glutamine and penicillin-streptomycin, 50 ng ml-1 of insulin-
like growth factor (IGF-1, Sigma-Aldrich), and ACA as noted: 0 mg ml-1 (0x ACA), 1 mg ml-1 
(1x ACA), or 3 mg ml-1 (3x ACA). Media was changed daily. Electrical stimulation was applied 
using a custom-built setup1,24 starting on day 4 (Figure 3.2). Bio-bots were placed in warm 
DMEM between two sterilized Pt electrodes and a current was applied perpendicular to the 
longitudinal axis of the muscle strip with the following parameters: 20 V amplitude, 50 ms pulse 
width, 1 Hz frequency, and 10 min total stimulation per day. Optical stimulation of ChR2-C2C12 
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optogenetic bio-bots was applied as previously described2, starting on day 4, at 1 Hz frequency 
for 10 min total stimulation per day. 
 
3.2.4 Force and Diameter Measurements 
Images of the bio-bots were taken using a stereomicroscope (MZ FL III, Leica 
Microsystems) with a digital camera (Flex, SPOT Imaging Solutions). The Measure Tool in 
ImageJ software (National Institutes of Health) was used to measure muscle strip dimensions 
from top-view (diameter) and side-view (passive tension) images. The passive tension force of 
the muscle strip was calculated using an equation derived from Euler-Bernoulli linear beam 
theory: 𝐹! = (8𝐸𝐼/𝑙𝐿! )𝛿!"#, where E is the elastic modulus (319 kPa1, unless otherwise noted), 
I is the moment of inertia of the bio-bot beam, L is the beam length, l is the moment arm between 
the beam and muscle strip, and 𝛿!"# is the beam deflection.  
 
3.2.5 Viability Assays 
Cell viability was quantitatively determined using a metabolic colorimetric assay by 
incubating muscle strips in CellTiter 96 AQueous One Solution (MTS, Promega) and DMEM 
without phenol red (LifeTechnologies) in a 5:1 (v/v) ratio in the dark at 37ºC. After 4 h, 
absorbance was measured at 490 nm using a microplate reader (Synergy HT, BioTek). The 
absorbance of a blank sample without cells was subtracted from each reading, and results were 
normalized to day 3.  	  
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3.2.6 Immunofluorescence and Histology 
Muscle strips were removed from bio-bot skeletons and rinsed in PBS. For fluorescent 
staining, tissues were fixed in 4% paraformaldehyde (Electron Microscopy Services) for 30 min 
and permeabilized with 0.25% Triton X-100 (Sigma-Aldrich) for 10 min. After blocking in 
Image-iT® FX (Molecular Probes) overnight at 4ºC, muscle strips were incubated with MF-20 
(1:400, Developmental Studies Hybridoma Bank, The University of Iowa) and anti-sarcomeric 
α-actinin primary antibodies (1:400, Abcam) overnight at 4ºC, rinsed 3x with PBS, and 
incubated with Alexa Fluor® 488 goat anti-mouse and Alexa Fluor® 568 goat anti-rabbit (both 
1:400, ThermoFisher) overnight at 4ºC in the dark. Muscle strips were rinsed 3x with PBS, 
incubated with 4’,6-diamindino-2-phenylindole (DAPI, 1:5,000 in sterile DI water, Sigma-
Aldrich) for 10 min, rinsed, and imaged with a confocal microscope (LSM 710, Zeiss). For 
histology, frozen muscle strips were embedded in OCT compound (TissueTek), cut into 14 µm 
sections using a cryostat (CM3050, Leica), mounted on glass slides, stained with a Masson’s 
Trichrome kit (Polysciences, Inc.), and imaged using a digital pathology slide scanner (C9600, 
NanoZoomer). 
 
3.2.7 Muscle Strip Nucleic Acid Extraction and Assays 
Muscle strips were removed from bio-bot skeletons, snap frozen in liquid nitrogen, and 
stored at -80ºC until use. Before RNA isolation, tissues were lysed using a rotor-stator 
homogenizer (TissueRuptor, Qiagen). Total RNA was then extracted using an RNeasy Mini Kit 
(Qiagen). Alternatively, DNeasy Blood and Tissue Kit (Qiagen) was used to isolate total 
genomic DNA from muscle strips. The concentration of DNA or RNA was measured at 260 nm 
with a spectrophotometer (NanoDrop 1000). 
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3.2.8 Muscle Strip Protein Extraction and Assays 
Muscle strips were snap frozen in liquid nitrogen and stored at -80ºC until use. Upon 
thawing, muscle strip cells were digested in lysis buffer with freshly added 0.1mM leupeptin 
(Calbiochem) for zymography and Western blotting, or RIPA buffer (Thermo Scientific) for total 
protein measurements and muscle creatine kinase (MCK) assays. Lysis buffer consisted of 20 
nM Tris–HCl at pH 7.5, 5 mM ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid 
(Sigma-Aldrich), 20 mM β-glycerolphosphate (Alfa Aesar), 150 mM NaCl (BDH), 1 mM 
sodium orthovanadate (Sigma-Aldrich), 10 mM NaF (Sigma-Aldrich), 1% Triton X-100 (EMD 
Chemicals), and 0.1% Tween-20 (Fisher Scientific)25. After sonication and centrifugation, the 
protein extract supernatant was collected. Using a Pierce BCA Protein Assay Kit (Thermo 
Scientific), total muscle strip protein content was measured at 562 nm with a spectrophotometer. 
Extracted protein supernatant was used to determine MCK production using a Liquid Creatine 
Kinase Reagent Set (Pointe Scientific), and absorbance was measured at 340 nm with a 
microplate reader. 
 
3.2.9 Cathepsin and MMP Zymography 
We have previously optimized protocols for multiplex zymography to detect mature 
cathepsins K, L, S, and V25,26. MMP zymography has also been optimized for detection of pro- 
and mature forms of MMP-2 and MMP-927. For gelatin zymography, SDS-PAGE gels (12.5% 
for cathepsins, 10% for MMPs) were impregnated with 5 mg ml-1 soluble gelatin substrate. 
Samples were prepared with a non-reducing loading dye (5× − 0.05% bromophenol blue, 10% 
SDS, 1.5 M Tris, 50% glycerol) and separated by electrophoresis resolved at 200V for 1 h at 4°C. 
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Gels were washed in renaturing buffer and then incubated in assay buffer overnight, specific to 
proteases being probed. Renaturing buffer contained 65 mM Tris buffer at pH 7.4 with 20% 
glycerol for cathepsins, and 2.5% Triton-X 100 for MMPs. Assay buffer contained 0.1 M sodium 
acetate buffer at pH 4.0, 1 mM EDTA, and freshly added 2 mM dithiothreitol for cathepsins, and 
50 mM Tris-HCl at pH 7.4, 10 mM CaCl2, 50 mM NaCl, and 0.05% Triton X-100 for MMPs. 
After overnight incubation, gels were stained for 2 h in 4.5% Coomassie blue stain (Sigma-
Aldrich) with 10% acetic acid and 25% isopropanol. Gels were then destained with 10% 
isopropanol and 10% acetic acid, and imaged with an ImageQuant LAS 4000 (GE Healthcare). 
Densitometry quantification of white band intensity (indicating active protease) was preformed 
using ImageJ, and all results were normalized to day 3 (the start of muscle differentiation). In all 
results, one representative gel image is shown for each experiment.  
 
3.2.10 Western Blots 
Muscle strip protein extracts were prepared with loading dye with the additional of β-
mercaptoethanol, boiled for 5 min, and loaded into a 12.5% SDS-PAGE gel. Proteins were 
separated by molecular weight under electrophoresis resolved at 150V and then transferred to a 
nitrocellulouse membrane using a Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad) at 10V for 
30 min. Membranes were blocked for at least 1 h in Odyssey Blocking Buffer (LI-COR 
Bioscience) diluted 1:2 in PBS, then incubated with primary antibodies (1:1000) for goat 
polyclonal mouse cathepsin L (R&D Systems), or rabbit polyclonal cystatin C (Millipore) 
overnight at 4°C with constant agitation. Proteins were detected with a LI-COR Odyssey scanner 
using anti-goat or anti-rabbit secondary antibodies (1:5000 with 0.1% Tween, Invitrogen) tagged 
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with an infrared fluorophore. Densitometry was preformed using ImageJ, and results were 
normalized to day 3.  
 
3.2.11 Statistical Analysis 
Results are presented as mean ± standard error of the mean (SEM; zymography and 
Western Blots), or standard deviation (SD; all else), as noted in figure captions. Statistical 
analyses included tests for significance (one-way ANOVA followed by Tukey’s Multiple 
Comparison Test, performed using OriginPro software, or two-tailed t-tests, performed using 
Microsoft Excel) and survival (Kaplan-Meier analysis, performed using OriginPro software). For 
muscle strip life expectancy and survival analysis, outliers were defined as data points outside of 
± 1 SD from the mean. 
 
3.3 Results 
3.3.1 Development and Maturation of Skeletal Muscle Bio-Bots 
In order to fabricate the skeleton of skeletal muscle bio-bots, we used stereolithographic 
3D printing28–30 to polymerize a hydrogel with customizable geometric and design parameters. 
The skeleton consisted of a flexible beam connecting two rigid pillars, inspired by 
musculoskeletal physiology of tendon and bone1 (Figure 3.3a-i). C2C12 myoblasts at a density 
of 5 x 106 cells ml-1 were mixed with ECM proteins including fibrinogen, thrombin, and 
MatrigelTM; the liquid suspension was added to the holder and polymerized to form a solid 
muscle strip around the hydrogel skeleton (Figure 3.3a-ii,iii). After three days in proliferation 
media, the tissue was compacted around the pillars, and the bio-bot (consisting of the hydrogel 
skeleton and attached muscle strip) was released as a freestanding biological machine (Figure 
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3.3a-iv). Myoblasts were then induced to differentiate with the addition of horse serum and 
insulin-like growth factor (IGF-1). Striated, multinucleated myotubes were visible throughout the 
muscle strip (Figure 3.3a-v).  
Over the course of the experiment (twelve days), the total DNA present in the muscle 
strips increased over ten-fold, from 2.1 ± 1.1 on day 3 to 23.8 ± 5.9 µg on day 12. The total 
protein content increased as well, and was significantly amplified on day 12 (356.8 ± 58.1 µg) 
compared to day 3 (235.7 ± 63.2 µg, Figure 3.3b). Muscle creatine kinase (MCK) activity, a 
quantitative gauge of myogenic differentiation, was significantly increased as early as day 6, and 
reached a maximum output of 560.4 ± 62.3 U/L on day 12 (Figure 3.3c). 
 
3.3.2 Cathepsin and MMP Zymography without ACA 
Multiplex zymography was used to examine the activity of cell-secreted or cell-
associated cysteine cathepsins and matrix metalloproteinases (MMPs) in muscle strips at various 
time points. Polyacrylamide gels were impregnated with gelatin to create a substrate that could 
be degraded by active proteases. Muscle strips were lysed and loaded for zymography (Figure 
3.4a-i,ii,iii). After protein separation by electrophoresis, gels were washed in a renaturing buffer 
that allowed proteins to re-fold into their native conformation, and then incubated in assay buffer 
overnight for optimal enzyme activity to degrade the substrate (Figure 3.4a-iv). Both renaturing 
and assay buffers were specific to the proteases examined. Gels are then stained with Coomassie 
Blue stain, which stains all proteins, and destained; areas of white bands indicated proteolytic 
activity (Figure 3.4a-v). On the cathepsin zymogram, bands were identified for Cathepsin L, 
both unbound (CatL, 25-37 kDa) and bound to matrix proteins in the muscle strip tissue 
(CatL+tissue, 75 kDa; Figure 3.4b). On the MMP zymogram, bands were identified at 62-72 
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and 82-92 kDa, pertaining to MMP-2/pro-MMP-2 and MMP-9/pro-MMP-9, respectively 
(Figure 3.4c). 
In the absence of any anti-fibrinolytic treatment (0x ACA), muscle strips produced active 
cathepsins and MMPs, and the amount of active enzyme increased over the course of 12 days. 
The activity of each protease was quantified by densitometry and normalized to the beginning of 
skeletal muscle differentiation on day 3. On day 12, the amount of active CatL displayed a 
significant (3.9 ± 1.1-fold) change, and amount of active CatL+tissue increased by 2.8 ± 0.9-fold. 
Electrical stimulation of muscle strips significantly increased the expression of both active CatL 
and CatL+tissue (5.5 ± 1.1 and 3.5 ± 0.7-fold compared to day 3, respectively; Figure 3.4b). 
Additionally, the amount of active MMP-2 and MMP-9 in muscle strips both increased on day 
12, both with (1.2 ± 0.2 and 1.3 ± 0.5-fold) and without electrical stimulation (1.6 ± 0.4 and 1.6 ± 
0.7-fold; Figure 3.4c). Western blotting confirmed the identity of two mature isoforms of the 
cysteine protease CatL (including heavy chain [HC] CatL), as well as the presence of cystatin C 
(CysC), an endogenous cysteine protease inhibitor. Pro-forms of both MMPs and CatL were also 
present (Figure 3.4d). 
 
3.3.3 Muscle Strip Life Expectancy 
Breakdown of the muscle strip was defined as detachment from the hydrogel skeleton 
(Figure 3.4a-i), rendering the bio-bot non-functional. In the absence of any anti-fibrinolytic 
treatment (0x ACA), muscle strips demonstrated an average life expectancy of 8.2 ± 1.6 days 
until rupture (Figure 3.5a). However, incubation of the serine protease inhibitor ACA in medium 
lengthened the life expectancy of the muscle strips; addition of 1 mg ml-1 (1x) and 3 mg ml-1 (3x) 
ACA significantly increased the averages to 17 ± 8.7 and 50.7 ± 66.7 days until rupture, 
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respectively. Kaplan-Meier survival analysis provided an additional method of comparison 
between treatment groups (Figure 3.5b-c). Finally, increasing the concentration of ACA from 1x 
to 3x did not significantly alter cellular viability in the muscle strips (Figure 3.6a). 
 
3.3.4 Loss of Tissue Structure and Mechanical Integrity 
Over the time course of the experiment, muscle strips began to degrade (most notably, in 
the middle region of the tissue) in the absence of anti-fibrinolytic treatment (Figure 3.6b). Five 
days after cell seeding, 0x ACA muscle strips displayed cross-sectional diameters already 
significantly reduced from those treated with 3x ACA (2.1 ± 0.1 versus 2.4 ± 0.1 mm, Figure 
3.6c). On day 12, the diameters of all groups were significantly reduced (a range of 73.1 ± 19.2 
to 78.4 ± 10% from their day 5 values). The 0x ACA muscle strips displayed a lower passive 
tension and faster decrease in static force over time compared to both 1x and 3x ACA treated 
muscle strips. As early as day 8, the passive tension was significantly lower for 0x ACA; by day 
12, it had dropped to 815.5 ± 428.1 µN, compared to 1327.6 ± 172 and 1509.5 ± 213.4 µN for 1x 
and 3x ACA, respectively (Figure 3.7a). Additionally, histological staining for Masson’s 
Trichrome, a connective tissue stain, indicated that the addition of ACA helped to maintain the 
presence of ECM proteins supporting the differentiated myotubes (Figure 3.7b). Neither 
application of daily electrical stimulation nor increasing the concentration of ACA beyond 1x 
caused any statistical difference in average passive tension during this time span (Figure 3.7c). 
 
3.3.5 Cathepsin and MMP Zymography with 1x and 3x ACA 
In the presence of a serine protease inhibitor, muscle strips cultured with 1x and 3x ACA 
continued to produce active cathepsins and MMPs. On day 12, the amount of active CatL 
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displayed a 0.9 ± 0.2-fold change with 1x ACA and a 0.7 ± 0.3-fold change with 3x ACA 
compared to day 3. The amount of active CatL+tissue displayed a 1.2 ± 0.2-fold change with 1x 
ACA and a 2.3 ± 0.1-fold change with 3x ACA, significantly increased from day 3 (Figure 3.8a). 
Both the amount of active MMP-2 and MMP-9 increased by day 6, but decreased below day 3 
levels on day 8. On day 12, MMP-2 was again upregulated (1.1 ± 0.3-fold and 1.3 ± 0.5-fold 
change for muscle strips cultured with 1x and 3x ACA), while levels of active MMP-9 continued 
to decrease significantly compared to day 3 levels (0.5 ± 0.2-fold and 0.5 ± 0.2-fold change for 
muscle strips cultured with 1x and 3x ACA) (Figure 3.8b). 
However, when comparing muscle strips cultured with 0x ACA to those cultured in 1x 
and 3x ACA after 12 days, we observed a reduction in the amount of active protease that was 
statistically significant for CatL (0.9 ± 0.2-fold and 0.7 ± 0.3-fold, compared to 3.9 ± 1.1-fold for 
0x; Figures 3.9a and 3.9c-i), but not significant for MMP-2 or MMP-9 (Figures 3.9b and 3.9c-
iii). Increasing the ACA concentration beyond 1x did not further enhance this reduction in active 
CatL, and electrical stimulation did not significantly alter the expression of any of the cathepsins 
or MMPs cultured with ACA. Finally, Western blotting also verified the presence of the pro-
form of CatL, as well as the presence of CysC (Figure 3.10). 
 
3.3.6 Varying Hydrogel Skeleton Stiffness and Cell Seeding Density 
The hydrogel-muscle platform was modified to introduce tunable variations in the muscle 
strip as well as the 3D printed skeleton1. To test the hypothesis that concentration of cells within 
the muscle strip affected the amount of active proteases produced, muscle strips seeded at a 
density of 5 x 106 cells ml-1 were compared to those with 2.5 and 10 x 106 cells ml-1. On day 12, 
active CatL and CatL+tissue showed no significant change compared to muscle strips with 2.5 or 
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10 x 106 cells ml-1 cultured in 1x ACA (Figure 3.11a). However, there was an increase in the 
amount of total MMP-2 (from 0.4 ± 0.1 to 1.1 ± 0.2-fold change) with increasing density, and a 
concurrent decrease in the amount of total MMP-9 (Figure 3.11b) when increasing or decreasing 
the cell density. 
When cultured in the serine protease inhibitor ACA, muscle strips coupled to hydrogel 
beams with an optimal modulus of 319 kPa (used in previous bio-bot demonstrations1,2) had 
retained their passive tension over time (Figure 3.7a). To assess whether cells in the muscle strip 
responded differently when subjected to a varying degree of static force, we altered the 
mechanical microenvironment felt by the myotubes during differentiation by 3D printing 
hydrogel skeletons with varying stiffness values (411 and 489 kPa). Muscle strips cultured in 1x 
ACA for 12 days in higher tension showed no significant change in the amount of active CatL or 
CatL+tissue compared to those on skeletons with a stiffness of 319 kPa (Figure 3.12a). However, 
the total amount of active protease was reduced for both MMP-2 and MMP-9 (Figure 3.12b) in 
muscle strips cultured on skeletons with higher stiffness. Western blotting corroborated the 
presence of the pro-form of CatL as well as CysC in these muscle strips (Figure 3.12c). Thus, 
the amount of active cathepsins, but not total MMPs, was independent of both cell seeding 
density as well as varying microenvironment stiffness within the muscle strip. 
 
3.3.7 Optical Stimulation of ChR2-C2C12 Muscle Strips 
To test if dynamic optical stimulation of muscle strips contributed to an increase in 
protease activity, bio-bots were fabricated using ChR2-C2C12s (myoblasts infected to express an 
optogenetic ion channel2). ChR2-C2C12 optogenetic bio-bots were cultured in 1x ACA and 
subjected to daily optical stimulation by an external blue light pulse that depolarized the cells to 
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produce contraction. The muscle strips from ChR2-C2C12 optogenetic bio-bots were collected 
on day 6 (to compare to non-optogenetic bio-bots) and on day 12 (to compare to both non-
optogenetic bio-bots as well as ChR2-C2C12 bio-bots without optogenetic stimulation) for 
zymography. Just as daily electrical stimulation had not altered the expression of CatL or MMP-
2 over 12 days, the application of daily optical stimulation for ChR2-C2C12 optogenetic bio-bots 
did not have a significant impact on the amount of active CatL, CatL+tissue, MMP-2 or MMP-9 
(Figure 3.13). Finally, there was no fundamental difference between ChR2-C2C12 and non-
optogenetic muscle strips with regards to the amount of active cathepsins or MMPs at either time 
point, and optical stimulation of ChR2-C2C12 optogenetic bio-bots resulted in similar trends in 
active CatL, CatL+tissue, MMP-2 and MMP-9 expression as electrical stimulation (Figure 
3.14a-d). Western blotting confirmed the presence for pro-form of CatL and CysC in the ChR2-
C2C12 optogenetic bio-bots (Figure 3.14e). 
 
3.4 Discussion and Conclusions 
The role of the basal lamina in providing the necessary elasticity and strength for muscle 
is of critical importance. It also provides key binding sites for sequestration of myogenic growth 
factors for muscle development and helps to maintain neuromuscular junctions (NMJs). Collagen 
IV, laminin-2, and proteoglycans are present in abundance in skeletal basal lamina. In the 
hydrogel-muscle platform of skeletal muscle bio-bots, natural ECM proteins comprise an 
engineered system that provides mechanical and biochemical support to differentiating myotubes, 
modeling a physiological arrangement. After myoblasts withdraw from the cell growth cycle and 
commit to a myogenic lineage during differentiation, they migrate to (and then physically fuse 
with) to other myoblasts to create multinucleated myotubes with one cytoplasm, and increase 
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expression of muscle-specific genes in adult muscle fibers13,31,32. The cells in the muscle strips 
exhibited these morphological and genetic changes, observable by immunostaining (Figure 3.3a) 
and the presence of mature muscle proteins (Figure 3.3c). During injury, a similar process of 
migration and fusion is observed by quiescent satellite cells, or myoblast progenitors, present in 
the basal lamina33. 
In vivo, protease activity is regulated by a strict balance between expression, activation, 
and inhibition; this balance plays a major role in the degree of matrix degradation and resulting 
cellular processes21. In vitro, degradation and resulting instability are drawbacks to tissue 
engineering with fibrin, and an inhibitor must be incorporated to prevent indiscriminate matrix 
digestion in systems lasting longer than a few hours. The anti-fibrinolytic agent ACA binds to 
the lysine binding sites present on both plasmin and its activating agent plasminogen, which can 
be produced by C2C12s11. ACA prevents plasmin from being activated and binding to (and 
subsequently degrading) fibrin by competitive and stoichiometric inhibition10. Incubation with 
increasing concentrations of ACA helped to preserve the structural integrity of the muscle strips 
and significantly increased the lifetime before rupture (Figure 3.5). Though the protease 
inhibitor aided in the maintenance of passive tension in the muscle strips over time and slow 
their degradation of muscle strips at earlier time points, it did not significantly reduce tissue loss 
by day 12 (Figure 3.6c). Since ACA inhibits serine proteases, the need for an investigation of 
the other protease families, including cysteine cathepsins and MMPs, was also apparent. 
In gel zymography is a versatile technique used to determine protease activity by 
incubation in a gel substrate composed of degradable proteins. As it does not require antibodies, 
is relatively inexpensive, and allows for visual confirmation of enzyme identity (and 
determination of active quantity) by molecular weight separation, zymography is useful in the 
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study of both cathepsins and MMPs25,26, across a number of tissue types34–37. Using a well-
characterized in gel zymography technique wherein electrophoresis separated cysteine proteases 
of interest from muscle strip lysate25,26, we quantified the amount of active cathepsins as well as 
MMPs over time and in various culture conditions (Figures 3.4b-c, 3.8, 3.9, 3.11, 3.12a-b, 
3.13a-b, and 3.14a-d). Cathepsins are implicated in a number of disease states (including tissue-
destructive processes that are implicated in cancer, arthritis, and osteoporosis), as well as 
mechanisms of normal tissue physiology26,35,38–41. They are also upregulated during myogenic 
differentiation, with CatL protein levels and proteolytic activities increasing in greater quantities 
compared to other major skeletal muscle cathepsins13,31. Although many different proteases have 
been implicated in myogenesis as well as injury, CatL has been recognized as a major player in 
muscle atrophy and wasting13,31. We observed that the amount of active CatL present in the 
muscle strips increased steadily over time, and was most highly expressed in the absence of ACA. 
Its activity on day 12 was significantly higher in all 0x muscle strips compared to 1x and 3x 
ACA, both with and without electrical stimulation (Figure 3.9c-i), indicating that the presence of 
ACA may prevent some processes associated with physiological muscular breakdown and 
potentially reduce the expression of CatL. This hypothesis could explain the extended lifetime 
observed in the presence of ACA. 
MMPs are involved in normal mammalian cell processes such as migration, adhesion, 
and proliferation; they comprise a range of proteases capable of degrading all ECM proteins and 
their upregulation has also been reported in various pathologies and disorders. Because MMPs 
are bound to the cell membrane or secreted, their role in myogenic differentiation, development, 
and injury is primarily extracellular, and they interact with specific ECM proteins over varied 
timelines42. The resulting cellular alignment, differentiation of adult myofibers, or remodeling of 
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muscle tissue architecture is a direct result of MMPs degrading ECM proteins that may hinder 
myoblast migration and fusion15,33. They can also be activated (directly or indirectly) by other 
proteolytic enzymes including plasmin and plasminogen22, which are present in our system. Both 
MMP-2 and MMP-9 can act on various collagen substrates, some of which are localized in our 
engineered muscle strips due to the presence of MatrigelTM 15.  
Expression of MMP-9 has been shown to be upregulated in myoblast cultures (both 
primary and C2C12) during migration and before cell fusion14,33. The processes concerning 
mature myotube formation witness a decrease in expression over time. We observed a decline in 
amount of active MMP-9 at later time points in muscle strips cultured with 1x and 3x ACA 
(Figures 3.8b, 3.13b, and 3.14b,d). Since upregulation of MMP-9 is also associated with early 
acute inflammation and initiation of muscle regeneration in proliferating and migrating satellite 
cells33, it is likely that only the earlier stages of muscle strip compaction and differentiation 
involve processes that resemble the recruitment (and subsequent fusion) of satellite myoblasts 
after injury. 
MMP-2, which is secreted by C2C12s, is constitutively produced in lower levels in 
healthy adult muscle and does not play a large role in myoblast migration or fusion. It is involved 
more heavily in later stages of C2C12 myofiber differentiation14,21,33. Active MMP-2 was 
slightly increased in all conditions on day 12 compared to day 3, although not significantly 
(Figures 3.8b and 3.9c-iii), suggesting that while myogenic differentiation was observed, the 
complete extracellular remodeling of matrix proteins that accompany later stages of muscular 
maturation may not have been visible during this experimental timeline. Though a period of less 
than two weeks proved relevant for this application of biological machines, an investigation on a 
longer time scale would provide more detailed temporal data on expression of specific MMPs as 
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well as cathepsins. Additionally, levels of MMP-2 (which can be secreted by satellite cells) 
increase gradually during later stages of injury, then return to baseline levels, suggesting an 
important role in repair and regeneration of new muscle fibers14,21. The introduction of deliberate 
inflammation or injury to the muscle strips could test this hypothesis in future studies. 
The fabrication of skeletal muscle bio-bots offers flexibility in varying almost any 
parameter in the system. We also investigated the effect of altering certain variables whose 
affects on bio-bot functionality we have previously reported: cell density, hydrogel stiffness1, 
and dynamic optogenetic stimulation2. Varying these conditions revealed that the amount of 
active MMP depended on design parameters, while the amount of active cathepsin was 
independent of these environmental changes or applied stimuli. When the cell seeding density for 
muscle strip formation was varied, the amount of active cathepsin was unchanged (Figure 3.11a). 
The amount of active MMP-2, however, significantly increased with cell concentration (Figure 
3.11b). It is possible that the increase in initial myoblast density accelerated the fusion and 
differentiation process. MMP-2 has been shown to increase with the presence of mature 
myotubes21,22, substantiating the observation as the cell concentration was increased to 10 x 106 
cells ml-1. 
When muscle strips were differentiated under higher static tension, the amount of active 
cathepsin L decreased, although again not significantly (Figure 3.12a). Interestingly, the amount 
of active MMP-2 and MMP-9 both decreased in the presence of higher static tension (Figure 
3.12b), despite an extracellular presence in a condition that favors higher degrees of myofiber 
alignment and differentiation. This may indicate reduced myotube formation in these bio-bots 
under higher tension.  
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Finally, when ChR2-C2C12 optogenetic bio-bots were subjected to optical stimulation, 
we observed no change in the amount of active CatL or MMPs (Figures 3.13 and 3.14). This 
indicates that optical stimulation did not alter proteolytic expression profiles associated with 
myogenic differentiation or injury, and confirms that the electrical stimulation is not responsible 
for this proteolytic activity by cathepsins and MMPs. Though electrical stimulation is a useful 
tool because it allows for the global and coordinated stimulation of all excitable cells within the 
muscle strip, optogenetics provides a less invasive and more specific alternative. 
Biological building blocks – different cell types or tissues in an instructive environment – 
can be assembled in various ways to promote the emergence of cellular systems with well-
defined functionality, allowing for the realization of dynamic cellular machines with the ability 
to interface with the environment and other living systems43. However, as these biological 
machines increase in complexity, it may be critical to design systems that could be engineered 
with a specific life expectancy and exhibit greater consistency. Forward engineering of 
biological and mechanical properties, plus knowledge of how these factors affect factors such as 
protease activity, can potentially dictate a system’s sustainability. A machine designed to ‘fail’ or 
‘break’ within a certain window or range of time (after performing a specific task, for example), 
could be programmed to upregulate expression of certain proteases with the introduction of 
inflammatory cytokines such as tumor necrosis factor-α (TNF-α), which accelerates 
overexpression or activation of some proteases14,39. On the other hand, the addition of a protease 
inhibitor (such as the strong-binding endogenous cysC26,44,45, the broad-spectrum cathepsin 
inhibitor E-6426,39,45, or tissue inhibitors of metalloproteinases (TIMPs)15,46 that tightly regulate 
MMP activity) could aid in the programming of a machine requiring a longer lifespan by 
lowering the amount of active proteases. Most likely, the majority of future living biological 
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systems will require an intricate balance between the activity and inhibition of serine and 
cysteine proteases as they exist and function together in a proteolytic network47. The ratio 
between proteases and their inhibitors (such as the important equilibrium required between 
MMPs and TIMPs in skeletal muscle14,15,22,33) is critical to maintaining a balanced state. 
Looking forward, as neuromuscular control and vascularization are introduced into 
engineered living systems, it will be critical that we understand what proteases are involved in 
these processes and how the cells may adapt to the new environment. Proteolysis of the basal 
lamina is critical in angiogenesis, and MMP-2 and membrane-type 1 (MT1) MMP involvement 
has been seen in capillary growth14. Furthermore, MMP-2, MMP-7, and MMP-9 are co-localized 
at neuromuscular junctions in healthy tissue14. Taken together, these highlight the importance of 
recognizing that the proteases that appear to be involved in normal muscle strip development will 
also be involved in these other cellular processes, and must be accounted for in future 
development of engineered living systems.  
Finally, because skeletal muscle cathepsins can also hydrolyze myogenic proteins such as 
myosin, troponin T, and tropomyosin31,48, it may also be worth examining whether the activity of 
these proteases in intracellular degradation (and subsequent breakdown or atrophy of muscle 
fibers) contributes in any way to failure of the engineered muscle system. Lastly, increased 
expression and regulation of cathepsins31,49 and MMPs15 has been observed in dystrophic 
muscles; therefore this platform could also be used for the study of disease-specific models and 
treatments of diseases such as muscular dystrophy or other myopathies. 
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3.5 Figures 
 
 
 
 
Figure 3.1. Polymerization and Degradation of Fibrin. Fibrinogen is cleaved by thrombin to 
yield fibrin monomers that can be polymerized into protofibrils. The addition of the protease 
plasmin can lead to hydrolysis of the fibrin branching network, yielding degradation products. 
However, the inhibitor aminocaproic acid (ACA) can be added to prevent plasmin from 
becoming its active form. For more detail, see references6,8,50. 
 
 
 
 
 
Figure 3.2. Timeline of Bio-Bot Development and Analysis. Skeletal muscle bio-bots were 
fabricated and seeded on day 0. On day 3, DM was added to induce differentiation of skeletal 
muscle. Electrical or optical stimulation was applied on days 4-12, as noted. Samples were snap 
frozen for gelatin zymography on days 3, 6, 8, and 12. 
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Figure 3.3. Development and Differentiation of Skeletal Muscle Bio-Bots. (a) Bio-bot process 
flow. (i) A Stereolithography apparatus (SLA) was used to 3D print a millimeter-scale hydrogel 
skeleton and holder. (ii) C2C12s were mixed with a liquid solution of ECM proteins that 
included fibrinogen, thrombin, and MatrigelTM. (iii) When added to the holder, the cell-gel 
solution compacted to form a solid muscle strip. Scale bar, 2 mm. (iv) The freestanding bio-bot 
(consisting of the muscle strip coupled to the hydrogel skeleton) could be released from the 
holder and subjected to electrical stimulation. (v) Immunostaining revealed the presence of 
striated and multinucleated myotubes (α-actinin, red; MF-20 myosin, green; DAPI nuclear stain, 
blue). Scale bar, 50 µm. (b) Total DNA and protein levels increased over the time course of the 
experiment (n = 3-4 muscle strips per time point). (c) Muscle creatine kinase (MCK) activity was 
significantly increased as early as day 6, and reached a maximum output on day 12 (n = 3 muscle 
strips per time point). The rate of increased MCK activity slowed between days 8 and 12, 
confirming that this was a relevant stopping point for the experiments. All plots represent mean ± 
SD. * indicates significance (p < 0.05) between conditions at the same time point; ^ indicates 
significance compared to initial time point. 
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Figure 3.4. Gelatin Zymography of Cathepsins and MMPs without ACA.  
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Figure 3.4 (cont.). Gelatin Zymography of Cathepsins and MMPs without ACA. (a) Muscle 
strip zymography process flow. (i) Degrading muscle strips were removed from hydrogel 
skeletons. (ii) Muscle strips could be fixed and stained for further analysis. (iii) Tissues were 
digested in lysis buffer. Isolated proteins were run through gel electrophoresis. (iv) Gels were 
incubated in renaturing and assay buffers. (v) Gels were stained with Coomassie Blue; bright 
bands indicated the activity of specific proteases, which were separated by molecular weight. (b) 
Cathepsin zymography identified the activity of CatL and CatL+tissue at days 3, 6, 8, and 12, in 
the presence or absence of electrical stimulation (n = 3-5 muscle strips per condition). (c) MMP 
zymography identified the activity of MMP-2 and MMP-9 at days 3, 6, 8, and 12, in the presence 
or absence of electrical stimulation (n = 3-5 muscle strips per condition). For MMP zymograms, 
upper bands reflect inactive enzyme (proMMP) and lower bands reflect active enzyme. (d) 
Western blotting confirmed the presence of cathepsins and related proteins, such as CysC (n = 3-
5 muscle strips per condition). All plots represent mean ± SEM. ^ indicates significance (p < 
0.05) compared to initial time point. 
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Figure 3.5. Bio-Bot Life Expectancy. (a) In the absence of any anti-fibrinolytic treatment (0x 
ACA), muscle strips demonstrated an average life expectancy of 8.2 ± 1.6 days until rupture. 
However, incubation in medium with the serine protease inhibitor ACA lengthened the life 
expectancy of the muscle strips. Box plots represent 25th, 50th, and 75th percentiles, with average 
values marked as (x) and whiskers representing ± SD. Data are presented to the left of the boxes 
(n = 6-13 muscle strips per condition, excluding outliers). * indicates significance (p < 0.05) 
between time points. (b) Kaplan-Meier survival analysis provided an additional method of 
comparison by plotting survival fraction of each treatment group as a function of time. (c) 
Kaplan-Meier survival curves are shown for each treatment group (0x, 1x, 3x ACA) as a 
function of time. 95% confidence intervals (CI) are also shown (n = 6-13 muscle strips per 
condition, excluding outliers). 
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Figure 3.6. Loss of Tissue Structure. (a) Increasing the concentration of ACA from 1 to 3 mg 
ml-1 did not adversely affect cell viability within the muscle strips, as quantified using a MTS 
colorimetric assay (n = 6-7 muscle strips per condition). The number of living cells was assumed 
to be directly proportional to the absorbance. (b) Muscle strips began to degraded (most notably, 
in the middle region of the tissue), as shown in top-view images. Scale bar, 1 mm. (c) Average 
muscle strip tissue diameter as a function of time and ACA treatment, expressed as a percentage 
of original tissue diameter and actual dimensions (n = 2-9 muscle strips per condition). Though 
the diameters of all groups on day 12 were reduced, the addition of 3x ACA helped to maintain 
the integrity of the tissue longer. * indicates significance (p < 0.05) between conditions at the 
same time point; ^ indicates significance compared to initial time point. 
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Figure 3.7. Loss of Mechanical Integrity. (a) (i-ii) Muscle strips cultured without ACA 
displayed a lower passive tension and faster decrease in static force over time. (ii) After day 8, 
the passive tension was significantly lower for 0x muscle strips (n = 4-7 per time point) 
compared to both 1x (n = 5-6 per time point) and 3x ACA (n = 5-7 per time point). Scale bar, 1 
mm. (b) Histological staining for Masson’s Trichrome indicated that the addition of ACA helped 
to maintain the ECM in muscle strips. Scale bar, 200 µm. (c) Muscle strip passive tension for 1x 
and 3x ACA, with and without electrical stimulation, over time. There was no significant 
difference in measured tension force across ACA treatment groups or stimulation regimens (n = 
5-10 muscle strips per time point). Plots represent mean ± SD. * indicates significance (p < 0.05) 
between conditions at the same time point; ^ indicates significance compared to initial time point. 
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Figure 3.8. Gelatin Zymography of Cathepsins and MMPs with 1x and 3x ACA. (a) Cathepsin 
zymography identified the amount of active CatL and CatL+tissue at days 3, 6, 8, and 12, in the 
presence or absence of electrical stimulation, for 1x and 3x ACA (n = 3-6 muscle strips per 
condition). (b) MMP zymography identified the amount of active MMP-2 and MMP-9 at days 3, 
6, 8, and 12, in the presence or absence of electrical stimulation, for 1x and 3x ACA (n = 4-7 
muscle strips per condition). All plots represent mean ± SEM. ^ indicates significance (p < 0.05) 
compared to initial time point. 
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Figure 3.9. Comparison of Active Cathepsins and MMPs in 0x, 1x, and 3x ACA Cultured 
Muscle Strips. (a) Cathepsin zymography identified the amount of active CatL and CatL+tissue 
and (b) MMP zymography identified the amount of active MMP-2, and MMP-9, with and 
without electrical stimulation, for day 12 conditions compared to the initial time point of day 3. 
(c) ACA prolonged the lifetime and reduced the amount of active CatL in locomoting biological 
machines. All plots represent mean ± SEM. * indicates significance (p < 0.05) between 
conditions at the same time point; ^ indicates significance compared to initial time point. 
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Figure 3.10. Western Blotting of CatL in Muscle Strips with ACA. (a) Western blotting 
confirmed the presence of cathepsins and related proteins in muscle strips cultured with 1x and 
3x ACA over time. (b) Western blotting of CatL, with and without electrical stimulation, for day 
12 conditions compared to the initial time point of day 3 (n = 4-7 muscle strips per condition). 
All plots represent mean ± SEM. * indicates significance (p < 0.05) between conditions at the 
same time point; ^ indicates significance compared to initial time point. 
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Figure 3.11. Gelatin Zymography of Cathepsins and MMPs in Muscle Strips with Varying Cell 
Density. For day 12 muscle strips cultured with 1x ACA and fabricated with varying cell 
densities (2.5, 5, or 10 x 106 cells ml-1), (a) cathepsin zymography identified the amount of active 
CatL and CatL+tissue and (b) MMP zymography identified the amount of active MMP-2 and 
MMP-9 (n = 3-4 muscle strips per condition). 
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Figure 3.12. Gelatin Zymography of Cathepsins and MMPs in Muscle Strips with Varying 
Hydrogel Skeleton Stiffness. For day 12 muscle strips cultured with 1x ACA with a hydrogel 
skeleton stiffness of 319, 411, or 489 kPa, (a) cathepsin zymography identified the amount of 
active CatL and CatL+tissue and (b) MMP zymography identified the amount of active MMP-2 
and MMP-9 (n = 3-4 muscle strips per condition). (c) Western blotting confirmed the presence of 
cathepsins in muscle strips with varying hydrogel stiffness, for day 12 conditions compared to 
the initial time point of day 3 (n = 3-4 muscle strips per condition). All plots represent mean ± 
SEM. * indicates significance (p < 0.05) between conditions at the same time point. 
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Figure 3.13. Gelatin Zymography of Cathepsins and MMPs in Muscle Strips with Applied 
Optical Stimulation. For ChR2-C2C12 optogenetic muscle strips, (a) cathepsin zymography 
identified the amount of active CatL and CatL+tissue at days 6 and 12, and (b) MMP 
zymography identified the amount of active MMP-2 and MMP-9 at days 6 and 12, in the 
presence or absence of optogenetic stimulation (n = 3 muscle strips per condition). All plots 
represent mean ± SEM. ^ indicates significance (p < 0.05) compared to initial time point (day 6). 
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Figure 3.14. ChR2-C2C12 Optogenetic Bio-Bots. Gelatin zymography identified the amount of 
active (a) CatL, CatL+tissue, (b) MMP-2, and MMP-9, on days 6 and 12, for both non-
optogenetic bio-bots and ChR2-C2C12 bio-bots without stimulation. (c-d) Amount of active 
proteases on day 12, for both non-optogenetic bio-bots subjected to electrical stimulation and 
ChR2-C2C12 bio-bots subjected to optical stimulation. (e) Western blotting confirmed the 
presence of cathepsins in ChR2-C2C12 optogenetic muscle strips on days 6 and 12, with and 
without optical stimulation (n = 3 muscle strips per condition). All plots represent mean ± SEM. 
^ indicates significance (p < 0.05) compared to initial time point (day 6 for panel a). 
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CHAPTER 4: A 3D PRINTED PLATFORM FOR 
MODULAR NEUROMUSCULAR MOTOR UNITS ∗ 
 
4.1 Introduction 
Engineering living cellular machines requires the interaction of one or more cell types in 
an instructive environment1. These systems could be comprised of micro- or macro-scale 
subunits engineered to cooperatively perform certain tasks. Modularity of these subunits 
(consisting of cells, tissues, and biomaterials, along with growth factors or other biochemical 
signals) allows for “forward-engineering” of the system by assembling the components in 
diverse manners, like building blocks, thus expanding the functionality of the systems. For 
example, we recently demonstrated a modular skeletal muscle tissue “ring” that could be coupled 
to a 3D printed skeleton to produce net motion2. This bio-integrated actuator (bio-bot) was a 
functional cellular system that exhibited dynamic and adaptive behavior based on both its 
inherent design as well as its surroundings. 
Our previously demonstrated muscle-powered biological machines2,3 used externally 
applied electrical or optogenetic signals to stimulate an engineered skeletal muscle tissue to 
contract. Skeletal muscle is the principal actuator in many animals4, and its inherently modular 
and scalable nature renders it a natural component of many cellular systems. The ability to 
respond to stimuli by producing force (resulting in events such as fluid motion or net 
displacement, in a pump or motile bioactuator, for example) is an intuitive design principle of 
many systems. However, a more complex biological system with greater functionality would 
likely require the integration and coordination of multiple cell types; i.e., moving from a 																																																								
* This chapter has been adapted from the following publication: Caroline Cvetkovic, Max H. 
Rich, Ritu Raman, Hyunjoon Kong, and Rashid Bashir. “A 3D Printed Platform for Modular 
Neuromuscular Motor Units.” Microsystems & Nanoengineering. (In Press.) 2017. 
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homotypic cluster such as a cell sheet5–7 or an engineered muscle strip8,9 (with a singular cell 
type) towards a heterotypic co-culture such as a neuromuscular junction (NMJ), with multiple 
cell types1. In vivo, skeletal muscle fibers are innervated by the axons of somatic motor neurons 
(MNs) and do not inherently contract without stimulation from an excitatory neurotransmitter10. 
Early research in the formation of NMJs in 2D has primarily focused either on the co-
culture of excised or isolated muscle and neural tissues in vitro11,12, or the differentiation of 
mouse13–16 or human17–19 embryonic stem cells into MNs (usually through the formation of 
embryoid bodies, or EBs), which were then co-cultured with excised or engineered muscle 
tissues. Beyond applications in regenerative medicine and therapeutics20, however, only a few 
studies have achieved 3D NMJ platforms or applied neuromuscular research to living cellular 
systems using embryonic or neural stem cells21–23. Furthermore, there is a lack of research 
demonstrating the possibility of translating such an arrangement to a potentially autonomous, 
scalable, and forward-engineered platform – necessary characteristics of a mobile and functional 
cellular system or machine. 
Here, we present a modular cellular system, made up of multi-layered tissue rings 
containing integrated skeletal muscle and MNs embedded in an extracellular matrix (ECM). The 
MNs were differentiated from mouse embryonic stem cells through the formation of EBs, 
spherical aggregations of cells grown in suspension culture. The EBs were integrated into a 
tissue ring with skeletal muscle, which was differentiated in parallel, to create a co-culture 
amenable to both cell types. The multi-layered rings were then sequentially placed on a 
stationary 3D printed hydrogel structure resembling an anatomical muscle-tendon-bone 
organization (Figure 4.1). The use of stereolithographic 3D printing (an additive rapid 
prototyping technique)24,25 to create a flexible yet integrated tissue arrangement allows for 
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iterative design modifications on a range of length scales. This system demonstrates functional 
NMJ behavior and controllable outputs including engineered muscle contraction upon applied 
chemical stimulation, and permits control over physical, mechanical, and biochemical cues.  
 
4.2 Materials and Methods 
4.2.1 Fabrication of Hydrogel Ring Molds and Bio-Bot Skeletons 
CAD software (AutoCAD) was used to design hydrogel ring molds and bio-bot 
skeletons2. Briefly, parts were exported in .stl format, sliced into layers using 3D Lightyear 
software (v1.4, 3D Systems), and fabricated using a modified Stereolithography apparatus (SLA 
250/50, 3D Systems). 22x22 mm-square cover glass slides were treated in an oxygen plasma 
system to render the surface hydrophilic, chemically treated with 2% (v/v) 3-
(trimethoxysilyl)propyl methacrylate (3-TPM, Sigma-Aldrich), and adhered to a 35 mm culture 
dish, as detailed previously2. This treatment ensured chemical tethering of the fabricated 
hydrogel to the underlying glass slide. For hydrogel ring molds and bio-bot skeletons, liquid pre-
polymer solutions were prepared as previously described3: 20% (w/v) poly(ethylene glycol) 
dimethacrylate of MW 1000 g mol-1 (PEGDMA 1000, Polysciences, Inc.) and 20% (v/v) 
poly(ethylene glycol) diacrylate of MW 700 g mol-1 (PEGDA 700, Sigma-Aldrich), respectively, 
dissolved in phosphate buffered saline (PBS) with 0.5% (w/v) 1-[4-(2-hydroxyethoxy)phenyl]-2-
hydroxy-2-methyl-1-propanone-1-one photoinitiator (Irgacure 2959, BASF). After fabrication, 
hydrogel parts were rinsed in PBS and then disinfected in 70% EtOH for at least 1 h. Sterilized 
parts were stored in sterile PBS at 4ºC until use. 	  
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4.2.2 Cell Culture 
Skeletal Muscle. Proliferating C2C12s (murine myoblasts) were maintained in muscle 
growth medium consisting of Dulbecco’s Modified Eagle Medium (DMEM, Cellgro) with 10% 
(v/v) fetal bovine serum (FBS, VWR), 1% (v/v) penicillin-streptomycin (10,000 U ml-1, Cellgro), 
and 1% (v/v) L-glutamine (Cellgro). Cells in culture were passaged before confluence. All cells, 
cultures, and tissue rings were incubated at 37ºC and 5% CO2. 
Mouse Embryonic Stem Cells (mESCs). A feeder layer of mouse embryonic fibroblasts 
(CF-1 mitomycin-C inactivated MEFs, Applied Stem Cell, Inc.) was pre-plated 2 d prior to stem 
cell culture at a density of 3 x 104 cells cm-2 in DMEM with 10% (v/v) FBS, 1% (v/v) penicillin-
streptomycin, and 1% (v/v) L-glutamine. HBG3 mESCs (Hb9-GFP, ArunA Biomedical) were 
thawed and expanded at a density of 5 x 104 cells cm-2 on top of the MEF layer in mESC 
proliferation medium consisting of EmbryoMax ES DMEM (EMD Millipore) with 15% (v/v) 
FBS, 1% (v/v) each of penicillin-streptomycin (5000 U ml-1, Gibco), L-glutamine, EmbryoMax 
nucleosides (EMD Millipore), and MEM non-essential amino acids (Gibco), 0.1 mM β-
mercaptoethanol (Gibco), and 0.1% (v/v) ESGRO mouse leukemia inhibitory factor (mLIF, 
EMD Millipore). Cells were passaged before colonies reached confluence. 
Embryoid Bodies (EBs) Containing Motor Neurons (MNs). As previously 
described15,22, to initiate differentiation, HBG3 mESCs were switched to neural differentiation 
medium containing 50% (v/v) Advanced DMEM/F12 (Gibco), 50% (v/v) Neurobasal (Gibco), 
10% (v/v) KnockOut serum replacement (Gibco), 1% (v/v) penicillin-streptomycin (5000 U ml-1), 
1% (v/v) L-glutamine, and 0.1 mM β-mercaptoethanol. After 1 h of incubation in serum-free 
neural differentiation medium, cells were trypsinized, centrifuged, and replated at a density of 1-
2.5 x 106 cells per 10 cm tissue culture dish (day 0). On day 1, floating cells in suspension were 
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collected and replated in a new dish, and adhered cells were discarded. On day 2, floating EBs 
were collected and replated in differentiation medium with 1 µM purmorphamine (EMD 
Millipore) and 1 µM retinoic acid (Sigma-Aldrich). On day 5, floating EBs were collected and 
the medium was supplemented with 10 ng ml-1 each of glial-derived neurotrophic factor (GDNF, 
Neuromics) and ciliary neurotrophic factor (CNTF, Sigma-Aldrich) to make complete neural 
differentiation medium. Differentiated GFP+ EBs were used between days 5-7. 
 
4.2.3 Multi-Layered Tissue Ring Formation 
For the formation of layer 1 of the multi-layered tissue rings, 5 x 106 cells ml-1 (final 
density of C2C12s in the cell-gel solution) were combined with fibrinogen (4 mg ml -1, Sigma-
Aldrich), thrombin from bovine plasma (0.5 U mg-1 fibrinogen, Sigma-Aldrich), and MatrigelTM 
basement membrane (30% (v/v) of total cell-gel solution, Corning) on ice. Muscle growth 
medium was added to bring the cell-gel solution to its final volume (80 µl, 4 x 105 cells total per 
ring, unless otherwise noted), and the solution was added to the well of a hydrogel ring mold 
(day 0). Molds were previously aspirated of excess liquid to ensure consistent cell-gel densities. 
Tissue rings were allowed to incubate for 2 h before adding warm growth medium with 1 mg ml 
-1 ACA, which was exchanged daily. On day 1, tissue rings were switched to muscle 
differentiation media consisting of DMEM with 10% (v/v) heat-inactivated horse serum (HS, 
Gibco), 1% (v/v) penicillin-streptomycin, 1% (v/v) L-glutamine, 1 mg ml-1 aminocaproic acid 
(ACA, Sigma-Aldrich), and 50 ng ml-1 LONG® R3 human insulin-like growth factor (IGF-1, 
Sigma-Aldrich). On day 3, layer 2 was added to the hydrogel ring molds and allowed to compact 
around layer 1. Differentiated EBs were individually selected for being GFP+ and mixed with the 
cell-gel solution. The cell-gel solution (60 µl, 3 x 105 cells total per ring) was otherwise identical 
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to layer 1. Tissue rings were allowed to incubate for 2 h before adding warm complete neural 
differentiation medium with 1 mg ml-1 ACA and 50 ng ml-1 IGF-1. 
 
4.2.4 Staining and Imaging 
Immunocytochemistry. Samples were rinsed in PBS, fixed in 4% paraformaldehyde 
(Electron Microscopy Services) for 30 min, rinsed again, permeabilized with 0.25% Triton X-
100 (Sigma-Aldrich) for 10 min, and blocked in Image-iT® FX Signal Enhancer (Molecular 
Probes, ThermoFisher) overnight at 4ºC. Samples were incubated with primary antibodies, MF-
20 anti-myosin heavy chain (1:400, Developmental Studies Hybridoma Bank, The University of 
Iowa) or anti-glial fibrillary acidic protein (GFAP, 1:1000, Chemicon, EMD Millipore), in 
Image-iT® FX at 4ºC overnight. After rinsing 3x with PBS, samples were incubated with 
secondary antibodies, either Alexa Fluor® 488 goat anti-mouse IgG or Alexa Fluor® 568 F(ab')2 
fragment of goat anti-mouse IgG (both 1:400, ThermoFisher), in Image-iT® FX in the dark at 
4ºC overnight. After rinsing 3x with PBS, samples were incubated with 4’,6-diamindino-2-
phenylindole (DAPI, 1:5,000 in sterilized de-ionized water, Sigma-Aldrich) for 10 min, rinsed, 
and imaged in a 35-mm glass-bottom dish (MatTek) using a confocal microscope (LSM710, 
Zeiss). For imaging of acetylcholine receptors (AChRs), live samples were first incubated with 
tetramethylrhodamine α-bungarotoxin (TRITC-conjugated α-BTX, 1:1000, Molecular Probes, 
ThermoFisher) in complete neural differentiation medium for one hour at 37ºC, then fixed and 
imaged as detailed above. 
Scanning Electron Microscopy (SEM). Samples were rinsed in PBS, fixed in 4% 
paraformaldehyde, and dehydrated using a series of ethanol solutions: 37% (10 min), 67% (10 
min), 95% (10 min), and 100% (3x 10 min). Hexamethyldisilazane (HMDS, Polysciences, Inc.) 
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was added for 5 min, then allowed to vaporize. Gold/palladium was deposited on the dried 
sample for 70 s using a sputter coater (Desk II, TSC). Images were acquired using an 
environmental scanning electron microscope (SEM, XL30, Philips/FEI). 
Area Measurements. A digital camera (Flex, SPOT Imaging Solutions) on a 
stereomicroscope (MZ FL III, Leica Microsystems) was used to take images of the multi-layered 
tissue rings during compaction. SPOT Software (v5.2, SPOT Imaging Solutions) and ImageJ 
software (National Institutes of Health) were used to measure tissue area dimensions over time. 
Neurite Growth Measurements. After day 9 of differentiation, EBs were plated on 
either collagen I (Gibco) or MatrigelTM coated dishes in complete neural differentiation medium. 
EBs containing motor neurons expressed GFP+ and thus did not require additional cell markers. 
Live samples were imaged on days 10-14 using an inverted fluorescent microscope for 2D 
cultures (IX81, Olympus) or a confocal microscope for 3D tissue rings (LSM710, Zeiss). The 
NeuronJ plug-in (ImageScience) for ImageJ was used to measure neurite growth distances 
(Figure 4.2).  
 
4.2.5 Chemical Stimulation of Multi-Layered Tissue Rings 
To stimulate motor neurons in tissue rings, L-glutamic acid (glutamate, Sigma-Aldrich) 
was added to cell culture medium in a bath application of either 200 µM or 400 µM, as noted. 
Tissues were then transferred to fresh medium. After chemical stimulation, the nicotinic AChR 
antagonist (+)-tubocurarine chloride hydrochloride pentahydrate (curare, Abcam) was added to 
cell culture medium in a bath application of 25 µM. Tissues were then rinsed in PBS and 
transferred to fresh medium. 	  
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4.2.6 Video Capture and Movement Tracking 
Muscle contraction within tissue rings was captured using a digital camera on a 
stereomicroscope with a capture rate of 5-10 frames s-1. Image sequences were exported to .avi 
files. A custom Matlab script was used to calculate x-y displacement of user-specified regions of 
interest using normalized 2D cross-correlation, as described previously3. 
 
4.2.7 Statistical Analysis 
All results are presented as mean ± standard deviation. OriginPro software (v9.1) was 
used to calculate significance (one-way ANOVA followed by Tukey’s Multiple Comparison 
Test). 
 
4.3 Results 
4.3.1 Differentiation of Embryoid Bodies Containing Motor Neurons 
To attain motor neurons (MNs), we induced mouse embryonic stem cells (HBG3 mESCs, 
from a transgenic mouse cell line) to directly differentiate using a protocol that recapitulates 
spinal motor neuron maturation in embryonic development in vivo13,15,22. Temporal addition of 
relevant growth and signaling factors pushed cells to become neural progenitor cells and then 
MNs. First, HBG3 mESCs were proliferated on a feeder layer of mouse embryonic fibroblasts 
(MEFs) to support their propagation, preserve pluripotent capacity, and prevent differentiation. 
When colonies became confluent (Figure 4.3), cells were switched to differentiation medium, 
trypsinized, centrifuged, and replated in a cell culture dish. MEFs adhered to the dish while 
HBG3 mESCs differentiated in suspension and aggregated to become spherical EBs (Figure 
4.4a). We added retinoic acid and purmorphamine (caudalizing and ventralizing signaling 
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molecules that drive neural progenitors first toward spinal and then motor neuron identities, 
respectively13) on day 2, and supplemented EB cultures with glial cell line-derived neurotrophic 
factor and ciliary neurotrophic factor (GDNF and CNTF, neural growth factors that promote MN 
survival26) on day 5. EBs increased in size and circularity over time, with the initial cell seeding 
density on day 0 playing a role in the size of differentiated EBs (Figure 4.4b).  
Cells expressed green fluorescent protein (GFP) under the control of the postmitotic 
motor neuron-specific Hb9 promoter (Figure 4.5a); thus, we could visually confirm 
differentiation of MNs without the addition of exogenous factors or antibodies. Fluorescent 
imaging revealed that EBs also contained proliferating glia (Figure 4.5b), which are known to 
contribute to the formation and maintenance of the NMJ as well as differentiation and survival of 
MNs11. When allowed to adhere to natural ECM substrates such as collagen I (Figure 4.6a) and 
MatrigelTM (Figure 4.6b-c), EBs containing MNs attached readily and extended neurites across 
the gels. Neurites grew 417.5 ± 154.8 and 999.1 ± 356.9 µm after 4 days of attachment 
(propagating at nearly linear rates of 88.6 and 264.8 µm day-1) on collagen I and MatrigelTM 
surfaces, respectively (Figure 4.6d). Similarly, EBs adhered to (and extended neurites across) 
the surface of 2D layers of differentiated C2C12s (Figure 4.7a). After 5 days of co-culture, we 
identified clusters of post-synaptic acetylcholine receptors (visualized with fluorescently-
conjugated α-BTX, which binds to a subunit of AChR) near the termination of neurite extensions 
on myotubes (Figure 4.7b).	
 
4.3.2 Development of Multi-layered Tissue Rings in Hydrogel Molds 
To fabricate the macroscopic structures necessary for the development and co-culture of 
engineered tissue rings, we used a stereolithography apparatus to 3D print poly(ethylene) glycol- 
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(PEG-)based hydrogels. We designed and 3D printed a hydrogel ring mold (Figure 4.8a) to 
guide the formation of a liquid cell-gel solution into a solid engineered muscle tissue. The mold 
contained rectangular-shaped wells that forced the compacting cells and ECM into a ring-shaped 
tissue. A cell-gel solution consisting of 80 µl of C2C12 myoblast precursor skeletal muscle cells 
and ECM proteins (MatrigelTM and fibrinogen) was injected into the mold (Figure 4.8b). The 
polymerization of the matrix proteins (thrombin was added to cleave fibrinogen and form a 
cross-linked fibrin network) as well as the traction forces exerted by the myoblasts on 
surrounding proteins resulted in compaction of the tissue into a solid ring (Figure 4.8c-i). After 1 
day, we added differentiation medium containing 10% horse serum in order to induce fusion of 
myoblasts into mature muscle fibers, or myotubes (Figure 4.8d). Medium was also 
supplemented with aminocaproic acid (ACA, an inhibitor to prevent degradation of the ECM by 
cell-secreted proteases) and insulin-like growth factor (IGF-1, which is known to increase 
myoblast fusion and muscle hypertrophy27,28).  
After 3 days of allowing the first muscle layer to compact and differentiate in the 
hydrogel ring mold, we added a second layer of cell-gel solution (Figure 4.8c-ii). This mixture 
contained the same C2C12 and ECM components as the first layer, as well as differentiated EBs 
that were individually selected for being predominantly GFP+ (thus containing MNs). Co-culture 
medium was switched to complete neural differentiation medium supplemented with ACA and 
IGF-1. 
Layer 2 compacted around the first and the cross-sectional tissue area decreased daily to a 
lower limit of 17.9 ± 1.6 mm2, or approximately 22% of the original area dictated by the 
hydrogel ring mold, after 5 days of co-culture (Figure 4.8e). We controlled the thickness of the 
tissue by varying the initial cell-gel volume; initial volumes of 60, 80, and 90 µl (containing 3 x 
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105, 4 x 105, and 4.5 x 105 cells in each ring) resulted in ring tissues with layer 1 cross-sectional 
areas of 11.7 ± 1.6, 13.9 ± 2.4, and 17.1 ± 4.6 mm2 (14.3, 17.1, and 21.0% of the original area) 
after 5 days, respectively (Figure 4.8f). 
Various imaging modalities confirmed the presence of both differentiated muscle as well 
as GFP+ EBs in the multi-layered tissue rings. Compaction of layer 2 brought the EBs in close 
contact with layer 1 during the first 24 h of co-culture (Figure 4.9a). By this time, the myoblasts 
in layer 1 had differentiated to form elongated, multinucleated myotubes that expressed mature 
myosin protein (Figure 4.9b). 
 
4.3.3 Spontaneous Muscle Contraction in Co-Culture 
Following the addition of layer 2 with MN-containing EBs to the hydrogel ring molds 
(Figure 4.10a-i), we observed spontaneous contraction of differentiated muscle in layer 1 as 
early as 2 h after co-culture. Two regions of muscle in layer 1, approximately 600 and 800 µm 
from the nearest group of EBs, twitched at approximately 1.6 contractions sec-1, with local 
displacements measuring 9.9 ± 1.8 and 6.8 ± 1.9 µm per twitch for regions 1 and 2, respectively 
(Figure 4.10a-ii). After 24 h of co-culture, after layer 2 had begun to compact into a solid ring 
(Figure 4.10b-i), we observed continued spontaneous contraction. The muscle twitched with 
decreased frequency (approximately 0.9 contractions sec-1) and amplitude (6.5 ± 0.9 and 8.7 ± 
1.6 µm per twitch) compared to hour 2 (Figure 4.10b-ii), and contraction eventually ceased. 
 
4.3.4 Transfer of Multi-layered Tissue Rings to Hydrogel Skeletons 
We designed and fabricated a stationary skeleton, composed of a pillar connecting two 
stiff beams, representing a physiological muscle-tendon-bone arrangement (Figure 4.11a). The 
beam of the skeleton was chemically tethered to a glass slide and thus provided a static 
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mechanical stretch to the tissue rings. When both layers fused into one tissue, the compliant ring 
was physically placed onto a 3D printed structure (Figure 4.11b). 
Within the multi-layered tissue rings, EBs began to extend neurites from GFP+ MNs. 
Using confocal imaging, we confirmed that the extension propagated in 3D throughout the tissue, 
both in the direction of other EBs as well as toward differentiated muscle (Figure 4.12a). 
Neurite length significantly increased between days 3 and 9 of co-culture, from 207.4 ± 153.2 to 
433.6 ± 372.5 µm (Figure 4.12b). 
 
4.3.5 Chemical Stimulation of MNs in Multi-layered Tissue Rings 
On day 9 after co-culture, we chemically stimulated MNs by adding glutamate. Multi-
layered tissue rings were first subjected to a bath application of 200 µM glutamate in complete 
neural differentiation medium. Through video recordings, we observed that local muscle 
contraction began in response to chemical stimulation of MNs (Figure 4.12c). When we 
increased the glutamate concentration from 200 to 400 µM, the frequency of muscle twitching 
increased from 1.08 to 1.33 contractions sec-1, while the average displacement decreased from 
6.3 ± 0 to 4.4 ± 0.2 µm per twitch (Figure 4.12d). The addition of 25 µM tubocurarine chloride 
(curare), an irreversible nicotinic NMJ antagonist and muscle relaxant23 that blocks AChRs, 
halted the contractions; no further muscle twitching was observed. 
 
4.4 Discussion and Conclusions 
The engineered hydrogel-muscle ring platform, which we demonstrated previously for 
muscle-powered biological machines2, is ideal for introducing different cell types and 
biomaterials. Here we present a method for overcoming some of the challenges associated with 
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innervating 3D muscles15. Prior work has confirmed that ESC-derived MNs attained 
electrophysiological properties that were characteristic of native spinal motor neurons14; we 
demonstrate an ability to integrate MN-containing embryoid bodies into a cellular system and 
achieve outputs representative of a functional NMJ. A ring tissue design with directional force 
production allowed for a physiological neuron-muscle co-culture with greater potential for 
innervation in 3D, while an adaptable fabrication system provided physical cues and structural 
support for maturation and synergy of both neurons and muscle in a relevant engineered tissue 
system. By allowing the two major cell types to differentiate in parallel before combining them 
into one co-culture system, we were able to create a flexible platform in which cells and tissues 
can be combined with 3D printed scaffolds in a modular and user-friendly manner. 
Compaction in the hydrogel ring mold or transfer to the skeleton did not hinder the 
further maturation of either major cell type. C2C12s differentiated into mature myotubes in the 
presence of IGF-1, whose use we previously reported to accelerate muscle differentiation in 3D 
engineered systems on a physiologically relevant manner3. We also hypothesized that forcing the 
tissue to compact and differentiate in this constrained environment would result in greater 
myotube alignment along the longitudinal axis2, as this static mechanical cue imposed during 
muscle development would contribute to improved functionality and force production29,30. The 
design and fabrication of an instructive environment for this cellular system were easily achieved 
with the use of stereolithographic 3D printing24,25. This manufacturing technology has widely 
been utilized for applications in tissue engineering not only due to the user’s control over 
specific design, geometric, and mechanical parameters, but also for its ability to fabricate 
biomaterials (hydrogels whose properties can mimic cells’ natural micro-environments) and also 
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encapsulate various cell types in three dimensions31,32, in a short time frame and on a range of 
length scales. 
The mammalian NMJ forms as a result of mutually stimulating signaling from both MNs 
and skeletal muscle fibers. Neurons can provoke the post-synaptic terminal site at the muscle, 
and likewise, skeletal fibers can induce pre-synaptic differentiation on neurons26. One outcome is 
the clustering of AChRs, which are uniformly distributed throughout myotubes but become 
greatly concentrated at the post-synaptic membrane, due to both AChR redistribution throughout 
the membrane and increased synthesis33. Another outcome is the extension and branching of the 
neuron’s axon into a motor nerve terminal that can release neurotransmitters (such as ACh) at the 
NMJ. We observed both outcomes, signifying functional NMJ formation. The extension of 
neurites across 2D surfaces (Figure 4.6) was a promising observation indicating the potential to 
extend neurites throughout engineered tissues and innervate the skeletal muscle. Indeed, we 
observed a similar phenomenon in 3D multi-layered tissue rings (Figure 4.12a).  
In a functioning NMJ, muscle contraction is induced by an excitatory neurotransmitter 
that is released from a MN at the synaptic cleft between cells, binds to a post-synaptic receptor, 
and depolarizes the cell on which it acts, thus increasing that cell’s excitability and probability of 
firing an action potential34. When the nicotinic neurotransmitter ACh binds to its specific 
membrane receptor (AChR) on the muscle cell, it initiates an intracellular signaling cascade 
resulting in the release of calcium ions from the sarcoplasmic reticulum in the muscle fiber, 
terminating in actin-myosin contraction10,35. Before ACh is released, however, the MN must be 
chemically stimulated by an excitatory neurotransmitter that induces a neuronal action 
potential34,36. Various studies have reported the use of glutamate in chemical activation of 
neuromuscular systems with high success, as it is a major excitatory neurotransmitter in the 
 127 
mammalian nervous system. We demonstrate that site-specific innervation of a group of muscle 
fibers in the multi-layered tissue rings allowed for muscle contraction via chemical stimulation 
of MNs, with the frequency of contraction increasing with glutamate concentration. The decrease 
in displacement per contraction followed a physiological relationship between force output and 
frequency for functional skeletal muscle3,37; the engineered tissue ring had less time to return to 
baseline tension between each successive stimulus as the frequency of neuronal firing increased. 
Because the addition of curare terminated the contractions, we confirmed that both the muscle 
contraction was MN-induced as well as the presence of a functional NMJ. 
Further enhancements to the multi-layered tissue ring system could allow for the 
development of an autonomous biological actuator. With a bio-fabricated system permitting 
controllable mechanical and geometric attributes on a range of length scales, our novel 
engineered cellular system can be utilized for easier integration of other modular “building 
blocks” in living cellular and biological machines. This modular NMJ platform is the foundation 
of a novel heterotypic cellular system, and has the potential to address larger challenges in 
medicine and biology. Target applications could include micro-scale tissue fabrication for organ-
on-a-chip mimics of neurodegenerative diseases or drug screening for neuromuscular diseases in 
an autonomous platform. 	  
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4.5 Figures 
 
 
 
Figure 4.1. Skeletal muscle cells and motor neurons were combined into a fabricated 3D co-
culture system. C2C12 myoblasts were differentiated into multinucleated myotubes (i) and 
combined with extracellular matrix proteins to create an engineered muscle ring tissue (ii). In 
parallel, mouse embryonic stem cells (HBG3 mESCs) were differentiated into motor neurons 
through the formation of embryoid bodies (EBs) (iii-iv), then combined with the engineered 
muscle tissue and (v) ECM proteins on (vi) 3D printed hydrogel devices. Scale bars, 50 µm (ii 
and iv), 500 µm (iii), and 10 µm (iv, inset). 
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Figure 4.2. Examples demonstrating the use of NeuronJ, an ImageJ plugin, to measure the 
extension of neurites in (a) 2D MatrigelTM and (b) 3D tissue rings (image reproduced from 
Figure 4.12a). 
 
 
 
 
 
Figure 4.3. mESC Proliferation. (a) Mouse embryonic fibroblasts (MEFs) were seeded as a 
feeder layer prior to culture of (b) mouse embryonic stem cells (HBG3 mESCs), which grew in 
colonies during proliferation. All scale bars, 200 µm. 
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Figure 4.4. Embryoid Body Growth. (a) EBs aggregated more cells, grew in diameter, and 
became more spherical over time (shown at (i) day 2, (ii) day 6, and (iii) day 8 of differentiation). 
(b) Embryoid bodies (EBs) increased in size over a week of differentiation. The starting cell 
density of HBG3 mESCs influenced the size of mature EBs, with a larger initial density resulting 
in larger average cross-sectional area, as well as a larger range (standard deviation) of diameters 
of resulting EBs. Box plots represent 25th, 50th, and 75th percentiles, with average values marked 
as (x) and whiskers representing ± standard deviations. Data are presented (along with normal 
distribution curves) to the left of the boxes (n = 20-25 EBs per density and time point). 
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Figure 4.5. Differentiation of EBs. (a) EBs in suspension culture expressed GFP under the Hb9 
promoter, providing a visual marker for motor neuron differentiation. Scale bars, 200 µm. (b) 
Confocal images (xy, large box; xz; yz) of an EB (day 8 of differentiation) demonstrated the 
presence of Hb9-GFP+ motor neurons (green) as well as glia (red) throughout the entire EB. 
Scale bars, 100 µm. 
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Figure 4.6. Attachment of EBs to ECM Surfaces. Differentiated embryoid bodies attached 
readily to 2D ECM-coated substrates such as (a) collagen I (shown after (i) 2, (ii) 3, and (iii) 4 
days of attachment) and (b) MatrigelTM (shown after (i) 1 and (ii) 2 days of attachment). All scale 
bars, 100 µm. (c) EBs extended neurites radially outward. These neurites formed synapses with 
each other, which could be visually observed with SEM imaging, as shown. Scale bars, 50 µm. 
(d) The EBs extended GFP+ neurites from motor neurons across the surface of the gels upon 
attachment. Plot represents mean ± standard deviation (n = 103-298 neurites from 3-7 images 
per time point).  
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Figure 4.7. Attachment of EBs to C2C12s. (a) EBs also attached to 2D cultures of differentiating 
C2C12s and extended neurites across the surface of the myotubes. Scale bars, 200 µm. (b) 
Clusters of post-synaptic acetylcholine receptors (AChRs, red, stained with α-bungarotoxin) 
were visible near the termination of neurite extensions on myotubes, 5 days after co-culture. 
Scale bars, 100 µm.  
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Figure 4.8. Multi-Layered Tissue Rings. (a) Shown are (i) computer-aided design models, and 
(ii-iii) actual 3D printed hydrogel ring molds. (b) Ring molds guided the formation of a liquid 
cell-gel solution into a solid engineered muscle tissue. (c) Schematic of two-layer muscle-neuron 
ring system. (i) The first layer of myoblasts and ECM proteins compacted to form a solid muscle 
ring. (ii) After 3 days, cell-gel solution containing differentiated EBs was added to the mold and 
compacted around the first layer to form a second layer. Images are shown 48 hours after cell 
seeding. Scale bars, 2 mm. (d) During differentiation, C2C12 (i) myoblasts proliferated and then 
fused to form (ii) myotubes containing multiple nuclei. Scale bars, 200 µm. (e) As the cell-gel 
solution compacted to form a muscle ring, the cross-sectional tissue area decreased over time. (f) 
Tissue thickness was controlled by varying the initial cell-gel volume. All plots represents mean 
± standard deviation (n = 3-6 rings analyzed per time point and volume). 
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Figure 4.9. Differentiation of Multi-Layered Tissue Rings. (a) Compaction of layer 2 brought 
the EBs in close contact with differentiated muscle in layer 1. (i) Phase contrast and (ii) 
fluorescent images demonstrated the presence of EBs in layer 2, 2 hours after co-culture. Scale 
bar, 1 mm. (b) (i) Phase and (ii) confocal images of the two-layer system 24 hours after co-
culture demonstrated multinucleated myotubes in layer 1 and GFP+ motor neurons in the EBs in 
layer 2. Scale bar, (i) 1 mm and (ii) 100 µm. 
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Figure 4.10. Spontaneous contraction of the muscle in layer 1 was observed (a) 2 hours and (b) 
24 hours after the addition of layer 2 containing EBs to the hydrogel ring molds. (i) Phase 
contrast images demonstrating two regions where spontaneous contraction was observed. (ii) 
Displacement was measured for two regions of muscle contraction, which followed a periodic 
pattern and varied slightly depending on proximity to EBs. Frequency of contraction decreased 
between hours 2 and 24. All scale bars, 200 µm. 
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Figure 4.11. Transfer of Multi-Layered Tissue Rings to Hydrogel Skeletons. (a) Designed and 
fabricated dimensions of bio-bot skeletons. Shown are (i) computer-aided design models, and (ii) 
actual 3D printed hydrogels. (b) Muscle-neuron tissue rings were transferred to 3D printed bio-
bot skeletons, made of a beam (chemically tethered to an underlying glass slide) connecting two 
pillars. Top view; scale bar, 1 mm. 
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Figure 4.12. Chemical Stimulation of MNs in Multi-Layered Tissue Rings. (a) Soon after the 
addition of layer 2, (i) single or (ii) groups of EBs began to extend neurites outward through the 
tissue (shown here 9 days after co-culture). Scale bars, 200 µm. (b) Neurite growth from EBs in 
tissue rings significantly increased over time. Box plots represent 25th, 50th, and 75th percentiles, 
with average values marked as (x) and whiskers representing ± standard deviations (n = 51-185 
neurites from 4-10 EBs per time point). (c) Video recordings demonstrated that site-specific 
innervation of a group of muscle fibers allowed for muscle contraction via chemical stimulation, 
with the frequency of contraction increasing with glutamate concentration. The addition of 25 
µM curare halted the contractions, indicating that muscle contraction was motor neuron-induced. 
(d) The frequency of contraction increased with glutamate concentration (from 1.08 to 1.33 
contractions/s with 200 and 400 µM glutamate, respectively). After the addition of 25 µM curare, 
the frequency decreased to 0 observed contractions. Plot represents mean values. 	  
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CHAPTER 5: CHARACTERIZATION AND 
OPTIMIZATION OF AN AUTONOMOUS 
NEUROMUSCULAR BIO-BOT ∗ 
 
5.1 Introduction 
Over the centuries, engineers have harnessed the power of traditional materials such as 
metal, ceramics, wood, and plastic to construct machines that were designed to perform specific, 
controllable tasks. These materials exhibit mechanical or chemical properties that behaved 
predictably and reliably. However, their (typically inefficient) output requires an input of energy 
that must be sustained. The use of natural, biological materials (such as proteins, cells and 
tissues) has gained acceptance as a source of energy for biological actuators, micro-machines, 
and other types of cellular systems1,2. In particular, skeletal muscle is an innate power source, 
and comprises the basic power source of actuation in most mammals3. The hierarchical 
organization, modularity, and scalable nature of mature skeletal muscle fibers (which can be 
combined in parallel to increase force production, for example), lends itself to “building with 
biology,” with the potential for locomotion and self-repair3,4. Furthermore, skeletal muscle can 
interface with multiple other mammalian cell types, such as neurons and endothelial cells, 
lending it promise as a potential platform for drug screening or tissue-on-a-chip mimics probing 
heterotypic cell interactions, in addition to biological soft robotics. 
																																																								
* Portions of this chapter have been adapted from the following publications: (1) Ritu Raman, 
Caroline Cvetkovic, and Rashid Bashir. “A Modular Approach to Design, Fabrication, and 
Characterization of Muscle-Powered Biological Machines.” Nature Protocols. (In Press.) 2017; 
and (2) Gelson Pagan-Díaz, Caroline Cvetkovic, Parijat Sengupta, and Rashid Bashir. 
“Modulating Effects Of Light Stimulation During Development Of Motor Neuronal Embryoid 
Bodies.” (In Preparation.) 2017. 
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Various studies have engineered skeletal muscle tissues and studied their usefulness for 
bio-actuators. Early work in this sphere demonstrated 3D myooids comprised of differentiated 
skeletal muscle5,6, tissue engineered constructs of myotubes embedded in natural extracellular 
matrix (ECM) proteins such as collagen and fibrin7–10, micro-grooved sheets of myotubes11, 
micro-patterned muscular thin films12,13, and contractile porous muscle networks14,15. These 
studies were performed on both primary cells as well as myoblast precursor cell lines such as 
C2C12s. However, few systems have shown net movement from an autonomous, freestanding 
biological machine composed of skeletal muscle. We have previous demonstrated locomotive 
biological machines that were powered by the contraction of skeletal muscle upon electrical or 
optical stimulation16,17.  
However, one limitation with a homotypic cellular system (i.e., one that contains a 
singular cell type, such as a skeletal muscle strip or ring) is that the machine is restricted to the 
functionalities of the cells from which it is composed. As biological machines become 
increasingly complex, it will be necessary to incorporate multiple cell types for greater utility. As 
an initial step in developing an autonomous biological machine with a heterotypic co-culture, we 
investigated the integration of pluripotent stem cell-derived motor neurons (MNs) with 
engineered skeletal muscle tissue. Though various studies have examined the co-culture of 
embryonic stem cell-derived MNs with skeletal muscle, the limited number demonstrating 
neuromuscular junction (NMJ) formation using murine C2C12s were restricted to 2D18–21. Here, 
we present a thorough characterization and optimization of a co-culture system that harnesses the 
potential of skeletal muscle as the actuating component in a biological machine through 
integration of these cell types, and creates an environment that is prime for functional NMJ 
formation. Finally, by utilizing optogenetic muscle cells10 that contract in response to blue light 
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stimulation, the muscle-neuron biological machine could be controlled in a more precise 
spatiotemporal manner. 
 
5.2 Materials and Methods 
5.2.1 Fabrication of Hydrogel Ring Molds and Bio-Bot Skeletons 
Printed parts (hydrogel ring molds and bio-bot skeletons2) were designed using 
computer-aided design software (AutoCAD). Using 3D Lightyear software (v1.4, 3D 
Systems), .stl designs were sliced into layers, and then fabricated with a user-modified 
Stereolithography apparatus (SLA 250/50, 3D Systems). Parts were built in a layer-by-layer 
fashion on top of hydrophilic 22x22 mm-square cover glass slides that were secured inside 35 
mm culture dishes2. Slide surfaces were chemically treated with 2% (v/v) 3-
(trimethoxysilyl)propyl methacrylate (3-TPM, Sigma-Aldrich) to ensure chemically tethering to 
the hydrogels. As described previously3, liquid pre-polymer solutions for 3D printed hydrogels 
consisted of either 20% (w/v) poly(ethylene glycol) dimethacrylate of MW 1000 g mol-1 
(PEGDMA 1000, Polysciences, Inc.) or 20% (v/v) poly(ethylene glycol) diacrylate of MW 700 g 
mol-1 (PEGDA 700, Sigma-Aldrich), dissolved in phosphate buffered saline (PBS). Both 
PEGDMA 1000 (ring molds) and PEGDA 700 (bio-bot skeletons) pre-polymer solutions 
contained 0.5% (w/v) 1-[4-(2-hydroxyethoxy)phenyl]-2-hydroxy-2-methyl-1- propanone-1-one 
photoinitiator (Irgacure 2959, BASF). Following hydrogel fabrication, parts were rinsed in PBS, 
sterilized in 70% EtOH, and stored at 4ºC in sterile PBS until use. 	  
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5.2.2 Culture and Differentiation of Mouse Embryonic Stem Cells (mESCs) 
Two days prior to stem cell culture, an underlying feeder layer of mouse embryonic 
fibroblasts (CF-1 mitomycin-C inactivated MEFs, Applied Stem Cell, Inc.) was pre-plated into a 
6-well plate at a culture density of 3 x 104 cells cm-2. MEFs were maintained in DMEM with 
10% (v/v) FBS, 1% (v/v) L-glutamine, and 1% (v/v) penicillin-streptomycin. After 2 days, 
HBG3 mESCs (Hb9-GFP, ArunA Biomedical) were plated on top of the MEF layer at a culture 
density of 5 x 104 cells cm-2. Cells were maintained in mESC proliferation medium containing 
EmbryoMax ES DMEM (EMD Millipore) with 15% (v/v) FBS, 1% (v/v) L-glutamine, 1% (v/v) 
penicillin-streptomycin (5000 U ml-1, Gibco), 1% (v/v) MEM non-essential amino acids (Gibco), 
1% (v/v) EmbryoMax nucleosides (EMD Millipore), 0.1% (v/v) ESGRO mouse leukemia 
inhibitory factor (mLIF, EMD Millipore), and 0.1 mM β-mercaptoethanol (Gibco). Cells were 
passaged before colonies reached confluence. 
To initiate differentiation into motor neurons (MNs), HBG3 mESCs were switched to 
neural differentiation medium (nDM) containing 50% (v/v) Neurobasal (Gibco), 50% (v/v) 
Advanced DMEM/F12 (Gibco), 10% (v/v) KnockOut serum replacement (Gibco), 1% (v/v) L-
glutamine, 1% (v/v) penicillin-streptomycin (5000 U ml-1), and 0.1 mM β-mercaptoethanol15,22. 
After 1 hour in nDM, HBG3 mESCs were trypsinized, centrifuged, resuspended in nDM, and 
plated in a 10 cm tissue culture dish (day 0). After 24 hours, floating cells were collected and 
replated in a new dish (day 1). On day 2, floating EBs in suspension were collected and replated 
in a new dish in differentiation medium with 1 µM retinoic acid (Sigma-Aldrich) and 1 µM 
purmorphamine (EMD Millipore), while adhered cells were discarded. On day 5, floating EBs in 
suspension were collected and allowed to settle in a 15 ml conical tube. When EBs were 
aggregated at the bottom, the media was manually changed to complete nDM supplemented with 
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10 ng ml-1 each of ciliary neurotrophic factor (CNTF, Sigma-Aldrich) and glial-derived 
neurotrophic factor (GDNF, Neuromics). Differentiated GFP+ EBs were used between days 5-8. 
 
5.2.3 Culture and Differentiation of Skeletal Muscle Cells 
C2C12s, a murine skeletal myoblast cell line, were proliferated in muscle growth medium 
(GM) containing Dulbecco’s Modified Eagle Medium (DMEM, Cellgro), 10% (v/v) fetal bovine 
serum (FBS, VWR), 1% (v/v) L-glutamine (Cellgro), and 1% (v/v) penicillin-streptomycin 
(10,000 U ml-1, Cellgro). During proliferation, cells were passaged before confluence. To 
differentiate the myoblasts into myotubes, cells or tissue cultures were switched to muscle 
differentiation medium (mDM) containing DMEM, 10% (v/v) heat-inactivated horse serum (HS, 
Gibco), 1% (v/v) L-glutamine, and 1% (v/v) penicillin-streptomycin.  
 
5.2.4 Engineered Muscle Tissue Ring Formation 
To form engineered muscle tissue rings, 5 x 106 C2C12s ml-1 (final density in the cell-gel 
solution, unless otherwise noted) were mixed with ice-cold MatrigelTM basement membrane 
(30% (v/v) of total cell-gel solution, Corning), fibrinogen (4 mg ml -1, Sigma-Aldrich), and 
thrombin from bovine plasma (0.5 U mg-1 fibrinogen, Sigma-Aldrich). GM was added to bring 
the cell-gel solution to its final volume (60, 80, or 100 µl per ring, as noted). The solution was 
then injected into one well of an aspirated hydrogel ring mold (day 0). Muscle tissue rings were 
incubated for 2 hours before adding warm GM with 1 mg ml-1 aminocaproic acid (ACA, Sigma-
Aldrich). On day 1, media was switched to mDM with ACA and 50 ng ml-1 LONG® R3 human 
insulin-like growth factor (IGF-1, Sigma-Aldrich). All cells and cultures, and tissue rings were 
incubated at 37ºC and 5% CO2. 
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For incorporation of EBs, muscle tissue rings were differentiated in mDM until day 7. 
Differentiated EBs were individually selected for being GFP+ and allowed to settle in an 
Eppendorf tube. Muscle rings were aspirated of medium, and a 2.5 µl micro-pipette was used to 
apply the EB directly on top of the tissue ring. Muscle rings were allowed to incubate for 2 h 
before adding warm medium (75% mDM and 25% nDM, unless otherwise noted) with 1 mg ml-1 
ACA and 50 ng ml-1 IGF-1. 
 
5.2.5 Muscle Co-Culture Media Study in 3D and Protein Assays 
Muscle tissue rings (80 µl per ring) were maintained in mDM until day 7, then switched 
to 75% mDM and 25% nDM, 50% mDM and 50% nDM, nDM containing 10% (v/v) HS, or kept 
in 100% mDM. All formulations also contained IGF-1 and ACA. On day 14, muscle tissue rings 
were electrically stimulated. Contraction was captured with a stereomicroscope containing a 
digital camera. Calculation of x-y displacement of user-specified regions of interest was 
performed with a custom script (Matlab) using normalized 2D cross-correlation3. 
For protein analysis, muscle tissue rings were snap frozen in liquid nitrogen and stored at 
-80ºC. At the time of use, tissues were digested in RIPA buffer (Thermo Scientific) for 30 min, 
sonicated on low speed, and centrifuged. Protein supernatant was collected for determination of 
MCK production. A Liquid Creatine Kinase Reagent Set (Pointe Scientific) was used to measure 
MCK activity with a microplate reader at 340 nm. A Pierce BCA Protein Assay Kit (Thermo 
Scientific) was used to measure total muscle tissue protein content (from the leftover supernatant 
extract) with a spectrophotometer at 562 nm. 
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5.2.6 Staining and Imaging 
Immunocytochemistry. Samples were collected, rinsed in PBS, fixed with 4% 
paraformaldehyde (Electron Microscopy Services) for 30-40 min, rinsed in PBS again, and 
permeabilized with 0.25% Triton X-100 (Sigma-Aldrich) for 10-15 min. Blocking was 
performed overnight at 4ºC in Image-iT® FX Signal Enhancer (Molecular Probes, 
ThermoFisher). Samples were then directly incubated in primary antibodies at 4ºC in Image-iT® 
FX: MF-20 anti-myosin heavy chain (1:400, Developmental Studies Hybridoma Bank, The 
University of Iowa) for muscle tissues, or anti-glial fibrillary acidic protein (GFAP, 1:1000, 
Chemicon, EMD Millipore) for EBs and MNs. After overnight incubation with primary 
antibodies, samples were rinsed 3x with PBS and then incubated in secondary antibodies at 4ºC 
in Image-iT® FX in the dark: Alexa Fluor® 488 goat anti-mouse IgG or Alexa Fluor® 568 
F(ab')2 fragment of goat anti-mouse IgG (both 1:400, ThermoFisher). After overnight incubation 
with secondary antibodies, samples were rinsed 3x with PBS and then incubated in 4’,6-
diamindino-2-phenylindole (DAPI, 1:5,000 in sterilized de-ionized water, Sigma-Aldrich) for 
10-15 min. Samples were rinsed 3x with PBS and then imaged using a confocal microscope 
(LSM710, Zeiss). To image acetylcholine receptors (AChRs), live samples containing MNs were 
first incubated with tetramethylrhodamine α-bungarotoxin (TRITC-conjugated α-BTX, 1:1000, 
Molecular Probes, ThermoFisher) in warm medium for one hour at 37ºC, then fixed, stained with 
other antibodies of interest, and imaged as detailed above. 
Scanning Electron Microscopy (SEM). Tissue samples or cells were collected, rinsed in 
PBS, fixed with 4% paraformaldehyde for 30-40 min, rinsed in PBS again, and dehydrated in 
EtOH solutions of increasing concentrations: 37% (10 min), 67% (10 min), 95% (10 min), and 
100% (3x 10 min). Samples were incubated with hexamethyldisilazane (HMDS, Polysciences, 
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Inc.) for 5 min to allow vaporization. Finally, gold/palladium was deposited on the dehydrated 
sample using a sputter coater (Desk II, TSC). Samples were imaged using an environmental 
scanning electron microscope (SEM, XL30, Philips/FEI). 
 
5.2.7 Image Processing for Analysis of Cellular Morphology 
Muscle tissue rings were fixed, stained with DAPI nuclear stain, and imaged as detailed 
above. Image files were opened in ImageJ software (National Institutes of Health), converted to 
8-bit, and rotated 90º. A Fast Fourier Transform was performed, and a centered circle was drawn, 
on the binary images. The Oval Profile plug-in was used to compute the radial sum of intensity 
around the circle, providing the FFT (alignment versus position on the circle). To quantify 
circularity, a threshold was applied to the binary images in order to highlight the nuclei (stained 
with DAPI). The Watershed algorithm was then applied to segment nuclei that were touching, 
and the Analyze Particles feature (with Shape Descriptors option) was used to examine the 
selected nuclei for circularity values. 
 
5.2.8 Statistical Analysis 
All results are presented as mean ± standard deviation (SD). Significance (one-way 
ANOVA followed by Tukey’s Multiple Comparison Test) was calculated using OriginPro 
software (v9.1). 	  
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5.3 Results 
5.3.1 Neuromuscular Bio-Bot Development 
Development of the muscle-neuron biological machines (“neuromuscular bio-bots”) was 
achieved using a three-step process: 3D printing of hydrogel structures, differentiation of muscle, 
and differentiation of motor neurons (MNs). The individual components were then integrated in 
a step-wise sequence. First, we used a laser-based Stereolithography apparatus (SLA) to fabricate 
a hydrogel ring mold and a bio-bot skeleton22 using a PEGDA-based material (Figure 5.1a). The 
bio-bot skeleton consisted of a beam connecting two pillars of uneven length, and mimicked a 
physiological musculoskeletal arrangement in which tendons connect muscle to bone16. 
To create engineered muscle rings, we mixed C2C12 myoblasts (from a skeletal muscle 
precursor cell line) with a liquid solution of ECM proteins that included fibrinogen, thrombin, 
and MatrigelTM basement membrane proteins. The cell-gel solution polymerized and compact in 
a hydrogel ring mold, thus forming a solid ring tissue (Figure 5.1b). The addition of muscle 
differentiation medium (mDM) with IGF-1 on day 1 prompted the fusion and maturation of the 
myoblasts into multinucleated and elongated myotubes that expressed mature muscle proteins 
such as heavy-chain myosin. On day 3, we transferred the muscle rings onto fabricated bio-bot 
skeletons. The bio-bot skeleton was chemically bound to a glass slide to prevent bending of the 
beam, thus keeping the differentiating muscle in a state of static tension. 
In parallel, we proliferated mouse embryonic stem cells (HBG3 mESCs, Figure 5.1b-i) 
on a layer of feeder embryonic fibroblast cells to form colonies. Next, we differentiated MNs 
using an established protocol20,23. The addition of neural differentiation medium (nDM) on day 0 
prompted the cells to aggregate and form spherical embryoid bodies in a suspension culture (EBs, 
Figure 5.1b-ii). On day 2, we supplemented nDM with the caudalizing and ventralizing factors 
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retinoic acid and purmorphamine, respectively, to push cells towards a spinal and motor neuronal 
fate. On day 5, we added glial cell line-derived (GDNF) and ciliary (CNTF) neurotrophic 
factors24. On day 7, EBs contained visible MNs (Figure 5.1b-iii). 
 
5.3.2 Characterization of Motor Neurons in Embryoid Bodies 
As HBG3 mESCs aggregated, the size of the EBs increased steadily over time. The cross-
sectional area grew from 4195.2 ± 2954.5 µm2 on day 3 of differentiation to 41819 ± 32195.8 
µm2 (0.04 ± 0.02 mm2) on day 9. The average area increased with a linear rate of 6908.3 µm2 
day-1, and significantly so between days 3 to 5 and days 5 to 6 (Figure 5.2a). These areas 
corresponded to diameter values that increased from 69.2 ± 23.6 µm to 215 ± 84.3 µm on days 3 
and 9, respectively, with linear growth of 26.1 µm day-1. Because the HBG3 mESCs expressed 
green fluorescent protein under the Hb9 (motor-neuron specific) promoter, differentiation of 
MNs could be visually verified as fluorescent intensity increased over time (Hb9-GFP; Figure 
5.2b). Finally, staining for anti-glial fibrillary acidic protein (GFAP) confirmed the presence of 
glia as well as differentiated MNs in the EBs after 1 day of attachment (Figure 5.2c-i). When 
EBs were adhered to a 2D collagen substrate for 4 days, the glia proliferated around the 
periphery (Figure 5.2c-ii). 
With the increase in size during differentiation, the relationship between cell number and 
EB size remained linear for both spherical and non-spherical (i.e., EB cluster) aggregates 
(Figure 5.2d). Confocal imaging revealed a distribution of Hb9-GFP+ cells that was notably 
amplified around the periphery of the EBs (Figure 5.3a-b). Quantitative analysis of Hb9-GFP 
expression throughout two separate groups of neighboring EBs demonstrated that fluorescence 
intensity (measured in arbitrary units, A.U.) was increased at the edges and decreased in the 
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center when measured across a cross-sectional slice from the middle region of the EB z-stack. 
However, when measured across a cross-sectional slice from a region closer to the top or bottom 
of the EB z-stack, the fluorescence intensity was less variable between the edges and center, and 
instead decreased in the regions between neighboring EBs (Figure 5.3c). 
 
5.3.3 Optimization of Engineered Skeletal Muscle Rings 
Early iterations of engineered skeletal muscle bio-bots were composed of a solid muscle 
strip that was permanently bound to the hydrogel skeleton and had a diameter of over several 
millimeters16. We redesigned and fabricated flexible muscle rings with smaller cross-sectional 
diameters that could be physically placed onto a fabricated bio-bot skeleton. Immunostaining 
(Figure 5.4a) and histology (Figure 5.4b) provided means for observing the alignment of 
orientation of cells within the muscle rings. Staining for myosin and a-actinin revealed the 
presence of mature muscle markers, as well as sarcomeric striations within the myotubes (Figure 
5.4c). 
Analysis of the myotubes’ nuclear orientation and morphology (representative 
of myofiber orientation; Figures 5.5 and 5.6a-b) within the muscle tissues revealed a higher 
degree of nuclear elongation (i.e., lower average circularity value of 0.72 ± 0.1 versus 0.79 ± 0.1; 
Figure 5.6c), and metabolic activity (134.1 ± 22.1% versus 102.4 ± 11% cellular viability on day 
12; Figure 5.6d), in muscle rings as compared to the muscle strips, respectively. Furthermore, 
they demonstrated a higher degree of cellular alignment (Figure 5.6b), quantified by Fast 
Fourier Transform (FFT) analysis of DAPI-stained nuclei. While both FFT curves have peaks at 
90º and 270º (the common longitudinal axis of the bio-bot), muscle rings displayed a wider 
 153 
average distribution (and increased area under the curve) around these axes, indicating a higher 
degree of local and global alignment compared to muscle strips.  
Moving forward with optimization of an engineered muscle ring that could globally 
contract upon applied external stimulation, we investigated the influence of various parameters 
on functional output, specifically active tension in response to electrical stimulation. Rings 
seeded with an initial myoblast density of 5 x 106 cells ml-1 produced active tension forces 
averaging 143.9 ± 36 µN per contraction after 7 days of differentiation (Figure 5.7a). After an 
additional 7 days, the average active tension force per contraction dropped to 40.6 ± 15.6 µN on 
day 14. Maintaining the same initial cell-gel volume (60 µl) but doubling the initial myoblast 
density to 10 x 106 cells ml-1 amplified the active tension forces 167.2 ± 57.1 and 62.5 ± 10.2 µN 
per contraction on days 7 and 14, increases of 116.1% and 153.8% from 5 x 106 cells ml-1, 
respectively.  
Choosing an initial myoblast seeding density of 10 x 106 cells ml-1, we subsequently 
analyzed the effect of muscle ring size (or diameter, which we changed by altering the initial 
cell-gel volume added to the ring molds). A smaller initial cell-gel volume produced a thinner 
muscle tissue ring, and vice versa. Muscle tissue rings of 60, 80, and 100 µl cell-gel volume 
produced contractile forces of 167.2 ± 57.1, 203.7 ± 74.2, and 417 ± 90 µN per twitch on day 7, 
respectively (Figure 5.7b). 
 
5.3.4 Co-Culture Media Study for Muscle 
Next, we studied whether co-culture media targeted for neural differentiation (nDM with 
purmorphamine, retinoic acid, and the neural growth factors GDNF and CNTF) could similarly 
support viability and differentiation of skeletal muscle. In 2D, C2C12s that were immediately 
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switched to nDM without first differentiating in mDM demonstrated no loss in viability over 
time and still formed multinucleated and elongated myotubes (Figure 5.8a). Furthermore, we 
found no significant difference in viability between muscle cells in 2D that were switched to 
nDM (98.7 ± 1.5% viability) versus those maintained in mDM for 7 days after plating (99.3 ± 
1% viability; all values normalized to cells maintained in muscle growth medium containing 
10% FBS; Figure 5.8b).  
To create a more relevant representation of how the co-culture media would affect tissue 
formation, maturation, and functionality in the neuromuscular bio-bot system, we translated the 
study to 3D tissue rings containing only C2C12s. After one week of differentiating the muscle 
rings in mDM, we tested the following co-culture media formulations: 100% mDM, 75% (v/v) 
mDM and 25% (v/v) nDM, 50% (v/v) mDM and 50% (v/v) nDM, and nDM containing 10% 
(v/v) HS, all with IGF-1 and aminocaproic acid (ACA). After one week in co-culture media, 
there was no significant difference between any of the four formulations with regards to cell 
viability, which ranged from 97 ± 17.9% to 115.3 ± 53.4% (all values normalized to rings 
maintained in 100% mDM; Figure 5.9a). 
Finally, we measured protein expression levels within digested muscle strips after one 
week of differentiation and one week in co-culture media. While there was no significant 
difference between the total protein concentrations (a range of 1.02 ± 0.2 to 1.5 ± 0.3 mg ml-1), 
the other three formulations resulted in muscle creatine kinase (MCK) activities that were 
significantly reduced when compared to the 100% mDM control (Figure 5.9b). Muscle rings 
cultured with 75% mDM and 25% nDM, 50% mDM and 50% nDM, and nDM containing 10% 
(v/v) HS produced MCK activity levels of 64.4 ± 17, 32.8 ± 12.8, and 24.5 ± 29% of the control 
group. 
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5.3.5 Neurite Extension 
When differentiated EBs were removed from suspension culture and allowed to adhere to 
2D ECM substrates (such as collagen I or MatrigelTM basement membrane), neurons began to 
extend processes almost immediately across the gels. Neurites were visible by Hb9-GFP 
expression and extended out radially from EBs at distances of hundreds of microns (Figures 
5.10 and 5.11a). Moreover, the neurite extensions formed connections with each other away 
from the EB surfaces, forming the basis of a motor neuronal network, visible by SEM imaging 
(Figure 5.11b). Finally, we tested the following co-culture media formulations: 100% nDM, 
50% nDM and 50% mDM, and 25% nDM and 75% mDM, all with IGF-1 and aminocaproic acid 
(ACA). From visual examination, neurite extension from EBs plated on 2D MatrigelTM 
substrates was not impacted by co-culture medium (Figure 5.12). 
 
5.3.6 Incorporation of EBs and Muscle Rings 
To complete the integration of the neuromuscular bio-bots, we integrated EBs and muscle 
tissue rings that had been fully differentiated in parallel. After 7 days of compaction and 
development, muscle rings (on hydrogel skeletons which were still adhered to glass slides) were 
removed from mDM and aspirated of excess medium in order to provide a surface for EBs. 
Floating EBs that had been collected and allowed to settle were aspirated of excess medium and 
gently coated across the surface of the muscle rings with the use of a micropipettor, with care 
taken to place the EBs near the middle regions of muscle between the pillars (Figure 5.13a). 
After allowing the EBs to adhere for 2 h, we incubated the neuromuscular bio-bots in co-culture 
medium containing 75% mDM and 25% nDM. Immunostaining confirmed that the spherical 
 156 
EBs did indeed contain Hb9-GFP+ MNs, and that the myotubes in the muscle ring were 
expressing a mature heavy chain myosin (Figure 5.13b), and SEM imaging provided a 
topographical visualization of EBs on the surface of muscle rings (Figure 5.13c). Furthermore, 
after 9 days of co-culture, acetylcholine receptor (AChR) clustering was evident on myotubes 
(Figure 5.14a). The muscle tissue rings maintained their mechanical and structural integrity in 
the presence of added EBs, and the hydrogel skeletons could be physically removed from the 
glass slide in order to obtain a freestanding and autonomous neuromuscular bio-bot (Figure 
5.14b). After 30 days of co-culture, individual EBs were no longer visible as aggregates on top 
of the muscle rings; rather, the cells had re-distributed themselves around the entire muscle ring 
surface (Figure 5.14c). 
 
5.3.7 Embryoid Bodies Containing Optogenetic Motor Neurons 
To engineer neuromuscular bio-bots containing optogenetic (light sensitive) MNs, we 
employed photosensitized HBG3 mESCs23. The cells expressed the cationic membrane channel 
Channelrhodopsin-2 (ChR2) and depolarized in response to blue light stimuli22,25,26. Using the 
aforementioned protocol, we differentiated optogenetic HBG3 mESCs into MNs through the 
formation of EBs. There was no significant difference in size between ChR2+ and ChR2- EBs 
after 12 days of differentiation (Figure 5.15a-b). Cells expressed a membrane-bound tdTomato 
fluorescent tag indicative of ChR2 expression (Figure 5.15c-i), in addition to Hb9-GFP 
expressed by MNs alone (Figure 5.15c-ii). 
Optogenetic MNs were then integrated into neuromuscular bio-bots as described above. 
EBs adhered to the surface of muscle rings tethered to bio-bot skeletons (Figure 5.16a-b). Both 
ChR2-tdTomato and Hb9-GFP expression persisted on the 3D neuromuscular bio-bot system 
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(Figure 5.16c). Confocal imaging revealed ubiquitous ChR2-tdTomato expression throughout all 
cells originating from optogenetic HBG3 mESCs, with a subset of cells in the EBs demonstrating 
MN lineage (Figure 5.17). 
 
5.4 Discussion 
Early work in the development of autonomous skeletal muscle-powered biological 
machines utilized an engineered muscle strip joined to a 3D printed hydrogel skeleton. 
Electrical16 or optical22 stimulation of the excitable cells produced a global contractile response 
that allowed the asymmetric bio-bot to ‘walk’ along a surface in fluid. While this was a powerful 
first demonstration of untethered locomotion in a skeletal muscle-powered machine, the muscle 
tissue was engineered in a way that permanently tethered it to the bio-bot skeleton, making it 
difficult to adapt the methodology for different skeleton designs. To target this limitation, we 
redesigned the 3D printed injection mold to produce skeletal muscle “rings” which could be 
manually transferred to any of a wide variety of bio-bot skeletons17. Alignment of myotubes 
along the longitudinal axis of the bio-bot provided an axis along which the majority of the 
mature muscle fibers contracted synchronously upon stimulation, a characteristic of hierarchical 
skeletal muscle in vivo (Figures 5.5 and 5.6). 
In this demonstration, we differentiated MNs from an embryonic stem cell line, an 
attractive cell source because of its pluripotent potential, for integration onto an autonomous 
biological machine containing a heterotypic co-culture. MNs were differentiated in EBs that 
were hundreds of microns in size and could be physically handled and placed onto differentiated 
skeletal muscle rings in a modular fashion. The EBs also contained glia, which are supportive of 
the neuromuscular synapse27. Furthermore, their morphology modeled that of developing germ 
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lineages, in which peripheral cells maintain viability while interior cells undergo apoptosis and 
leave behind a cavity (Figures 5.2 and 5.3).  
Synaptogenesis is a cooperative event between pre- and post-synaptic terminals at the 
neuromuscular interface24,28; thus, we were interested in optimizing culture conditions to create 
an environment that permits emergence of a neuromuscular junction (NMJ) as well as 
maintenance of the synapse and all cell types over time. To achieve this, we performed 
sustainability studies that build on preliminary work by measuring viability of C2C12s in 3D 
muscle ring cultures as well as the functionality of differentiated MNs when cultured in various 
media formulations. It was necessary to appropriately balance the cell density, volume of tissue 
(and thus the number of cells present), differentiation time, and production of myogenic proteins 
necessary for contraction (i.e., MCK). We found that it was advantageous to allow both the 
muscle and MNs to differentiate independently for as long as possible (7 days) before integration. 
The combination of 75% mDM and 25% nDM, with appropriate concentrations of growth 
factors (GDNF, CNTF, and IGF-1) and ACA, allowed for a balance of nutrients necessary to 
maintain the skeletal muscle in a differentiated state while also providing neurotrophic factors 
necessary for neurite extension and innervation. This media formulation was chosen for all 
subsequent co-culture studies. Further study of neurite growth and viability will determine 
whether this formulation is most advantageous for the EBs in the co-culture as well. 
Without the formation of a functional synapse, there can be no interaction between motor 
neurons and the muscle fibers, and thus no neuron-initiated contraction of muscle. We used a 
fluorescently-labeled α-bungarotoxin antibody (α-BTX, which binds irreversibly to postsynaptic 
receptors that become concentrated upon stimulus from MNs) to note the clustering of AChRs on 
myotubes (Figure 5.14a)28,29. The aggregation of AChRs on 3D neuromuscular bio-bots, along 
 159 
with adequate neurite extension observed in 2D, was promising evidence that the skeletal muscle 
rings could be innervated and maintain functional NMJs on a 3D system. In total, these 
preliminary data provide the groundwork for future studies of a functional neuromuscular 
biological machine. Next steps will include chemical or optical excitation of MNs, resulting in 
the release of excitatory neurotransmitters that can cause muscle contraction and thus net 
locomotion. 
In the future, we envision that this system can be used for applications beyond bio-
robotics and muscular actuators. As a functioning heterotypic co-culture, the muscle- neuron 
arrangement is a highly relevant machine for the study of neuromuscular diseases and related 
drug toxicity studies. To date, a subset of engineered cardiac30,31- and skeletal32,33 muscle-based 
tissues have been used for preliminary investigations into the effects of pharmacological agents 
on muscle form and function. However, few have utilized an engineered neuromuscular co-
culture platform for drug screening or discovery in the study of ailments including peripheral 
motor neuron diseases (causing downstream muscular effects, such as in amyotrophic lateral 
sclerosis or ALS), NMJ diseases (occurring at the synapses), myopathies, and muscular 
dystrophies – most of which are still without successful therapies. The study and treatment of 
neuromuscular disorders necessitates a system that encompasses both cell types, as well as their 
synapse, in a relevant microenvironment. 	  
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5.5 Figures 
 
 
 
Figure 5.1. Development of Neuromuscular Bio-Bots. (a) Fabrication of the muscle-neuron 
biological machines was achieved using a three-step process that began with 3D printing of 
hydrogel structures using a stereolithography apparatus (SLA). Scale bar, 2 mm. (b) Skeleton 
muscle (stained for MF-20 heavy chain myosin) and embryoid bodies (EBs) containing motor 
neurons (MNs, expressing GFP) were differentiated in parallel. The individual components were 
then integrated in a step-wise sequence. For muscle, C2C12s were mixed with a liquid solution 
of ECM proteins in order to form a solid muscle tissue ring that could be placed around a 
hydrogel skeleton. For MNs, first (i) HBG3 mESCs were induced to differentiate. (ii) Cells 
aggregated and formed EBs. (iii) EBs contained HB9-GFP+ MNs. All scale bars, 100 µm. 
 
  
MatrigelTM 
Fibrinogen 
Thrombin 
+ + + 
3D Printed Structures 
Hb9-GFP MF-20 
DAPI 
HBG3 mESCs 
Embryoid Bodies 
(EBs) 
Motor Neurons 
(MNs) 
C2C12s 
Differentiated 
Myotubes 
Engineered 
Muscle Ring 
NEURONS MUSCLE 
Z-Stage 
Laser 
3D Printer 
Pre-Polymer 
(PEGDA) 
a             Fabrication b                  Cell Culture And Differentiation 
(i) 
(iii) 
(ii) 
Bio-bot skeleton 
 161 
 
 
Figure 5.2. Characterization of Embryoid Body Growth and Differentiation. (a) Average EB 
size (cross-sectional area, bottom; diameter, top) increased over time during differentiation (n = 
40-170 EBs per time point). Boxplots represent 25th and 75th percentiles, with average values 
marked as (*) and whiskers representing ± standard deviations; * = p < 0.05. (b) Day 7 EBs 
contained many HB9-GFP+ cells, indicating differentiated motor neurons. Scale bar, 100 µm. (c) 
EBs contained HB9-GFP+ MNs as well as proliferating glia cells (stained for GFAP in red), after 
(i) 1 day and (ii) 4 days on a collagen surface after 8 days of differentiation. Scale bars, 100 µm. 
(d) The relationship between EB size and number of cells remained linear (R2 = 0.957), even for 
non-spherical EBs.   
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Figure 5.3. Embryoid Body Morphology. (a) A group of clustered EBs contained a majority of 
Hb9-GFP+ motor neurons around the periphery, visible by confocal slicing, with many fewer 
cells visible in the interior of the sphere. Scale bar, 50 µm. (b) Montage of z-stack images from 
Figure 5.3a. (c) Groups of two EBs were imaged using a confocal microscope. In both groups, 
layer 1 is a representative peripheral slice, while Layer 8 is an interior slice. GFP fluorescence 
intensity (indicative of MNs) was plotted as a function of designated distance (designated by the 
arrows) across the groups of EBs. In both cases, fluorescence intensity (A.U.) remains high 
across the EBs for Layer 1 slices, but decreases in Layer 8 slices, where there are fewer cells 
within the cavities.  
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Figure 5.4. Immunohistochemistry of engineered muscle tissues. (a) A confocal z-stack revealed 
the 3D nature of the muscle tissue, which contained elongated and multinucleated myotubes. 
Tissues were stained for MF-20 mature myosin, Channelrhodopsin-2 (optogenetic ion channel), 
and DAPI (nuclei). (b) Confocal imaging of muscle tissue slices highlighted sarcomeric 
striations characteristic of mature myofibers, visualized with an antibody against α-actinin 
protein. (c) Histological (H&E) staining distinguished myotubes (pink) and nuclei (blue). 
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Figure 5.5. Analysis of Nuclear Circularity and Alignment in Muscle Rings versus Strips.  
Starting with a fluorescent image of cellular nuclei, we converted the image to binary. We then 
applied a threshold to the binary image and used the Analyze Particles feature in ImageJ to bin 
and plot the circularity (1 = circular; 0 = linear) for each data set. Circularity plots represent all 
data points from Figure 5.6c (n = 2312 total nuclei for muscle rings; n = 2702 for muscle strips). 
Data from normal distributions represent mean values ± standard deviations; * = p < 0.05. To 
compute alignment, we performed FFT analysis on similarly oriented images and plotted the 
results (radial sums) as a function of degrees. FFT Alignment plots represent individual curves 
for muscle ring and strip samples; averaged data are shown in bold black lines on each plot (and 
plotted together for comparison in Figure 5.6b.   
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Figure 5.6. Cellular Orientation and Morphology in Muscle Rings versus Strips. (a) A 
comparison of muscle strip and ring designs and the effect on cellular orientation. (b) Analysis of 
overall nuclear alignment (representative of myofiber orientation) was performed with FFT 
analysis of DAPI-stained regions of both tissue designs at day 12. FFT curves represent averages 
of individual FFT analyses (n = 8 regions analyzed for muscle rings, n = 5 for muscle strips, with 
2 samples per design; individual curves are shown in Figure 5.5). (c) The circularity 
significantly decreased in muscle rings compared to muscle strips, revealing a more elongated 
nuclear profile and higher degree of alignment along the length of the ring (n = 16 total regions 
analyzed for muscle rings, n = 8 for muscle strips, containing images from 2 different z-planes; 
both from 2 samples each). Data from normal distributions represent mean values ± standard 
deviations; individual data points are shown in Figure 5.5; * = p < 0.05. (d) Cellular viability, 
determined by a MTS assay, was statistically increased on day 12 for muscle rings versus strips. 
Columns and error bars represent mean values ± standard deviations; * = p < 0.05. 
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Figure 5.7. Active Tension in Engineered Muscle Rings (a) Rings seeded with an initial 
myoblast density of 5 x 106 cells ml-1 produced active tension forces averaging 143.9 ± 36 µN 
per contraction upon applied electrical stimulation after 7 days of differentiation. After an 
additional 7 days, the average active tension force per contraction dropped to 40.6 ± 15.6 µN on 
day 14. Maintaining the same initial cell-gel volume (60 µl) but doubling the initial myoblast 
amplified the active tension forces 167.2 ± 57.1 and 62.5 ± 10.2 µN per contraction on days 7 
and 14, respectively (b) A smaller initial cell-gel volume produced a thinner muscle tissue ring, 
and vice versa. Muscle tissue rings of 60, 80, and 100 µl cell-gel volume produced contractile 
forces of 167.2 ± 57.1, 203.7 ± 74.2, and 417 ± 90 µN per twitch on day 7, respectively. 
Columns and error bars represent mean values ± standard deviations. 
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Figure 5.8. Muscle Co-Culture Media Study in 2D. (a) C2C12s were plated on a 2D surface and 
maintained in either muscle growth medium containing 10% FBS, muscle differentiation 
medium (mDM) containing 10% HS, or neural differentiation medium (nDM), all with IGF-1 
and ACA. (b) There was no significant difference in viability between muscle cells in 2D that 
were switched to nDM versus those maintained in mDM for 7 days after plating (n = 3 samples 
per media type; all values normalized to cells maintained in muscle growth medium containing 
10% FBS). Columns and error bars represent mean values ± standard deviations. 
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Figure 5.9. Muscle Co-Culture Media Study in 3D. (a) After one week of differentiating the 
muscle rings in mDM, we tested the following co-culture media formulations: 100% mDM, 75% 
mDM and 25% nDM, 50% mDM and 50% nDM, and nDM containing 10% (v/v) HS, all with 
IGF-1 and aminocaproic acid (ACA). After one week in co-culture media, there was no 
significant difference between any of the four formulations with regards to cell viability 
(normalized to rings maintained in 100% mDM; n = 3-8 muscle rings per media formulation). 
(b) Although there was no significant difference between the total protein concentrations, the 
other three formulations resulted in muscle creatine kinase (MCK) activities that were 
significantly reduced when compared to the 100% mDM control (n = 4-15 muscle rings per 
media formulation). Columns and error bars represent mean values ± standard deviations; * = p < 
0.05. 
  
100% 
 
 
 
 
0% 
Muscle 
Differentiation  
Medium (mDM) 
Neural 
Differentiation  
Medium (nDM) 
a 
b 
100%
mDM
75%-25%50%-50% nDM +
10%HS
0
50
100
150
Vi
ab
ili
ty
 (%
)
Media Type
(n
or
m
al
iz
ed
 to
 1
00
%
 m
D
M
)
 MCK  Protein
100%
mDM
75%-25%50%-50% nDM +
10%HS
0
50
100
150
*
*
M
CK
 A
ct
iv
ity
 (U
/L
) (
%
)
Media Type
(n
or
m
al
iz
ed
 to
 1
00
%
 m
D
M
)
*
0.0
0.5
1.0
1.5
2.0
[P
ro
te
in
] (
m
g/
m
l)
p=.052
 169 
 
 
Figure 5.10. Neuron Extension. When differentiated EBs were allowed to adhere to 2D ECM 
substrates (such as collagen I or MatrigelTM basement membrane), neurons began to extend 
processes almost immediately across the gels. Neurites were visible by Hb9-GFP expression and 
extended out radially from EBs. EBs also contained glia (visible by red GFAP fluorescence). 
Scale bar, 100 µm. 
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Figure 5.11. Neurite Extension and Network Formation Visible by SEM. (a) Neurites were 
visible by Hb9-GFP expression and extended out radially from EBs at distances of hundreds of 
microns. (b) The neurite extensions formed connections with each other away from the EB 
surfaces, forming the basis of a motor neuronal network. 
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Figure 5.12. Nueron Co-Culture Media Study. Neurite extension was examined in 2D cultures of 
EBs on MatrigelTM that were cultured in (a) 100% neural differentiation medium (nDM), (b) 
50% nDM and 50% muscle differentiation medium (mDM), or (c) 25% nDM and 75% muscle 
mDM. Scale bars, 100 µm. 
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Figure 5.13. Integration of Skeletal Muscle and MNs on Bio-Bots. (a) EBs were gently coated 
across the surface of the muscle rings with the use of a micropipettor, with care taken to place 
the EBs near the middle regions of muscle between the pillars, and allowed to adhere. Scale bar 
(left), 1 mm. (b) Immunostaining confirmed that the spherical EBs contained Hb9-GFP+ MNs, 
and that the myotubes in the muscle ring expressed a mature heavy chain myosin. Scale bar, 200 
µm. (c) SEM imaging provided a topographical visualization of EBs on the surface of muscle 
rings.  
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Figure 5.14. Co-Culture of Neuromuscular Bio-Bots. (a) After 9 days of co-culture, 
acetylcholine receptor (AChR) clustering was evident on myotubes that were immunostained 
with α-bungarotoxin. (b) Compacted muscle-neuron rings were transferred to 3D printed 
hydrogel skeletons, which could be released from glass slides to produce freestanding 
neuromuscular bio-bots. Scale bar, 2 mm.  
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Figure 5.15. EBs Containing Optogenetic MNs. (a) HBG3 mESCs were differentiated into MNs 
through the formation of EBs. (b) Optogenetic EBs did not significantly differ in size when 
compared to non-optogenetic EBs. (c) Cells expressed a (i) membrane-bound tdTomato 
fluorescent tag indicative of ChR2 expression, in addition to (ii) Hb9-GFP expressed by MNs 
alone. 
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Figure 5.16. Optogentic Neuromuscular Rings. (a-b) Optogenetic MNs were integrated into 
neuromuscular bio-bots using the same protocol. EBs adhered to the surface of muscle rings 
tethered to bio-bot skeletons. (c) Both ChR2-tdTomato and Hb9-GFP expression persisted on the 
3D neuromuscular bio-bot system. 
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Figure 5.17. Optogenetic EBs Containing MNs and Glia. Confocal imaging revealed ubiquitous 
ChR2-tdTomato expression throughout all cells originating from optogenetic HBG3 mESCs, 
with a subset of cells in the EBs demonstrating MN lineage. 
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CHAPTER 6: CONCLUSIONS AND FUTURE 
DIRECTIONS 
 
6.1 Summary and Conclusions 
In this Thesis, we demonstrated innovative advancements in biomaterials, tissue 
engineering, and 3D printing, as well as an integration of these technologies, to forward engineer 
millimeter-scale biological machines capable of complex behaviors. Cell-based soft robotic 
devices could have a transformative impact on our ability to design machines and systems that 
can dynamically sense and respond to a range of complex environmental signals. Due in part to 
their elastic nature and the living components that can permit a dynamic response to 
environmental and applied stimuli, these machines can have an array of applications and 
represent a significant progress towards high-level functional control over such systems. 
In Chapter 2, we demonstrated a living biological machine (“bio-bot”) composed of a 3D 
printed hydrogel skeleton coupled to an engineered muscle strip (composed of differentiated 
C2C12 skeletal muscle cells and ECM proteins such as fibrin, collagen, and MatrigelTM). 
Electrical stimulation of the myotubes produced a global contraction response that deformed the 
compliant hydrogel beam and moved the bio-bot along a surface in fluid with a maximum 
velocity of ~156 µm s-1, over 1.5 body lengths (BL) min-1. The introduction of deliberate 
asymmetry into the hydrogel skeleton, achieved using 3D printing by extending the length of one 
pillar, allowed for directional and controlled locomotion. The system allowed for a high degree 
of control over many properties, including geometric (CAD design and 3D printing), mechanical 
(hydrogel material properties such as stiffness), and biological (addition of IGF-1 growth factor). 
To our knowledge, this was the first demonstration of an untethered biological machine powered 
by engineered mammalian skeletal muscle and controlled purely via external signaling, and 
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represented an important advance in building bio-integrated soft robotic devices for a myriad 
array of applications in sensing and actuation. 
In Chapter 3, we investigated the life expectancy and proteolytic degradation of the 
engineered skeletal muscle powered machines. The ECM proteins that surrounded the 
differentiated myotubes in the muscle strips acted as an engineered basal lamina that provided 
physical support and biochemical cues to the cells. However, the proteins were susceptible to 
hydrolysis by cell-secreted and cell-associated enzymes that can compromise the mechanical 
integrity of the system by breaking down the ECM. We examined the expression and activity of 
three major proteases (plasmin, cathepsin L, and matrix metalloproteinases MMP-2 and MMP-9), 
while demonstrating the use of gelatin zymography to determine the effects of myogenesis and 
inhibitor concentration on cysteine protease expression. Equally important as validating a gain-
of-function event in a living biological machine is maintaining it over time, without any 
associated loss-of-function. The data presented in this chapter provided design considerations 
and an initial jumping-off point for the development of machines with controllable function, 
specific life expectancy, and greater consistency. 
In Chapter 4, we presented a living cellular system composed of multiple cell types. A 
modular system was made up of multi-layered tissue rings containing integrated skeletal muscle 
and motor neurons (MNs) embedded in an extracellular matrix. Building off an established 
protocol for the differentiation of MNs from mouse embryonic stem cells through the formation 
of embryoid bodies (EBs), we differentiated the two cell types in parallel and then combined 
them in a co-culture amenable to both. The multi-layered rings were then sequentially placed on 
a stationary 3D printed hydrogel skeleton resembling an anatomical muscle-tendon-bone 
organization. We demonstrated site-specific innervation of the skeletal muscle and a functional 
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neuromuscular junction (NMJ) controlled via chemical stimulation and inhibition. This was an 
important first step in the innervation and neuronal control of living muscle-powered biological 
machines. Moreover, the inherent modularity of the system could be utilized for easier 
integration of other modular “building blocks” in living cellular and biological machines. 
In Chapter 5, we further optimized and characterized a co-culture system that integrated 
differentiated skeletal muscle and MNs on a freestanding and potentially autonomous device. 
While the multi-layered tissue ring was a powerful first demonstration of a living system 
containing multiple functional cell types, we believed the output could be enhanced by limiting 
the obstacles that restricted innervation (and subsequent muscle contraction). The tangible result 
was a system in which EBs containing MNs were brought in closer contact to the skeletal muscle 
rings, reducing the distance required for neurites to travel through the tissue and increasing the 
diffusion of oxygen and nutrients to the inner muscle tissue. Multiple co-culture media 
formulations were tested in order to determine a balanced environment that was beneficial to 
both cell types. Additionally, we examined the effects of altering parameters such as cell density 
and tissue volume on muscle contraction. When taken together, the preliminary data presented in 
Chapter 5 set the stage for the development of an autonomous neuromuscular bio-bot that could 
be controlled via chemical or optical stimulation of motor neurons. 
 
6.2 Future Directions 
6.2.1 Life Expectancy and Degradation of Bio-Bots 
In Chapter 3, we investigated the life expectancy of the skeletal muscle bio-bots. 
Inhibiting the degradation of fibrin (a main ECM component of the muscle strips) by the 
protease plasmin, with the addition of aminocaproic acid (ACA), significantly extended the time 
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before rupture. However, the life expectancy of bio-bots cultured with 1x or 3x ACA still 
exhibited substantial variation and unpredictability. Although the bio-bots that did remain viable 
on the order of months continued to respond to electrical stimulation and also maintained a 
passive tension that was significantly unchanged over time (between days 5 and 140, Figure 6.1), 
there was a great deal of instability and randomness in the system that prevented predictable 
outcomes in the bio-bots and thus limited their potential and functionality. Next, we aim to 
explore methods to balance protease activity and inhibition in order to forward engineer 
machines with predictable and appropriate life expectancies. Controlling the life expectancy of 
the bio-bots could be achieved, in part, by forward engineering the cell-ECM interactions that 
lead to eventual breakdown and loss of function. 
We anticipate improved functional performance and increased life expectancy of bio-bots 
cultured with the broad-spectrum cathepsin inhibitor E-641–3, which would block all cathepsin 
activity, and cystatin C (CysC)2–4, an exogenous, strong-binding cysteine protease inhibitor. Bio-
bots could be maintained in culture media with E-64, or could be fabricated with C2C12s that 
express CysC under an inducible plasmid. An alternative (or additional) approach would be to 
add tissue inhibitors of metalloproteinases (TIMPs)5–9, which we hypothesize would slow 
degradation related to MMP activity within the muscle strip. TIMPs bind to active MMPs with 
high affinity in a 1:1 fashion and thus regulate their activity9. C2C12s can be transfected with a 
plasmid for TIMP-1/-2 to maintain a relevant protease-inhibitor balance, with or in place of the 
CysC plasmid. Immunostaining of muscle tissue samples for cathepsins and MMPs would allow 
for the visualization of specific regions of activity, perhaps providing valuable information about 
protease localization and other ways to diminish matrix degradation by deliberate design. 
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Alternatively, should the aim be to decrease life expectancy, or design a machine 
engineered to break down after performing a certain task, we propose the introduction of 
inflammatory cytokines or chemokines that can activate or accelerate the expression of cell-
secreted proteases1,8. It is known that MMP-2 and MMP-9 are upregulated in skeletal muscle 
following tissue damage and satellite cell activation, migration, and differentiation. Macrophages 
can secrete tumor necrosis factor-α (TNF-α, which is also associated with muscle wasting10) and 
interleukin-1 (IL-1, which can activate MMP promoters8) to upregulate MMP-9 upon muscular 
signaling11. Additionally, when TNF-α is inhibited, a concomitant partial reduction in CatL 
mRNA levels has been observed10. 
Finally, we aim to validate a novel method to customize the degradable substrate based 
on the tissue or biological system of interest. Traditional zymography relies on the degradation 
of a polyacrylamide gel typically impregnated with gelatin. Bio-bot muscle strips were 
composed in part of fibrin, which is made from the cleavage of the fibrinogen protein by the 
enzyme thrombin. We plan to demonstrate the ability to co-polymerize a fibrinogen-
polyacrylamide gel that could be subjected to electrophoresis and be degraded by cathepsins and 
MMPs of interest. 
 
6.2.2 Neuromuscular-Controlled Biological Machines 
A functional NMJ requires synergistic interactions of both neurons and muscle. Neurons 
must adequately process the input they receive, and be in close enough contact with the muscle 
to transmit the signal; muscle cells must be mature enough to twitch in response to 
neurotransmitter binding at AChRs, and in the case of soft robotics, produce plentiful collective 
force to achieve net motion of the device. In the neuronal piece, there must be sufficient 
innervation of muscle (1:1 neurons to myofibers in vivo); we anticipate sufficient muscle 
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contraction by increasing this ratio. The physical constraints of the system in vitro might limit 
the ideal scenario, leading to a lower innervation ratio. Thus, we would require either an equal or 
lesser number of muscle cells to produce higher force (potentially with the use of primary 
myoblasts), or devise a method to allow the myofibers to communicate via electrical coupling. 
The latter could be achieved via genetic engineering of C2C12s by overexpression of the 
connexin43 (Cx43) gap junction that permits propagation of electrical impulses, thus removing 
the need to innervate each myofiber for global deformation. Some reports have demonstrated 
successful overexpression of Cx43 (which is present in myoblast precursors) in mature myotubes 
using the MCK promoter12,13. 
Finally, though we have demonstrated preliminary evidence indicating clustering of 
AChRs in muscle (Chapters 4 and 5), we plan to concretely demonstrate NMJ formation and 
determine the time scale on which this phenomenon of synaptogenesis takes place in our 3D 
system, allowing for appropriate neuromuscular bio-bot stimulation. The combination of these 
plans will assist in the demonstration of a fully functional biological machine powered by the 
contraction of skeletal muscle upon neuronal stimulation. 
 
6.2.3 Neuromuscular Tissue-on-a-Chip for Drug Screening 
We aim to use our functional 3D neuron-muscle tissue as a model “tissue-on-a-chip” 
system in which to evaluate and screen potential drugs for toxicity and efficacy as well as 
therapeutic targets. Potential drug test beds must mimic native in vivo environments, be cost-
effective, provide non-destructive and real-time functional measurements without sacrificing the 
structure, and be sufficiently standardized to minimize variability; our innervated muscle system 
could potentially accomplish all of these14–17. Moreover, by combining multiple cell types in a 
heterotypic co-culture, we can more effectively model the response of a substance to more than 
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one organ system and signaling pathway, which is especially relevant for peripheral motor 
neuron or NMJ diseases as well as myopathies. In ALS, for example, the NMJ is destroyed, 
prompting axonal degeneration and motor neuron death, as well as eventual muscular effects18; 
likewise, muscular dystrophy patients often display NMJs that are morphologically abnormal19. 
As a long-term future direction, we also envision the muscle-neuron system described 
above as an inexpensive and easily modified platform that could be utilized for the examination 
of the macroscale effects of neurotoxins in vitro. Technological and scientific advancements over 
the past century have led to the development and usage of toxins as potential biological warfare 
agents. Of special interest are nerve agents, or biological toxins that affect the nervous system, 
by irreversibly phosphorylating and thus inhibiting acetylcholinesterase20. Because the inactive 
enzyme then cannot degrade acetylcholine (ACh) in the synaptic gap21, a toxic accumulation of 
ACh can occur. At the synapses (nicotinic, muscarinic, and within the central nervous system), 
synaptic transmission is eventually paralyzed20. The victim can then experience muscular 
weakness and skeletal muscle paralysis, and eventually may die from respiratory failure21. 
Another neurotoxin of specific interest is the botulinum neurotoxin (BoNT), a protein that is 
released from the microorganism Clostridium botulinum and which causes botulism, and is 
considered the most potent toxin known to humans.22 BoNTs bind to neurons and are 
internalized, initiating downstream effects that block the release of the neurotransmitter ACh at 
NMJs, leading to neuro- and muscular- paralysis with the potential for fatality23. The potentially 
large-scale lethal effects of such a powerful nerve agent as a bioweapon (even in small doses in 
the range of nanograms24) have become a serious threat in modern warfare with the potential for 
severe and adverse affects on public health, as well as high costs of cleanup22. Due to relative 
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availability and ease of production, as well as a robust and poisonous nature, the Center for 
Disease Control has listed BoNTs as a top threat24. 
The threat of nerve agents such as BoNT in modern biowarfare and bioterrorism requires 
the development and availability of rapid diagnosis and treatment technologies. Of particular 
necessity is the availability of an assay platform that can combine point-of-care testing24 without 
the high cost of live animal models. Our system allows for the study of effects on neurons, 
muscle, and the synapse, which is of particular use due to the development of antidotes that act 
on both the pre- and post-synaptic regions of the NMJ25. Moreover, the development of anti-
BoNT treatments demand a platform that can handle rapid and physiologically relevant outputs 
of drugs, antibodies, and therapeutics on living cell cultures. 
 
6.2.4 Incorporation of Other Cell Types and Functionalities  
As biological machines and systems increase in complexity, it will be imperative to 
design and coordinate the activity and function of multiple cell types. While ‘simple’ tasks such 
as net locomotion can be achieved with one cell type (cardiac or skeletal muscle), more 
complicated or specific tasks will require the integration of multiple cell types into clusters, 
networks, or systems (Figure 6.2). One example is a complex living biological machine that 
could detect an environmental or cancerous risk such as a toxin (requiring sensory neurons), 
move towards the threat (requiring force production from muscle and motor neurons), and 
neutralize the threat. Such an autonomous system would likely also require the addition of an 
exoskeleton for protection and longevity, a supply of media, and the ability to operate at room 
temperature or atmospheric conditions26.  
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6.3 Figures 
 
 
 
Figure 6.1. Long-term functionality of bio-bots cultured with ACA. (a) A bio-bot cultured with 
3x ACA exhibited spontaneous contraction of the muscle 7+ months after seeding, with pillar 
displacement ranging from 11-16 µm per twitch. (b) A bio-bot cultured with 3x ACA responded 
to electrical stimulation 7+ months after seeding (shown at 1 Hz and then 2 Hz) with global 
muscle contraction. All scale bars, 1 mm. (c) For bio-bots that had not ruptured at this time point, 
the passive tension measured at day 140 for 1x (n = 1) and 3x (n = 3) ACA was not statistically 
different from the tension measured on day 5. Plot represents mean ± SD. 
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Figure 6.2. As living biological machines increase in complexity, it will be imperative to 
integrate and coordinate multiple cell types, including (but not limited to) muscle for force 
production, neurons (motor and sensory) for sensing and processing, and endothelial cells for 
vasculature. Additionally, an exoskeleton would provide an additional layer of support and 
protection for long-term studies or atmospheric conditions. 	  
3D Printing 
Neurons 
Muscle 
Exoskeleton 
Vasculature 
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